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CHAPTER 1
-INTRODUCTION
INTRODUCTION
1.1 XENOBIOTIC METABOLISM
1.1.1 General
In the earth environment there exists an enormous number 
and variety of compounds, excreted from, secreted by, or from the 
carcasses of, microorgs-nisms, plants and animals, and from minerals. 
In recent years industrial man has made an increasing contribution 
towards this chemical complexity, both by his ingenuity in chemical 
synthesis and treatment of animal, vegetable and mineral products.
As a consequence, man and other animals are continuously 
exposed to a wide spectrum of compounds that are foreign to them. 
These compounds are often termed xenobiotics (from the Greek,
f >
meaning stranger to life). The majority'of such compounds have 
no nutritional potential and some are potentially toxic. The 
passage of xenobiotics into the body can occur by inhalation, 
ingestion or percutaneously.
Since the body's excretory mechanisms are geared to handling 
water soluble compounds, not lipid soluble ones, lipophilic 
xenobiotics must be converted by enzymes to more water-soluble 
compounds in order to be excreted. Frequently, but by no means 
invariably, these metabolites are less toxic than the parent 
compound.
1.1.2 Pathways of Xenobiotic Metabolism
The metabolism of xenobiotics is thought to occur in two 
phases: phase I (preconjugation) and phase II (conjugation)
(williams, I960).
The present study is concerned with various aspects of 
phase I metabolism and this aspect, therefore, will be given 
particular attention. The commonest phase I reactions in xeno­
biotic metabolism are oxidative, and may be visualised as 
hydroxylations (Gillette, I966); see Figure 1.1. The system 
bringing about hydroxylation has been termed a mixed function 
oxidase (Mason, 1957), since in the course of the reaction one 
oxygen atom of molecular oxygen is incorporated into the substrate 
and the other is used to form water. In the majority of cases, 
the above reactions occur in the liver endoplasmic reticulum by 
means of a haemoprotein (CO binding pigment) termed cytochrome P450 
(Coon et , 1973; Es tab rook ^  , 1973).
Cytochrome P450 has a tetrapyrrole prosthetic group 
containing ionic iron (termed protohaem) either in the ferrous 
(Pe++) or ferric (Fe+++) state, while the four nitrogen atoms of 
the tetrapyrrole are considered to bind to the iron. This complex 
is believed to be associated with microsomal lipoprotein.
FIGURE 1.1
The Means by Which a Variety of Drug Metabolism Reactions mav 
be Brought About by a Common Mechanism (After Gillette. 196o)
1. Aromatic hydroxylation 
E - CgH^ R - CgH OH
2. Aliphatic hydi’oxylation
R - CH — H  R _ CHgOH
3. Q-dealkylation
R - 0 - CH —
4. N-demethylation*
R - NH - CH_ 9£..>,
R - 0 - CHgOH ->R - OH + CH O
R - NH - CHg - OH d R - NHg + CHgO
5. Dearoination*
R - CH(NHg) - CH
6, S-oxidation^
R - C(NHg) - CH, R - CO - CHj + NHj
7. N-oxidation*
R - SOH - R'
(ch^)jN_T!Îj (CH^) N=0 + H"^
Not necessarily cytochrome P450 dependent reactions. 
C ]Postulated intermediates.
Cytochrome P450 is found in a wide variety of tissues and 
species, underlining its significance in biology.
In the case of the cytochrome P450 dependent metabolism 
systems, a wide variety of xenobiotics and compounds of physio­
logical importance act as substrates and NADPH is the pilmaiy 
electron donor. There is some evidence from both solubilized 
and reconstituted cytochrome P450 dependent systems that the 
stoichiometry of drug déméthylation complies with the above 
scheme (Lu and Goon, I968; Coon and Lu, I969; Autor ^  al.,
1973).
In recent years, a generalised hypothetical mechanism has 
evolved to describe reactions catalysed by cytochrome P450. Such 
a mechanism is shown in Figure 1.2, the individual steps being 
described below:
(1) The low spin form of cytochrome P450 (Fe+++) reacts with 
the organic substrate to form a high spin ferric substrate 
complex (Fee+++.S). It is likely that difference spectra 
are apparent at this stage.
(2) The feridc substrate complex (Fe+++,S) undergoes a one 
electron reduction, this donation occurring via NADPH
FIGURE 1.2
A Froposed Scheme for the Cyclic Reduction and Oxygenation 
Of Qytochrome PA50 During Interaction with Oxygen and Substrate
SOH Substrate
Fe
3+ (5)
Fe^ - SOH
3+
3+Fe
(2)
Fe^+ - Si.
Fe^+ - S
0.
Fe^ *^  - CO ^  Fe^+ - 8 
CO
2+Fe 8
e
After Estabrook ^  al.. 1973
cytochrome C reductase (Estabrook et al. , 1971 a ), a 
term largely synonymous with NADPH cytochrome P450 
reductase (Masters et al.. 1973).
(3) The ferrous substrate complex Pe++.S can react with 
carbon monoxide to form the GO complex (Fe++.CO), 
typified by an absorbance band at 450 nm, or the 
ferrous substrate complex can react with oxygen to
form a temaiy complex of haem iron, oxygen and substrate 
(Fe^+OgS) termed 03cycytochrome P450.
(4) The oxycytochrome P450 may then react with an electron 
transfer component undergoing a second stage of reduction 
and forming an as yet unidentified intermediate. The 
formation of distinct spectral species displaying 
absorptions at 440 and 490 nm have been linked with this 
intermediate (Estabrook et , 1971 a ). The 440 nm 
species has been partially characterised (Estabrook et 
al., 1971 bj Hildebrandt and Estabrook, 1971; Illing
Gt , 1974). Both cytochrome b5 and P450 reductase 
have been implicated in electron transport at this stage 
(Baron ^  al. , 1973; Estabrook et , 197I a, Hildebrandt 
and Estabrook, 1971).
(5) The cycle of cytochrome P450 reduction is completed 
by insertion of one atom of the bound molecular oxygen 
into the substrate, the other being incorporated in 
water.
1.1.3 The Reduction of Cytochrome P450
The pathway of electron transport from reduced pyridine 
nucleotide to cytochrome P450 is far from clear. Evidence has 
been presented to show that a flavoprotein termed NADPH cytochrome 
c reductase functions in the primary step of reduced pyridine 
nucleotide dehydrogenation (Ernster and Orrenius, I965; Masters 
et al. , I97I; Lu et , 19&9).
From a variety of evidence, Estabrook et (1973) concluded 
that liver microsomes contain an additional electron acceptor 
reducible by NADPH but not NADH. The chemical nature of such an 
additional acceptor may be the link mediating electron transport 
between the NADPH flavoprotein dehydrogenase and cytochrome P450 
(Ichikawa and Yamano, 1972; Hoffstrom et al., 1972).
It has also been demonstrated by Masters and Ziegler (l97l) 
that two NADPH dependent electron transport systems exist in 
porcine liver microsomal preparations, containing separate and 
distinct flavoproteins (Figure 1, 3 }. Theæ have been termed NADPH 
cytochrome c reductase. The second flavoprotein has been implicated 
with NADPH dependent mixed function amine oxidase (N-oxidase).
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1.1,4 N-oxidation
Bickel (1969, 1971), Jenner (l97l) and Uehleke (196I, I969) 
have demonstrated both in vivo and vitro that a large number 
of secondaiy and tertiary amines will undergo N-oxidation, while 
for primary amines, although the picture is more complicated, the 
same appears to be true (Kiese, I966; Miller and Miller, I969;
Booth and Boy land, I964). From a review of the literature there 
appears to be little agreement as to the significance of N-oxidation 
in the metabolism of different types of drugs; most investigators 
agree, however, that N-oxidation of polycyclic arylamines is respon­
sible for many of the toxic effects observed.
A mixed function oxidase that catalyses the N-oxidation of a 
large number of amines has been isolated from pig hepatic microsomal 
preparations (Ziegler and Mitchell, 1972). The isolated oxidase 
appears to be a flavoprotein conplex free of cytochromes, copper, 
iron and NADPH cytochrome c reductase. In addition, the isolated 
oxidase has been shown to be imraunologically distinct from 
cytochrome c reductase (Masters and Ziegler, 1971) while CO and
r .
SKP 525A produce no inhibition and phenobarbitone no induction 
(Bickel, 1971b).
' \ ' 
At least two dites, one catalytic, one regulatory, have
been reported that can interact with amines (Ziegler ad. , 197l).
A number of secondary and tertiary ally lamines appear to combine
with both sites. Secondary and tertiary derivatives of aniline
combine with the catalytic site; primary alky lamines appear to
combine 7/ith the regulatory site and activate the system. In
addition to primary amines, corrpounds containing a guanidine
group are effective oxidase activators; peptide hormones produce
similar effects (Ziegler et ai,, 1973). Ziegler has proposed
that the primary function of this enzyme is the establishment of
disulphide bridges in serum albumin.
1-1. 5 Precarcinogens and Proximate Carcinogens, their Activating 
and Inactivating Metabolism
Occasionally xenobiotics, although undergoing metabolism 
via a typical oxidative reaction, are initially transformed to 
potentially hazardous agents with greater toxicity than the 
parent canpound.
This concept, that innocuous chemicals may be converted in 
the body to highly toxic products, was first clearly defined by 
R.A. Peters, who introduced the term "lethal synthesis" to describe 
the process (Peters, I963). These "active metabolites" may
manifest their toxic action through combination with tissue 
proteins or nucleic acids to produce allergies, tissue lesions, 
genetic mutation or cancer (Levine, I966; Judah al. ,1970; 
Miller, 1970).
Polycyclic Hydrocarbons
Pullman and Pullman (1955) have suggested that for 
polycyclic hydrocarbons to have carcinogenic activity, 
possession of one C-C linkage having a double bond rather 
than aromatic character is essential. This double bond 
takes part in addition reactions in the so-called K region 
(Krebs = cancer)i There is also a second region in the 
molecule, the L region, containing active centres, recog­
nised by ease of substitution reactions (Figure 1,4)
(Pullman and Pullman, 1955; Daudel and Daudel, I966).
It is not ccmpletely certain that metabolic activation 
is necessary for carcinogenesis ty hydrocarbons, but most 
of the evidence supports this hypothesis (Arcos and Argus, 
1968; Boj»^ land, 1969), and metabolism of the carcinogen is 
known to be necessary to elicit its mutagenic activity 
(Ames j^,, 1973).
1 3
Boyland (1950) suggested that epoxides are formed 
during the metabolic activation of some double bonds of 
the molecule, and that these reactive products are responsible 
for the induction of cancer. In this simple foim, this 
hypothesis does not, however, explain why certain methyl 
substituted polycyclic hydrocarbons have greater carcinogenic 
potency than the unsubstituted cfcmpounds. Dipple et (1968) 
suggested that the introduction of methyl groups may lead to 
increased foimation of cations from the epoxides, while 
Nagata et jed. (I967) suggested that cations might arise from 
free radicals which have been shown to be produced from 
polycyclic hydrocarbons by tissue homogenates.
Demonstration of epoxide formation is complicated by 
the presence of epoxide hydras es which are inducible enzymes 
that catalyse the conversion of epoxides to dihydrodiols and 
have been claimed to inactivate the carcinogenic and cytotoxic 
metabolites (Oesch, 1972).
Direct evidence for the foimation of epoxides has
been obtained from a number of sources, including the use of 
3
H labelled polycyclic hydrocarbons in the presence of
epoxide hydrase inhibitors such as 3,4,dihydronaphthalene-
14
1,2,oxide (Grover et al., 197l) or after controlled heat 
treatment of microsomes to inactivate epoxide hydra.se 
(Selkirk et al., 1971 ). Indirect evidence for epoxide 
formations is deduced from the formation of dihydrodiols, 
phenols (Figure 1.4) (Beyland, E. and Chasseud, L.F., 1969).
The significance of the above work to carcinogenicity 
has, however, been questioned (Baird and Brookes, 1973;
Baird et al., 1973, 1975). These workers have examined the
3 ■
DNA of mouse embiyo cells treated with [. h1 7 , methylbenz[a3 
anthracene ,5,6-oxide (the K region epoxide). They concluded 
that their findings did not support mechanisms of binding of 
7-methylbenz [a] , anthracene to DNA in cells that require 
metabolic activation of the methyl group or the formation 
of a K-region epoxide. *
Despite these objections, the metabolic pathways shown 
in Figure, 1.4 provide a good example of various possible 
fates of a chemically and biologically active product formed 
in the endoplasmic reticulum, and hovr the extent of reaction 
with biologically impoitant sites can be influenced by the 
relative rates of enzymic formation of the product and its 
further metabolism by other enzyme stems.
1 5
FIGURE 1.4
Metabolism of Benz(a)anthracene at the K Region
Microsomal mixed 
function oxidase
■H.K region epoxide
Qytoplasmic glutathione-8- 
epoxide transferase + /
G.S.H. /
microsomal epoxide- 
V hydrase
Reduction with 
cellular consti- 
" tutents.
Dihydrodiol
S-CH_.CH.GO.Gly
HO
Glu
Phenolic compound
After Magee, 1974.
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Aflatoxins
As with the polyqyclic hydrocarbons, the bulk of the 
evidence suggests that metabolic activation is a requirement 
for carcinogenesis and mutagenesis.
Incubation of aflatoxin with microsomal prepa­
rations from rat or hamster plus NADPH lead to the formation 
of a reactive derivative that is toxic and mutagenic to DNA 
repair deficient bacteria (Gamer et al.. 1972; Gamer and 
Wilght, 1973; Gamer, 1973 a,b). Under similar conditions 
incubation of labelled aflatoxin leads to binding of 
radioactivity to DNA, RNA and polyribonucleotides (Gamer,
1973a). It has been suggested that the reactive metabolite 
may be the epoxide 2,3-epoxyaflatoxin B% (Figure 1.5) and 
that this might be the ultimate carcinogenic form of aflatoxin, 
Safrole
Safrole (4-allyl-l,2,methylene dioxybenzene) is a weak 
to moderately potent hepatocarcinogen. Borchert et al.
(1973a,b) have identified 1 'hydroxysafrole as a urinaiy 
metabolite of safrole in the rat, mouse, guinea pig and 
hamster after both oral and intraperitoneal safrole
1 7
FIGURE 1.5
Aflatoxin and Possible Proximate Metabolite
OGH
Aflatoxin B.
0 0
0
2,3 ,epo3çyaflatoxin.
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administration. 1 'hydroxysafrole had a greater carcinogenic 
potential than safrole and may be the proximate carcinogen 
which is metabolised further to the ultimate carcinogen, 
possibly I'acetoxysafrole, 1 'ketosafrole or the epoxide of 
1 *hydroxysafrole,
Harvey ^  jd. (1972 a, b) have demonstrated that the 
side chains of secorbarbital and related barbiturates are 
metabolised by the epoxy-diol pathv/ay. Stillwell et al.
(1974) reported the presence of a metabolite diol; 1,2- 
methylenedio3qy-4-(2,3-dihydro3q7propyl benzene) was present 
in unconjugated fractions in amounts coup arable to I'hydrojcy- 
safrole.
■ 1.2 .
1.2.1 Induction of Xenobiotic Metabolising Enzymes
Enzyme control mechanism may be classified into two broad 
categories. Firstly, there are those factors that regulate the 
amount of enzyme protein, and secondly, factors that affect the 
enzymic activity of specific protein without a quantitative change 
in the amount of protein.
As the levels of xenobiotic metabolising enzymes in liver 
are important for either their detoxification or "lethal synthesis".
1 9
changes m  the factors outlined above will have a profound effect 
upon toxicity. For example. Figure 1,6 shows that pretrea.tment of 
rats with the potent enzyme indueer3”methylcholanthrene markedly 
decreases the acute toxicity of a number of conpounds, even though 
itself may be regarded as a carcinogenic hazard. On the other 
hand, the insecticide schradan is an example of compounds that are 
relatively non-toxic until they are metabolised by the liver mixed 
function oxidase system to active metabolites.
Induction with Phenobarbitone and Polycyclic HydrocArhons
Preliminary studies on the mechanism of induction of micro­
somal enzymes indicated that the effects of polycyclic hydrocarbons 
differed from that of phenobarbitone in a number of wgys. For 
example, thioacetamide blocks the effects of phenobarbitone but 
not those of 3-methylcholanthrene (Sladek and Mannering, 1969),
Phenobarbitone increases the metabolism of many drug substrates 
of microsomal enzymes, whereas polycyclic hydrocarbons increase the 
metabolism of relatively few of them (Conney, A.H., I967). The 
effects of phenobarbitone and 3“*methylcholanthrene appear to be 
additive on the metabolism of drugs whose metabolism is increased 
by either inducer even when large dosages are employed (Brindleman 
and Mannering, 1970; Gram and Gillette, 197l)« A similar situation 
occurs in cell cultures (Gielen and Nebert, 1971),
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In phenobarbitone and 3-methylcholanthrene pretreated animals, 
significant differences in 3,4-benzpyrene metabolite patterns 
occurred (Holder et al.. 1974). The polycyclic hydrocarbons 
increased the amount of cytochrcme P450 (Sladek and ÏAannering, 1966; 
Hildebrandt , 1968) but did not increase the amount of NADPH
cytochrome C reductase (Hernandez et al, 1967; Van der Decken and 
Huttin, i960), whereas phenobarbitone increased both parameters 
(Orrenius et al.. 1965; Remmer and Merker, I965).
Phenobarbitone induced cytochrome P450 shows spectral 
absorption maxima at 450 nm with carbon monoxide as ligand or at 
430 and 455 nm with ethyl isocyanide. In contrast, 3-methylcholan- 
threne induces a hepatic microsomal haemoprotein with a maximum with 
carbon monoxide at 448 nm, and at 455 nm but not 430 nm with ethyl 
isocyanide (Alvares ^  , 1967; Sladek and Mannering, I966).
Using a reconstituted hydroxylation system, it has been shown 
that enzyme systems prepared from phenobarbitone and 3-methylcholan­
threne treated immature rats exhibited different substrate specificities, 
and that such specificities reside primarily in the cytochrome 
fraction rather than in the reductase or lipid fraction (Lu et al.,
1969, 1972). It was concluded from these studies that the cytochrcxne 
P450 fraction prepared from rats treated with phenobarbitone is 
catalytically different from cytochrome PV^ -S fraction detectable 
after pretreatment with 3-methylcholanthrene,
2 2
Using either pretreated animals or partially purified 
cytochrome P448 fractions, data was indicative that 3-methylcholan­
threne administration resulted in the formation of a new haemoprotein 
and that this cytochrome - cytochrome P448 or Pi450 - is not a 
result of the binding of 3-mQthylcholanthrene or its metabolites 
to the native cytochrome P450 (Alvares et , 1971 a,b ; Fujita 
et al^, 1973).
An alternative approach has been to investigate the properties 
of cytochrome P420, the degradation product of cytochrome P450, 
from 3-methylcholanthrene and phenobarbitone induced rats; here 
again the evidence pointed towards the formation of a new haemoprotein . 
being induced by 3-methylcholanthrene (Shoeman ^  al, , 1973),
1.2.3 Animal Pretreatment and the Protein - Lipid Environment
Changes in the protein-lipid interaction of rat endoplasmic 
reticulum have been investigated after 3-methylcholanthrene and 
phenobarbitone pretreatment. Early reports indicated that pre­
treatment with phenobarbitone increases the amount of endoplasmic 
reticulum, especially the smooth endoplasmic reticulum (Remmer ^  
al., 1961, 1963). Di-Augustine et. (1970), however, found no 
changes in substrate membrane interaction at 20° in 3-methylcholan- 
threne or phenobarbitone compared with induced animals using the 
fluorescent probe ANS (1-aniline naphthalene sulphonate).
' , 2 3
In later studies, however, (laitinen et , 1974, who again
utilised a n s ) the fluorescent pattern was different in microsomes 
obtained from 3-methylcholanthrene pretreated animals when compared 
to those that had received phenobarbitone. This study was carried 
out at 40 . The authors suggested that phenobarbitone administration 
changes the protein-interaction of the endoplasmic reticulum.
1.2.4 Induction Mechanisms for Phenobarbitone and 3-Methvlcholanthrene 
Mediated Increases in Enzyme Activity
Numerous attempts have been made to elucidate the molecular 
basis for the phenomenon of induction. Conney and Gilman (1963) 
shov/ed that enzyme induction could be inhibited by purorcycin and 
actinomycin D, implicating protein synthesis. Incorporation studies 
using labelled amino-acids supported this view (Kato et , I965). 
Administration of both 3-methylcholanthrene and phenobarbitone have 
been shown in rats to stimulate hepatic RNA-polyraerase activity 
(Gelboin ^  , 19&7), chromatin and nuclear template activity
( G e l b o i n ,  I 9 6 4 ; B re snick, 1970; Matsuraura and Omura, 1975).
A number of elaborate studies have been published which indi­
cate the importance of control of protein synthesis at the initiation . 
level (Miller and Schweet, I968; Brawerman et al., I969; Heywood,
1970), while Lanclos and Bresnick (1973) have provided a first 
insight into the effect of 3-methylcholanthrene upon the translational
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control mechanism by either controlling the rate of polyribosome 
formation or by the selection of specific messenger RI^ A.
Phenobarbitone has been shown to affect the catabolism of M-RNA 
in liver cells, but this drug-induced change in the apparent 
stability of M-RNA for microsomal enzymes does not seem to be 
directly related to the specific induction of microsomal enzymes 
(Matsumura and Omura, 1973).
Several lines of evidence suggest that alternative mechanisms 
may also contribute to the induction of drug metabolising enzyme 
systems. Phenobarbitone induction may be related to suppression 
of degradative enzymes, since hepatic microsomal components are 
reported to accumulate following phenobarbitone treatment, and 
through the stabilisation of preexisting protein (Jick and 
Schuster, 1966; Schenkraan, 1970).
Lechner and Pousada (l97l) have suggested that induction of 
hepatic microsomal enzymes by phenobarbitone is associated with 
an inhibition of microsomal ribonuclease activity. This inhibition 
has been correlated with reduction of microsomal RNA breakdown 
(Mycek, 1971) and stabilisation of hepatic ribosomal RNA (Cohen 
and Ruddon, 1970). No inhibition of microsomal ribonuclease 
activity was detectable after 3-metlylcholanthrene pretreatment 
(Louis-Ferdinand and Fuller/ 1972).
1.2.5 In Vitro Enhancement of Drug Metnbol i mm
An enhancement of drug metabolism may be defined as an 
increased rate of in vitro drug metabolism observed following 
the addition of other drugs or chemicals in the reaction mixture. 
This terra should be distinguished from the enzyme induction 
resulting from treatment of intact animals with other drugs or 
hydrocarbons involving de novo synthesis of enzyme. A number of 
drug metabolism systems have been reported to be enhanced by the 
addition of various chemical compounds; these are reviewed below.
Imai and Sato (1966a, 1968a) reported that ethyl isocyanide 
exerts both an inhibitoiy and a stimulatoiy effect upon microsomal 
aniline hydroxylase activity^ Increasing substrate concentration 
necessitated increasing ethyl isocyanide concentration to maintain 
maximal enhancement* Species differences were also apparent, 
maximal activity being observed in rabbit hepatic microsomes.
No enhancement could be produced using guinea pig microsomes, and 
results obtained from rat liver microsomes were intermediate 
between the two.
The enhancement appeared to be pH dependent (iraai and Sato,
- ' 
1966), and it was suggested that ethyl isocyanide exerts its effect
by promoting the rate of P450 reduction (imai and Sato, 1968b).
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200-30C^ of aniline hydroxylase enhancement can be produced 
\jy acetone and 2,2'bipyridine (Anders, I968, I969; Buhler and 
Rasmussen, I968), greatest activity being shown in rat hepatic 
microsomes, with rabbit being intermediate in sensitivity and 
mouse and dog lowest.
Aniline hydroxylation increase is due to decrease in both 
Km and Vmax (Anders, I969). Studies of the effect of acetone on 
the enhancement of 2,2 'bipyridine shov/ed that these agents did 
not produce an additive stimulation (Anders, 1971), indicating , 
that both conpounds stimulate aniline hydroxylase by the same 
mechanism. On the other hand, acetone only partially blocks the 
enhancing effect of 2,2'bipyridine.
Enhancements of aniline hydroxylase have been repoited in 
hepatic microsomes prepared from phenobarbitone and 3-raethyl- 
cholanthrene pretreated rats. Halothane, methoxyfluorane, diethyl 
ether and chloroform all enhance aniline hydroxylase (Van Dyke 
and Rikans, 1970; Korten and Van Dyke, 1973) J decreases in Km 
and Vmax being reported in phenobarbitone treated rats but not in 
methylcholanthrene treated rats.
A further complication in understanding the mechanism of 
enhancement of aniline hydroxylase has been reported ty Schenkman et 
-ÊÏ' » (1974) who found that urethsuie produced enhancement in liver
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tissue slices but not in hepatic microsomes or perfused liver; 
no explanation was offered for this phenomenon!
In mazy respects, reports of the enhancement of acetanilide 
hydroxylase appear to show parallels with aniline hydroxylase, 
with 2,2‘bipyridine and acetone producing a similar response to 
those elicited in aniline hydroxylase enhancement (Anders, 1972). 
Furthermore, metyrapone produces enhancements of acetanilide 
hydroxylase (leibman and Ortiz, 1973) and aniline hydroxylase 
(Kahl ^  , 1972), although the latter required much higher
substrate concentrations. Acetone does not alter the binding 
spectrum of aniline in rat hepatic microsomes (Daly et , I969).
It should be noted that acetone itself failed to produce 
a binding spectrum in rat hepatic microsomes (McLean, I967), 
but did bind to rabbit microsomes at high concentrations (imai 
and Sato, 1967). Therefore, if it is aesumed that binding spectra 
reflect the interaction of aniline with the active site of the 
enzyme, it follows that acetone may be acting at another site in 
the pathway, possibly by enhancing the dissociation of the enzyme- 
substrate complex. The finding that acetone acted as an 
uncompetitive activator, as shown by the effects on the kinetics 
of the reaction (Kny^Vmax is constant), is in agreement with this 
type of mechanism.
.
This proposed mechanism does not explain why acetone does 
not have the same effect upon type I substrates, nor why such
high acetone concentrations (0.5 M) are required to enhance the
' -  . >
metabolism of type II substrates.
An enhancement of the reduction of p-nitrobenzoic acid 
has been reported (Pingell et al.. 1973). This occurred v/hen
Q
A -tetrahydrocannabiol was incubated with rat hepatic microsomes.
Gigon ^  al. (19&9), have reported that in a CO atmosphere, 
type I substrates accelerate the reduction of cytochrome P450, 
whereas type II substrates decelerate it. Moreover, NADPH 
oxidation in air was stimulated by type I substrates but was 
either unaffected or inhibited by type II substrates.
The activities of some membrane bound enzymes are enhanced 
by treatments which grossly modify the microsomal membrane. For 
exanple, mild treatment of rat liver microscme preparations with 
Triton X-100 (Lenders and Kuff, I967), deoxycholate (Winsnes,
1972), digitonin, sonic at ion ^phospholipase A (Vessey and Zakim,
1971), trypsin digestion (Hanninen and Pukka, 1970) or peroxidation 
of microsomal phospholipid (Hogberg et al., 1973), activates UDP- 
glucuronyltransferase activity as assayed with p-nitrophenol as 
substrate.
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According to the manner in which the lipid phase is 
modified, microsomal UDP-glucuronyltransferase with different 
kinetic parameters are produced, though each is activated compared 
with the activity in untreated microsomes.
It should he home in mind that in the 1950’s a wide 
variety of treatments and in vitro additions were shown to modity 
mitochondrial activity. Later it became apparent that many were 
of non-biological significance or were artefacts of the methodology 
enplcyed.
:
1.3*1 Biphenyl
In recent years, a growing inteiest in the metabolism of 
biphenyl and its chlorinated derivatives has been apparent.
Mich attention has centred upon polychlorinated biphenyls 
(PCBS), industrial chemicals with a variety of applications in the 
manufacture of insulations and plastics. The toxicity of these 
compounds for industrial workers has been known for years, such 
as the occupational disease known as chloracne (Jones and Alden,
1936; Schwartz, 1936; Meigs eb al., 1954). More recently the 
consumption of rice bran oil accidentally contaminated by PC© 
resulted in many oases of chloracne in Japanese consumers 
(Crow, 1970).
o  o
The widespread distribution of PCBS throughout the ecosystem 
has been demonstrated (Hannon ^  al. , 1970; Creichus ^  al., ±973) 
with accumulation occurring in the food chain, and it has been 
suggested that declining populations of several species of 
raptorial and fish eating birds can be attributed to PCBS 
(Carlson and Duby, 1973), while in rats, mice and dogs PCBS have 
been reported as toxic, and hepatocarcinogenic in mice (Nagasaki 
^  al., 1972)
The hepatic microsomal enzyme inducing capacity of PCBS 
is well documented. These compounds have been shown to induce 
hepatic microsomal enzymes in the pigeon (Risebrough ^  al. , 1968), 
rat (street _et al., 1969; Litterst et al., 1972; Chen and Dubois,
1973) and American kestrel (Linear and Peakall, 1970).
In mammalian species, biphenyl urinaiy metabolites include 
the 2-hydroxy, 4-hydroxy, 4,4’-dihydroxy, 2,2-ldihydro3y, 3,4-di­
hydroxy and conjugated derivatives. The major La vitro hepatic 
microsomal metabolite is 4-tydroxybiphenyl, but 2-hydroxylation 
also occurs in rat, rabbit and hamster (Figure 1.7) (Creaven et 
^ . , 1965b; Raig and Ammon, 1970; Burke et , 1972), whilst 
in rat cell culture the metabolites are almost totally conjugate 
(Wiebkin^ P., 1975).
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FIGURE 1.7 
Mammalian Biphenyl Metabolism in Vitro
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A variety of cytochrome P450 inhibitors inhibit biphenyl-4- 
hydroxylase to a greater extent than biphenyi-2-hydro:jylase; 
inhibitors studied include carbon monoxide, metyrapone, SKF 525A 
and styrene oxide. Bipheny1-2-hydroxylase can utilise NADH; 
bipheryl-4-hydroxylase cannot (Burke, 19 73 ). Furthermore, 
in developing rats biphenyl-2- and -4-hydroxylation reach a 
maximum activity between 21 and 24 days ; after that biphenyl-2- 
lydroxylase activity drops more rapidly than bipheiy 1-4-hydroxylase 
as the animal ages (Basu .âi* » 197l). Thus different properties 
can be ascribed to biphenyl-2- and -4-tydro3ylation, and this 
indicates that the enzyme systems involved in the 2-hydroxylation 
and 4-tydroxylation of biphenyl are discrete entities.
Phenobarbitone and other drugs selectively induced biphery 1-4-; 
hydro3qylation, whilst carcinogenic polycyclic hydrocarbons were 
reported to selectively induce biphenyl-2-hydroxylation (Creaven 
and Parke, 1966). More recently Hook et al. (1975) reported that 
2,3,7,8-tetrachlorodibenz-p-dioxin induced biphenyl-2-hydroxylase 
by lOOC^ and bipheny 1-4-hydroxylase by 100^.
Epstein et (1970) reported that safrole and other 
methylenedioxyphenyl compounds enhanced biphenyl-2-hydro%ylase 
activity in vitro; the authors suggested that an allosteric 
conversion of biphery 1-4-hydroxylase to bipheny 1-2-hydroxylase 
occurred.
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Thus the possibility exists that potential carcinogens 
couid be detected lay their differential effects upon bipheny 1-2- 
hydrbxylasé.
The main theme of this thesis is to ascertain the validity 
of this lypothesis and to attempt to gain more information as to 
the mechanism of action of biphenyl-2-lydroxylase.
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CHAPTER 2
MATERIALS Aim METHODS
2.1 MATERIALS
2.1.1 Chemicals
Biphenyl was twice reclystallised from 96^ ethanol (m,p. 69°-70°), 
2-hydroxybiphenyI was reciystallised from 100-120 light petroleum to 
m,p. 56°-57°, 4-hydroxybipheryl was reciystallised from methanol to 
ra.p, 166°-167®.
NADPH, NADH arid glucose-6-phosphate dehydrogenase were supplied 
by Sigma Biochemicals Ltd, (London); NADP and glucose-6-phosphate 
were purchased from P. & L. Biochemicals Ltd., Milwaukee, U.S.A. All 
other conpounds, including chemical carcinogens, were of the highest 
available commercial purity.
2.1.2 Species
Syrian hamsters, pure line, gold strain, category 2, Wistar 
Albino rats and strain A/2 white mice were provided by the University 
of Surrey Anjjnal Unit,
Animals were bedded as litter, mate cage groups on sterolit 
bedding (Englehaid Coip, , Edison, N.J., U.S.A.), with water and food 
ad libitum. Envilonmental conditions were regulated with a constant 
tenperature (22 ), humidity (56^) and lighting (12 h. alternating 
light and dark).
For plant tissue studies, ripe Avocado pears were obtained from 
commercial retail outlets in the Guildford area.
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Eschericia Coll strain K 12 (kc 600, thre“, leu~, bi", lue” SM^) 
was kindly provided by Miss P. Hopgood (Liverpool Polytechnic). 
Saccharonyces cerevisiae was provided by Dr. A. Wiseman of this 
department.
2.2 METHODS
2.2.1 Animal Pretreatment
Conpounds studied for th eir effects in vivo were normally 
administered as a single intraperitoneal dose (usually 75 mg/kg body 
weight), utilising either groundnut oil or 1,15^ (w/v) aqueous KOI as 
carrier. Similar volumes of vehicle were given to control animals.
In one series of experiments a second dose of 3 j^—benzpyrene was 
administered 6 h. after the first. Actinomycin D (l mg/ g) was admini­
stered intraperitoneally immediately after a single dose of 3,4-benzpyrene 
where appropriate.
Long-term feeding studies were carried out by using Spratts 
powdered diet No, 1 containing 5^ (w/v) safrole, daily ^  libitum, 
while normal powdered lab. diet was provided for the control groups.
Fresh diet was prepared daily.
2.2.2 Transplantation of Tumours
Hepatoma was excised from hooded rats and the fibrous capsule 
removed and discarded. The outer viable region of the tumour was 
suspended in ice-cold P.B.S. (phosphate buffered saline, pH 7,4) and
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a single cell suspension was obtained by two passes with a large, 
loose-fitting Potter hand-homogeniser.
A sample of the cell suspension was examined microscopically 
and a viable cell count performed using trypan blue exclusion in a 
haemocy tometer,
8
The viable cell count was adjusted to 5 x 10 cells/ml in 
phosphate buffered saline, pH 7»4, and 0,1 ml of this suspension was 
injected subcutaneously into the right flank of hooded rats in the 
region of the thoracic cavity. The animals were then caged in groups 
of six and the tumours allowed to develop,
2*2.3 lÆlcrosomal Preparations in Mammals by Differentini Centrifugation
f
Animals were killed by cervical dislocation. Livers were rapidly 
removed and placed in chilled 1,15^ (w/v) KOI, and excess blood was 
washed off. All subsequent operations were carried out at 4^. The 
livers were then dried on filter paper and transferred to pre-weighed 
beakers containing 10 ml of 1.15% KOI buffered to pH 7.6 with 0.1 M 
potassium sodium phosphate.
Weighed livers were then scissor chopped and transferred into 
a Potter-Elvejhem homogeniser. Sufficient KOI was added to give a 
total of 4 ml per gm wet %ight of liver. The livers were then homo­
genised using a power driven pestle (2400 rg^).
The resultant homogenate was washed into 50 ml polycarbonate 
centrifuge tubes, and the homogenate centrifuged at 10,000 gay for
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10 minutes to sediment nuclei and mitochondria. The resultant
10.000 g supernatant was either used or poured into 25 ml polycarbonate 
centrifuge tubes and centrifuged at 105,000 gay for one hour to sediment 
the microsomal fraction. The supernatant fraction was discarded and 
the pellet scooped into a Potter homogeniser, where washing was carried 
out by homogenisation with 1.15^ KOI buffered to pH 7,6 with 0.1 M 
potassium sodium phosphate. The homogenate was recentrifuged at
105.000 gav for one hour. The supernatant was again decanted and thé 
pellet resuspended by homogenisation in 1.15% KOI buffered to pH 7*6, 
such that 1 ml of homogenate was equivalent to 1 gm wet weight of 
liver.
2,2.4 Microsomal Preparations in Mammals by Isoelectric Precipitation
To a post mitochondrial supernatant, prepared as described above, 
was added sufficient 0.2 M acetate buffer, pH 4.0, to lower the pH 
to 5.4. The aggregated microsomes were collected by centrifugation 
at 10,000 gav for 10 minutes. The pellet was washed by resuspension 
in 1.15^ (w/v) KGl glycerol (4 Iv/v), the pH was readjusted to 5.4 
and the suspension recentrifuged. The final pellet was resuspended 
in 0,1 M phosphate buffer, pH 7.4 , glycerol (4 Iv/r) to a final 
concentration of 1 gm liver equivalent per ml of microsomal suspension.
Preparative Procedure for the Production of Hepatic 
Microsomes by Isoelectric Precipitation
Postmitochondrial supernatant from 
liver homogenate (25^ w/v in 1.15% KCl)
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V
Discard supernatant
pH lowered to 5*4 with 
acetate buffer (0.2 M, 
pH 4.0)
Centrifuged 10,000 gav 
(lO minutes)
N /
Pellet
wash, recentrifuge
10,000 g^ av (10 ndns. )
N/
Discard supernatant
\l/
Pellet
\|/
Resuspend in 0.1 M phosphate 
buffer pH 7.4/glycine 
(4:1 v/v)
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2.2.5 Preparation of Rat Intestinal Epithelial Cell Microsomes
(From Harrison and Webster 1969, further modified by Shirkqjr I975).
After sacrifice of the animal, an incision was made immediately 
below the pyloric sphincter and a polythene cannula inserted. The 
intestine was filled with chilled (0^-4^) saline. The cannula was 
quickly withdrawn and the intestine clamped while cutting away the 
mesentaiy.
After cutting the intestine at the aboral end, the intestinal 
contents were flushed out with saline solution. Lengths of washed 
intestine (approx, 15 cm) were everted onto metal rods attached to à 
Vibromixer model E.I. (from A, G, Clemap, Zurich), They were vibrated 
vertically at a frequency of 100 Hz at an amplitude of 1,5 mm for 
one minute at 4 in 0.14 M NaCl. This medium, which contains mucus 
and acellular material, was discarded; the intestine was then further 
vibrated for 30 minutes in 0,l4 M NaCl containing 5 mî^  EDTA, pH 7.4.
The resultant cell suspension was centrifuged at 200 gjnax^  for one 
minute and the pellet was resuspended in 0.3 M sucrose, pH 7.4. The 
fractionation scheme then followed is outlined belcw,
2.2.6 Preparation of Rodent Lung Microsoroes 
(After Matsubara et al. 1974),
Animals were sacrificed and the lungs removed and placed in 
chilled 1,15% (w/v), 0,05 M Tris-HCl, pH 7.4, After removal of excess
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Preparative Procedure for the Production of Intestinal 
Epithelial Cell Microsones
Epithelial cells 
Homogenise (Potter 10-12 strokes 
60 secs, in 75 mM sucrose), PH 
adjusted to isotoniciiy. Diluted to \iy 
approx. 1 in 20. Centrifuged 
at 1500 X graax for 10 mins.
N/
Supernatant
V
Pellet, washed twice in 0,3M
sucrose and recentrifuged
\/
v
Supernatant
N/
Pellet discarded
/
s'
X /
Centrifuged 12p00 gmax x 10 minutes
A
Supernatant Pellet, washed in /J: volume of
0,3 M sucrose; recentrifuged,i
Supernatant
Nl/
Pellet discarded.
^ - —  -I
pH adjusted to 5,0 with sodium acetate buffer 
(pH 4,0), centrifuged at 23,000 x ©nax for 
10 minutes.
\k
Supernatant
N/
Pellet (microsomal)
\1/
Resuspended in 0,1 M tris-HCl buffer, 
pH 7*4, containing 20fo v/v glycerol.
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connective tissue, the tissue was minced in a new volume of "buffered
KOI and homogenised with a Potter-Elvejhem horaogeniser.
The homogenised material was centrifuged at 600 gav^  for 10
minutes and the supernatant was recentrifuged at 15,000 gav for 20
minutes. The pellet was discarded and the supernatant centrifuged at
105,000 gay, for one hour. The resultant microsomal pellet was rehomo- .
genised in 1 mM Tris-HCl, pH 7*4, and centrifuged at 105,000 gav for
a further 60 minutes. The final pellet was rehomogenised in 1 mLÎ
Tris-HCl "buffer to give a final concentration of 5 mg microsomal
protein per ml.
2.2.7 Preparation of E. Coli Spheroolasts
Cells were grown at 37° for 18 hours in 250 ml conical flasks
containing 100 ml of the following medium: HH Cl 20 g/l, NH/NO, 4 g/'l,
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NagSO^ anhydrous 8 g/l, K^HP0^12 g/l, KH^PO^ 4 g/l, %80, .7H0 0.4 g/l, 
threonine 200 mg/l, leucine 200 mg/l, thiamine hydrochloride 0.01 mg/l, 
sucrose 20% (W/V),
The sterile nutrient was then innoculated with the a"bo\’^e cell 
suspension (15/100 ml). Cells were harvested in the late log. phase 
and washed twice with 0,08 M phosphate buffer, pH 7.2, in readiness 
for spheroplast formation.
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Spheroplasts were , prepared by the Lysozyme -EDTA method of 
Gunthrie and Sinheimer (1963); the rate of spheroplast formation 
was estimated using a haeraocytometer, 95^ formation being observed 
after six minutes.
2.2.8 Preparation of Yeast Microsomes
Yeast was grown at 37° in sterile shake culture (50 revs/min.) 
in a medium containing 20% (w/v) glucose, it (w/v) yeast extract, 0.5^ 
(w/v) NaCl and 2% (w/v) peptone. Cells were harvested in the late log, 
phase of growth 40 hours after innoculation, by centrifugation.
Preparation of yeast cell microsomes was commenced bj»’ means of 
a Vibro mill which disrupted cells after six minutes treatment. 
"Microsomal fractions" were obtained by centrifugation of the dis­
rupted cells at 105,000 gav for one hour. The resultant pellet was 
washed with 0.1 M phosphate buffer, pH 7*4, by homogenisation and 
again centrifuged at 105,000 gav, for one hour. The washed pellet 
was finally resuspended in 1* 15^ (w/v) KOI buffered to pH 7.4 to give 
a final protein concentration of 10 mgs/ml,
2.2.9 Electron Microscopy
Liver preparations were cut into 1 mm cubes. The sanples were 
fixed in 4^ w/v glutaraldehyde in 5^ w/v sodium cacodylate. Post 
fixation staining was carried out by means of 2^ w/v Osmium tetroxide
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treatment for one hour. Samples were dehydrated in an ascending 
series of alcohol concentrations, viz: 3C^, 5C^, 70^, 9C^ and lOQ^
(v/v), each for two periods of 15 minutes. Samples were embedded in 
Araldite epoxy resin and heated at 60° for 36 hours for solidification.
Ultra-thin sections were cut with LKB ultramicrotomes using 
glass knives, placed upon "grids" and stained with 2?^  w/v Uraryl 
acetate prior to viewing.
2.2.10 Protein Determination
Protein was determined by the procedure of Lowiy et al. 1951. 
Tissue suspensions were diluted with 0.5 U NaOH to contain approxi­
mately 100-150 pg/ml of protein. To 1 ml aliquots of this dilution 
5 ml of freshly prepared Lowiy reagent C (lOO pts. 2% Na«CO,;lpt. 
CuS0^.5H20 : 1 pt. sodium potassium tartrate) was added and mixed.
After 10 minutes 0.5 ml of Folin-Ciocalteau (diluted 1:3 with 
distilled water) was added and immediately vortex mixed. Suitable 
blanks (l ml 0.5 N NaOH) and protein standards (ciystalline bovine 
serum albumen fraction V in 0.5 N NaOH, range 50-250 jjg proteir/ml) 
were also carried through the above procedure. After 30 minutes, 
the blue colour produced was monitored at 720 nm on a Pye Unicem 
SPI8OO spectrophotometer.
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2.2.11 Biphenyl Hydroxylation Preincubation System
Hepatic microsomes (to give a final protein concentration of 
2 mg/ml) were added to an NADPHg regenerating system containing 
glucose-ô-phosphate (25 mM), NADP (500 mlÆ), glucose-6-phosphate 
dehydrogenase (2 units/ml) and magnesium sulphate (0,5 #l). The 
compounds under investigation were added in either 0.5 ml of groundnut 
oil or 1.15^ (w/v) KCl and the system preincubated for 10 minutes 
at 37 in a shaking water bath (lOO cycles/minute). After this 
preincubation period, biphenyl (13 ni/l in 0.5 ml of 1.15^ KOI containing 
1.53^  w/v Tween 80) was added and the incubation continued for a further 
five minutes. The reaction was terminated by the addition of 1 ml of
4 N HOI. Separate controls were included in eveiy study, either 
biphenyl or test substance was omitted from the system or test conpound 
was added after termination of the reaction.
The contents of all tubes were extracted with 7 ml of n-heptane 
(containing 1.53^  w/v isoanyl alcohol) on a rotaiy shaker for 10 
minutes. After mixing for this period, the tubes were centrifuged 
for 10 minutes at 2000 ipm (MSB Mistral 6l 6 x 1 litre swing-out 
rotor). 2 ml of the upper n-heptane layer was then extracted with
5 ml of 0.1 N MoOH for 10 minutes in a rotary shaker ani centrifuged 
for 20 minutes at 2000 ijpm. The upper n-heptane layer was aspirated
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off and the fluorescence of the aqueous layer was measured at pH 5*5 
by placing 2 ml of the aqueous layer in a fluorimetric cuvette and 
adding 0,5 ml of 0,5 N succinic acid. Using a Perkin-Elmer MPP-3 
fluorimeter, the fluorescence of 4~hydro3ybiphenyl v/as measured at 
275 nm excitation and 334 nm emission and that of 2-hydroxybiphenyl 
at 290 nm excitation and 415 nm emission. Using the relevant 
standards, the concentration of 4-hydroxy biphenyl could be determined 
directly. However, in the case of 2-hydroxybiphenyl a correction is 
required since a fluorescent contribution for the 4-hydroxy isomer 
occurs at 415 nm.
For this correction, 4~hydro:5ybiphenyl (l) and 2-hydroxybipheryl 
(2) standards are required, and the correction is carried out as 
follows. Let the amount of 4-Hydroxy biphenyl in the test be (x) and 
the amount in standard (l) be (Y). If the reading of standard (l) 
at 415 is (a), then the contribution of 4-hydroxybipheryl in the 
test at 415 nm is AX/f, If the reading of the test at 415 nm is (b), 
then the corrected reading (c) fob 2-hydroxybiphenyl is B(AX/l).
(Creaven et al. I965).
For kinetic studies the relevant substrate concentrations of 
biphenyl, 2-hydroxybiphenyl and 4-h/droxybiphenyl are shown in 
Table 2.1.
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TABLE 2.1
Biphenyl Concentrations for Investigations of the Effects of 
Preincubation with Carcinogens upon its Hydroxylation Kinetics
Stock concentration 
(mmol/ml)
0.27 0.40 0.533 0.80 1.33 4.0
Incubation content 
(nmol per 2 ml)
135 200 266 400 660 2000
Incubation
concentration
(mmol/l)
0.0675 0.1 0.133 0.2 0.33 1.0
TABLE 2.2
Hydroxybiphenyl Concentrations for Investigation of the 
Effects of Carcinogens upon their Hydroxylation Kinetics.
Stock concentration 0.016 0.027 0,04
(nraol/l)
Incubation content 
(nmol/2 ml)
Incubation
concentration
(mraol/l)
8.0 13.6 20.0
0.08 0.16 0.40
40,0 80.0 200.0
0,004 0.0068 0.01 0.02 0.04 0.10
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2,2,12 Microsomal Metabolism of C^Cj Biphenyl
biphenyl, specific activity 2,7 p Ci per mg, 99^ 
radiochemically and 9 ^  chemically pure, was kindly provided by 
Dr, A. Munro, Pfizer Ltd,, Sandwich, Kent, 0,5 ml of a 1 rmVl solution 
in 1.15/^  KGl plus 1.5!^  Tween 80 was added to the preincubation system 
in place of unlabelled biphenyl (Section 2.2,11). After termination 
of the reaction and extraction into 7 ml of n-heptane, 5 ml of the 
n-heptane extract was taken and evaporated to diyness at 40° by 
bubbling through with oxygen-free nitrogen. The residue was redis­
solved in 0.1 ml methanol containing 2 mg/ml of unlabelled biphepyl,
. 2-hydroxybiphenyl, 4-hydro)ybiphenyl, if4' dihydroxybiphenyl and 
22' dihydroxybiphenyl. 65 pi of the methanol extract was then applied 
to silica gel (Merck A.G,, Darmstadt, Germany) thin layer chroma­
tography plates, and developed in benzene:ethanol (93:5 v/v).
The hydroxybiphenyl metabolites and unchanged biphenyl were 
located by quenching at 254 ivn of the plates' inherent fluorescence. 
After location, the relevant areas were scraped into screw-top vials 
and washed three times with 5 ml aliquots of methanol.
The aliquots were pooled and evaporated to approximately 5 ml 
with oxygen-free nitrogen. This was then transferred to radioactive 
counting counting vials and evaporated to diyness. Then 10 ml of 
toluene triton XlOO scintillant containing 0,33% (w/v) PPG
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(2,5-diphenyloxazole) (Shaw et al,, 197l) was added. Counting was 
for 10 minutes and repeated at least three times for,each vial. 
Subsequently, addition of 0.1 ml toluene standard 5080 dpm.
allowed a counting efficiency to be calculated. An efficiency of 
11% was recorded.
2.2.13 Further Metabolism of 2- and 4-hydroxybipheny 1
The preincubation qystem described previously (2.2.11) was 
used, substituting 0.5 ml of either 2-}ydroxybiphenyl or 4-hydroxy- 
biphenyl for biphenyl. Solutions were emplqj'^ ed to give concentration 
range of 25 to 300 nmole per 2 ml of incubate. To study the effects 
of preincubation with carcinogens upon the kinetics of flirther 
metabolism of 2-hydro:!çybiphenyl and 4~hydro3ybiphenyl, substrate 
concentrations outlined in Table 2.2 v/ere emplcyed.
2.2él4 4-hvdroxvlation of Aniline
The method of Nakanishi et al. (I971) modified for studies in 
the hamster was enplcyed. Incubation mixtures (2 ml) comprised an 
NADPH regenei-ating system (glucose-6-phosphate 25 mLî, NADP 500 nm, 
glucose-6-phosphate dehydrogenase 2 units/ml and magnesium sulphate 
0.05 mM), microsomal protein 2 mg/ml, aniline hydrochloride 0.01 m^ I 
and 1,15^ KCl buffered to pH 7*4 with 0.3 M phosphate buffer. The 
reaction was initiated by addition of aniline hydrochloride and 
continued for 10 minutes in a shaking water bath at 37° under oxygen.
sc
The reaction was terminated by tlie addition of 5 ml diethyl ether 
(containing 1.5^ v/v isoanyl alcohol). The incubation ndxture was 
then saturated with NaCl and extracted for 30 minutes at room 
temperature with 10 ml diethyl ether. The phases were separated 
by centrifugation and the ether layer (7 ml) was extracted for 30 
minutes with 4 ml freshly prepared 0.5 M K^PO^ containing 0.5^ (w/v) 
phenol. Phases were again separated by centrifugation., the ether 
layer was aspirated off and the extinction of the lower layer 
determined at 630 nm. Standards consisted of heat inactivated micro­
somal incubation containing 0.1 ml of 0.5 4-aminophenol.
2.2.15 cytochrome b^ and P450
The cytochrome b^ and P450 concentrations were determined
according to the method of Ullrich (1969), using a îÿe Unicam SPI8OO.
Cytochrome concentrations were expressed as nmol/mg protein using
extinction coefficients of I70 mlî cm between 409 and 424 nm for
—1 ' -1
cytochrome b^ and 91 mM cm between 480 and 500 nm for cytochrome 
P450.
• . ; . '■ ^
2.2.16 NADPH- and NADH-Cytochrome c Reductase
The activities of NADPH- and NADH-cy tochrome c reductase were 
determined accoiding to the method of Masters et (1967), The 
reaction mixture in 2.8 mi contained 1.5 mg microsomal protein,
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150 p.mol phosphate "buffer, pH 7.4-, and 150 pmol ferricytochrome c.
The reaction was started by the addition of 100 pmol NADPH or NADH.
To examine the effects of test compounds upon this reaction in vitro, 
microsomes were preincubated with these compounds for 15 minutes at 37°.
2.2.17 Other Microsomal Enzymes
These were determined by the following procedures: 
p-nitrobenzoate reductase (Gingell, 1970); cytochrome P450 reductase 
(Oigon ^  , 1964) ; p-nitroanisole N*-demethylation (Netter and
Seidel, 1964); benzpyrene hydroxylase (Euntzman and Bruggerman, I966); 
7-ethoxycoumarin de-ethylase (Ullrich ani Weber, 1972); and ethoxy- 
resorufin de-ethylase (Burke and Mayer, 1974).
2.2.18 Microsomal Malonaldehvde Assay
Slater and Sawyer (1971) reported a good correlation between 
lipid peroxidation and malonaldehyde formation,
1 ml of a liver microsomal suspension equivalent to approxi­
mately 20 mg of protein was mixed with 2 ml 10^ (w/v) trichloroacetic 
acid (TCA), stood in ice for 15 minutes, and then centrifuged at 
2000 rpm for 10 minutes. 2 mi. of the supernatant was mixed with 2 ml 
of 0.6^  (w/v) thiobarbituric acid and heated in a boiling water bath 
for 10 minutes.
After cooling, the extinction was measured at 535 nm relative 
to a malonaldehyde bis-diethyl acetal standard containing 25 nir/ml.
The extinction was directly proportional to malonaldehyde concentration 
up to 25 nrr/ml assayed. The standard was prepared by diluting 1,1,3,3“ 
tetraethoxypropane in 6.7^ trichloroacetic acid, which liberates the 
malonaldehyde bis-diethyl acetal.
2.2.19 Glucose-6-phosphatase
Glucose-6-phosphatese was assayed in 1 ml final volume. 
Preparations were incubated for 30 minutes at 37° with 40 mM 
potassium glucose-6-phosphate, 20 mM histidine- HOI buffer, pH 6.5, 
and 1 mI,T EDTA (De Duve et , 1955). The reaction was stopped by 
the addition of 5 ml trichloroacetic acid. Inorganic phosphate 
v/as then determined on 1 ml aliquots of filtrate in 5 ml final 
volume.
2.2.20 Estimation of RNA
ENA was assayed by the orcinol method for pentoses (Schneider, 
1957). Since the presence of sucrose interferes with the colorimetric 
reaction, the first precipitate was washed three times v/ith trichloro­
acetic acid ( 10^ w/v) and twice with ethanol. For extraction of RNA, 
the precipitate was treated for 20 minutes at 90° with 5 ml of 3%
(w/v) trichloroacetic acid. Absorbance was determined at 66O nm.
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2,2,21 Alkaline Phosphodiesterase I
Incubations were carried out for 10 minutes at 25 in 0.5 ml 
final volume containing 1.5 mM p-nitropherylthymidine 5 ' phosphate,
0,1 M glycine-NaOH buffer, pH 7.1, and 2 mf/I zinc acetate. The 
reaction was stopped by adding 1 ml of 0,1 N NaOH; the liberation 
of p-nitrophenol was assayed at 400 nm (Beafay et si., 1974).
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CHAPTER 3
AGE AI'ID DRUG METABOLISM
5 5
3.1 EFFECTS OF AGEING UPON BIPHENYL METABOLISM IN RATS. HAMSTERS AND IvŒGE
3.1.1 Foetal Drug Metabolism
One of the earliest studies on foetal drag metabolism was that 
of Brown and Zueler (1938), who showed that the glucuronide conju­
gation of 6-aminophenol and phenophthalein was deficient in foetal 
compared with adult guinea pigs. Later, Gartner and Arias (1963) 
demonstrated that o-aminophenol glucuronide formation occurred in 
foetal tissue slices, but not in homogenates.
Brown and Zueler (1958), Fouts and Adamson (1959), and Jondorf 
^  (1959) have all investigated mixed function oxidase activities
in foetal liver. Reactions studied including N-dealkylation, 0-dealky- 
lation, side chain hydrojqylation, sulphoxide formation and deamination 
of primary amines. Homogenate preparations from foetal rabbit and 
guinea pig livers were reported to possess no measurable activities 
for any ofHiese reactions.
Subsequently several reviews relevant to foetal drug metabolism 
have been published (Done I964, Sereni and Principi I968, Mirkin 1970, 
Netter 1971, Waddell 1972). Based upon these studies some generali­
sations regarding foetal drug metabolism can be made:
(1) Oxidative and reductive biotransformations tend to be uniformly 
deficient in the foetus of many animal species.
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(2) There are less clear-cut trends.among different conjugation 
process, but most appear to be deficient.
(3) Some hydrolytic enzymes are fairly well developed in the foetus; 
these enzymes may be related to the high rate of protein 
turnover in the foetus.
3*1.2 Neonatal Drug Metabolism
A deficiency of hepatic microsomal enzymes in the neonates of 
a number of species, including mice and guinea pigs, has been reported, 
(Jondorf et £d. 1959, Pouts and Adamson 1959, Kato et I964, Short . 
and Davies 1970).
A study in the rat of the development of hepatic aniline hydroxy­
lase and ethyl morphine N-demethylase showed that the total activities 
progressively increased as Km values decreased for the first three 
weeks after birth. There was no correlation with cytochrome P450 
changes (Gram ^  I969). Thus a characteristic pattern of hepatic
microsomal mixed function oxidase enzyme development is apparent with 
low levels of activity at birth, full adult activities occurring in 
most cases 20-30 days after birth.
3.1.3 Effects of Ageing upon Biphenyl Metabolism in Vitro
The effects of ageing upon biphenyl metabolism have previously 
been reported in the rat (Basu et 1971 )» In agreement vdLth other 
studies using different substrates, low levels of biphenyl-2- and
. ; ë y
if-hydroxylase activity were apparent at birth, maximal activity 
for each enzyme being observed at 20 and 50 days respectively.
With biphenyl-2-hydro3ylase an atypical pattern of development 
occurred between the 30th and 70th days, during which a rapid 
decline in activity was noted. No activity was detectable after 
70 days. In contrast, the activity of bipheny 1-4-hydroxylase 
showed no comparable decline in activity with age. The authors 
offered no explanation for this phenomenon and the biological 
implications remain obscure.
Since biphery 1-2-hydroxylase has been reported to be induced 
by some aromatic hydrocarbon carcinogens in the rat (Creaven and 
Parke 1966), on a superficial level the behaviour of biphenyl-2- 
hydro3ylase might be regarded as loosely mirroring that of 
cA-foetoprotein, o(-foetoprotein being a soluble protein detec­
table at relatively high levels in both the foetus and tumour 
tissue but reaching negligible levels in normal adults.
The aims of this study were to compare this atypical pattern 
of development of bipheny 1-2-hydroxylase in rats with development 
patterns of this enzyme in other rodent species, namely white mice 
and Syrian hamsters; to check whether the reported induction of 
biphenyl-2-hydroxylase was in any way linked to its apparent
B 8
inactivity in control animals, i.e. where the enzyme was latent; 
also, to ascertain whether changes induced by preparative procedures 
or changes in cofactor requirements might explain the above findings. 
Furthermore, a study of preparative procedures and cofactor require­
ments was needed to ensure valid comparisons between different ages 
and species.
3.2 EXPERIMENTAL
3.2.1 Homogenisation Procedures
The microsomal fraction is a complex mixture of subcellular 
particles which was first isolated by centrifugation (Claude 1943). 
Palade and Siekevitz (I956) concluded that the major microsomal 
components, the rough vesicles, smooth vesicles and ribosomes, were 
formed by a pinching off process that occurred during homogenisation. 
In fact, the microsomal fraction is more complex than was first 
believed. Elements of the Colgi complex; fragments of the plasma 
membranes, secretory vesicles and mitochondrial components may 
contribute to the composition of microsomes (Beaulifay et al. 1974)
A number of techniques have been used to prepare liver homo— 
genates including Waring blenders, tissue presses, and Potter- 
Elvejhem teflon pestle glass tube homogenisers. The latter were 
used throughout our stuty. All investigations were carried out at 4°, 
with hepatic tissue that had previously been scissor-minced.
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Pilot studies were undertaken with hepatic tissue obtained 
from wistar rats 60 days old, and homogenised for different periods 
of time* Homogenisation was divided into three phases : a downstroke,
a stationary phase and an upstroke. Each phase was carried out for 
three seconds, thus a nine-second homogenisation constituted one 
complete cycle. Studies were carried out in 1.15^ KGl buffered to 
pH 7*4 with Tris-HCl rather than phosphate buffer, in order to 
facilitate the glucose-6-phosphatase assay. Differential centri­
fugation was carried out to prepare nuclearj mitochondrial, microsomal 
and soluble fractions (Amar-Costesec et al. 1974).
The following biochemical markers were employed; glucose-6- 
phosphatase and NADPH cytochrome c reductase as microsomal markers, 
acid phosphatase as a lysosomal/mitochondrial marker, and alkaline 
phosphodiesterase I as a nuclear marker (Amar-Costesec ^  al., 1974) 
3.2.2 Effects of Species and Age on Optimal Assay Conditions
A survey of the literature indicates wide variations in the 
incubation systems enplcyed to measure microsomal enzyme activities. 
Mary authors have failed to ascertain optimal conditions for the 
reactions they have studied. This is especially important where 
enymic activities in different age groups and species are studied, 
since variations in optimal conditions could lead to a false inter­
pretation of apparent changes in enzyme levels.
G o
To investigate such a possibility in the biphenyl hydroxylase 
system, optimal requirements for the NADPH-regenerating system 
(glucose-6-phosphate, NADP and glucose-6-phosphate dehydrogenase) 
and for pH and concentration of Mg++, were established in repre­
sentative age groups of each species under investigation (rat, 
hamster and mouse),
3.3 RESULTS
3.3.1 Effects of Homogenisation
The effects of various periods of homogenisation upon the 
activity of the marker enzymes can be seen in Tables 3.1-3.4. Thé 
distribution of microsomal markers agreed witli that of previous 
Workers, approximately IQSfo of glucose-6-phosphatase and NADPH 
cytochrome c reductase activity residing in the microsomal fraction 
in each species regardless of age. Similarly under these conditions 
the microsomal location of biphenyl—2- and 4-lydro3ylase was 
established with 633S and 65^ of the total activity residing in the 
microsomal fraction.
Contradietoly data have been reported for the subcellular 
distribution of NADPH cytochrome c reductase. According to Phillips 
and Langdon (I963) and Tous ter ^  al. (I970) this enzyme was essentially 
located in the microsomal fraction when rat hepatic tissue was 
examined. Previously, however, de Duve ^ t al. (1955), in agreement
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with the observations made by Hogeboom and Schneider (1950), on 
mouse liver, had assigned it a dual location, 6 of the particu­
late activity being, associated with the mitochondrial fraction.
Alkaline phosphodiesterase I exhibited a bimodal distribution, 
being found in both the nuclear (39^) and microsomal (50^) fractions. 
Attention has been focused upon this peculiar behaviour (Thines- 
Sempoux ^ t ad, 1969)* Our observations are in good agreement with 
results presented in other laboratories (Touster et al. 1970) for 
rodent hepatic tissue.
Having established the quantitative subcellular distribution 
of these markers, effects of various periods of homogenisation with 
particular emphasis upon the microsomal fraction were investigated.
Studies in male I50 gm wistar rats indicated that for glucose- 
6-phosphatase activity, homogenisation times of 9, 18, 27 and 36 
seconds produced yields relative to total homogenate activity of 
72.5^ , 76.5^ , 74.5^ and 73*5^ respectively. Similarly for biphery 1-2- 
hydroxy lase, yields of 6l.l^, 63.1^ , 65.3^  and 65*5^  were found and 
f or bipheny 1-4-hydroxy lase, yields of 6l.%&, 63.2^ , 60.3^ and 59.^ 
were established (Tables 3.1-3*4). Measuring total activities 
instead of relative activities is obviously desirable but it is 
clearly difficult to achieve. The alternative is to use minimal 
periods of homogenisation, to prepare subcellular fractions and to 
relate longer periods of homogenisation to this.
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Using this approach the conÿarative effects of various periods' 
of homogenisation were established. From Tables 3.1 and 3.2 it can 
be seen that a 9 second period of homogenisation did not produce 
significantly different effects from 18 seconds. Homogenisation for 
27 or 36 seconds produced lower levels of glucose-6-phosphatase,
NADPH cytochrome c reductase, alkaline phosphodiesterase I and 
biphenyl-2-and 4-hydroxylase activities, (Tables 3*3 and 3.4)» although 
it should be noted that this could be dependent upon the units selected. 
An apparent decrease in en^me activity may occur with longer periods 
of homogenisation due to damage of the enzyme. It is possible also 
however that longer homogenisation periods could lead to higher yields 
of protein which could produce this apparent decrease in enzyme 
activity.
Thus the trend was for longer periods of homogenisation to 
produce relatively higher yields of microsomal enzymes but a possible 
decrease in the absolute enzyme activities as expressed in units/mg 
for protein(Table 3.5). Partly as a compromise and partly as the 
18 second homogenisation period gave the greatest reproducibility 
in results, the 18 second homogenisation procedure was used in the 
preparative regime for all subsequent studies.
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Follo-wing this initial study, the effects of the age of the 
animal on the effectiveness of the homogenisation procedure and 
relative enzyme yields was investigated. Using 12 and 110 day 
hamsters and 9 and 104 day wistar rats, no significant species 
differences were apparent in the microsomal distribution of 
biphenyl-2- and 4~hydroxylase (Tables 3.6-3.9). In both species 
the younger animals showed a greater proportion of enzyme activity 
in the "nuclear" than the "mitochondrial" fraction. For example, 
39*4^ of alkaline phosphodiesterase I activity resided in the 
"nuclear" fraction of 12 day old hamsters; 35*2^  was found in the 
"nuclear" fraction from 110 day hamsters. In 9 day old rats, 
l6,d^ of total biphery 1-2-hydroxylase activity resided in the 
’nuclear" fraction; in 104 day old rats this had dropped to 14. ^  
of the total activity. However, the relative distribution of the 
four microsomal enzymes studied, viz, glucose-6-phosphatase, 
bipherryl-2- and 4-hydro3çylase and NADPH cytochrome c reductase, 
were not significantly affected in either of the age groups studied, 
3.3*2 Optimal Assay Conditions
The cofactor, optimal pH, linearity of initial velocity and 
magnesium ion requirements of biphenyl-2- and 4-tydroxylase in 
different age groups of rat and hamster are shown in Tables 3.8-3*12,
6 9
VX)
tA
a
toI
■4^
H
Ü
%
g
•HI
to
A
+>
8
§
5
■s
-p0
1
I
q
H +>
rH •rH
t>
•H
-P3 Ü
cd
C\J
H <D
P
cd
0) ÜbO 0)
d bO
Ow Bo
0) X}
•p
H
I
CO
p
O
P
0)
rH <Po
d
B g)
8 p(H <D
s <U
cd P4
& to
cd
A
)) <D
A to
to
> p
k
to A
0) M
H o
to
%
cd
Ü to
•H p
-P H
ed d
A to
d 0)
W rt
CO
5
0)
■a
00o\
+1
CO
00
VO
00
00
+1
H
o\ o\
+>
-p
■p
M r-J
7 O
EH
03I
s
<5
5
r4
ü
•Vh
0
g
•H
-P
1 
+> 
03
A
I
g§
I
■s
+>ü
i
W «
+> o
CM CM
KO
KO VO
CO
I
o
s
0)
4 os
rr> 
CM 
+ 1
in
+>
VD +> 0)
lA
K\
û)
EH
CJ
<D
m
03
t)
ï3
S
S
<ü
!I
M
■S
f§
( »
00
m
I
(0I
•H+»
O
ü
ü
4-,
0
g
1
+3
•S
A
I
g
§
0)
%
1
(00)
1I
I
I
«M0
g1I
I
I<t3
â
CO
+1
%
+>
' »H
>
♦H
-P
Ü
Cd
<ü m? Éi rd
bO o>
O
g Q)
■3
CO voa\
H
+1
00
CXN
+1
LTV
VX)
VO V£)
m
00 h- VO
+1
»
iH
•H
7 2
E-i
<n
§
•H
-P
i
Ü
«
Ü
y
g
•HI■pw
A
I
i
0
1
to<u-p
I
I
g
t
«
o
§
p
0•H
p
1
u
0)
%
ON
toI
â
0)
P  <D
c > CO
ON
C\J VJ3 UN
O  O  ON CO ON
r-| VO 
• •
C\J KN
ON
CM 
+ 1
CMH
H
m
p <3N iH
+ 1
00
+1 +1 +1rH
UN
7 3
TABLE 3.10
Age Variation in Reaction Characteristics 
of Biphençyi Metabolism "by Rat Hepatic Microsomes
Results shown are mean values of six samples.
2-hydroxylat ion
' ' «  ■
Optimal Reaction Conditions Age 9-12 days Age 90-93 days
Optimal pH 7.7-7.8 7.7-7.8
Optimal NADP (mmol/l) 0.1-10.0 0.1-10.0
Optimal G-6-P (mmol/l) 2,0-15.0 2.0-15.0
Optimal Mg++ (mmol/l) 1.0-30.0 1.0-30.0
Optimal G-6-P dehydrogenase
(mg/ml) 0.2-0.3 0.2-0.3
Limit of linearity of initial
velocity (minutes of incubation) 5,0 5.0
4-hydroxylation
Optimal Reaction Conditions Age 9-12 days Age 90-95 days
Optimal pH 7.4-7.5 7.4-7.5
Optimal NADP (mmol/l) 0.1-10.0 0.1-10.0
Optimal G-6-P (mmol/l) 2.0-15.0 2.0-15.0
Optimal Mg++ (mmol/l) 1.0-30.0 5.5
Optimal 0-6-P dehydrogenase
(mg/ml) 0.2-0.3 0.2-0.3
Lindt of linearity of initial
velocity (minutes of incubation) 5.0 5.0
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TABLE 3.11
Age Variation in Reaction Characteristics 
of Biphenyl Metabolism by Mouse Hepatic Microsomes
Results showi are mean yalues of six samples.
2-hydroxylation
Optimal Reaction Conditions Age 21-35 days Age 60-6? days
Optimal pH 7.8-7.9 7.8-7.9
Optimal NADP (mmol/l) 0.1-10.0 0.1-10.0
Optimal G-6-P (mmol/l) 2.0-15.0 2.0-15.0
Optimal G-6-P dehydrogenase
(mg/ml) 0.2-0.3 0.2-0.3
Optimal % + +  (mmol/l) 1.0-30.0 1.0-30.0
Limit of linearity of initial
velocity (minutes of incubation) 5.0 5.0
4-hydroxylation
Optimal Reaction Conditions Age 21-35 days Age 60-6? days
Optimal pH 7.4-7.5 7.4-7.5
Optimal NADP (mmol/l) 0.1-10.0 0.1-10.0
Optimal G-.6-P (mmol/l) 2.0-15.0 2.0-15.0
Optimal G-6-P dehydrogenase
(mg/ml) 0.2-0.3 0.2-0.3
Optimal Mg-f+ (mmol/l) 1.0-30.0 6.0
Limit of linearity of initial
velocity (minutes of incubation) 5.0 5.0
7 5
TABLE 3.12
Age Variation in Reaction Characteristics 
of Biphenyl Metabolism hy Hamster Hepatic Microsomes
Results shown are mean values of six samples.
2-hydroxylation
Optimal Reaction Conditions Age 17-20 days Age 103-106 days
Optimal pH 7.9-8.1 7.9-8.1
Optimal NADP (mmol/l) 0.1-10,0 0.1-10.0
Optimal G-6-P (mmol/l) 2.0-15.0 2.0-15.0
Optimal Mg++ (mmol/l) 1.0-30.0 1.0-30.0
Optimal 0-6-P dehydrogenase ‘
(rag/ml) 0.2-0.3 0,2-0.3
Limit of linearity of initial
velocity (minutes of incubation) 7.0 7.0
4-hydroxy lation
Optimal Reaction Conditions Age 17-20 days Age 103-106 days
Optimal pH 7.4-7.5 7.4-7.5
Optimal NADP (mmol/l) 0.1-10*0 0,1-10.0
Optimal 0-6-P (mmol/l) 2.0-15.0 2,0-15.0
Optimal Mg++ (mmol/l) 1.0-30.0 5,0
Optimal G—6-P dehydrogenase
(mg/ml) 0.2-0.3 0.2-0.3
Limit of linearity of initial
yelocity (minutes of incubation) 7.0 7.0
7 GLittle variation in the above parameters was apparent for either 
the 2-hydroxylation or if“hydro3^ 1ation of biphenyl. The magnesium 
ion requirement for biphenyl-4-hydroxylase was an exception, 
showing a precise optimal requirement in the older but not the 
immature members of each species studied. To investigate the nature 
of the magnesium effects, studies were repeated utilising NADPH 
instead of a regenerating system, A similar response was observed, 
suggesting that the observed magnesium dependency was not due to an 
interaction with the NADPH-regenerating system (Fig. 3.14).
It can clearly be seen from Figs. 3.13 and 3.14 that in the 
older members of the species examined, a marked increase in optimal 
magnesium requirement occurred. This was found to be 6 mM/l in 67 
day old mice, 5 ran/l in 104 day old hamsters and 5*5 m%/l in 90 day 
old rats. It was only 2 mW/l in the case of 23 day old mice, 15 
day old hamsters and 9 day old rats.
Further investigations using older hamsters (Figure 3.17) 
indicated that Km but not Vmax values were significantly affected 
by the addition of magnesium ions. Thus with no added magnesium 
ions a Km value of 3.9 x 10 ^ (mol/l) for bipheny 1-4-hydroxylase 
was obtained, while at 5 mB^l Mg-f-f Km values decreased to O.63 x 
10 ^ (mol/l). At even higher Mg++ concentrations an apparent
7 7
FIGURE 3.15
Effects, of Magnesium Ions on Biphenyl~i4.«-hydroxvlase Activity
Microsomal samples were prepared from 23 day (■— ■— ■) and 6? day
old (  ^ a) mice. Biphenyl-4.-hydro3yla.se activity is expressed as nmol
product/mg microsomal protein/min. ± S.D. (Six animals).
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FIGURE 3.14
Effects of Magnesium Ions on Biphenvl-Z^.-hydroxylase Activity
Microsomal samples were prepared from 18 day ( m- n) and 104 day
old (at -a) hamsters. Biphenyl-4-hydro%ylase activity is expressed
as nmol product/mg microsomal protein/min. - S.D. (Six animals).
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FIGURE 3.15
Effect of Magnesium Ions on Biphenyl-2-hydroxylase Activity
Microsomal samples were prepared from 23 day (■— — ■) and 67 day 
old (a— — -a ) white mice, Bipheny 1-2-hydro %y la se activity is expressed 
as nmol product/mg microsomal protein/min. - S.D. (Six animals).
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FIGURE 3.16
Effects of Magnesium Ions on Biphenyl-2-hydroxyla3e Activity
Microsomal samples were prepared from 18 day ( #— —b ) and 104 day old
(a a) male hamsters. Bipheny 1-2-kydroxylase activity is expressed
as nmol product/mg microsomal protein/min. - S.D, (Six animals).
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TABLE 3.17 
Kinetic Effects of Magnesium Ions 
upon the Hydroxylation of Biphenyl
Hepatic microsomes were prepared from 121 day old hamsters. 
Values are Km 10 ^ mol/l) and Vmax 1 0 '^mol/min/mg microsomal 
protein) - S.D. (Six animals).
Magnesium 
0 oncentrati on 
mmoi/i '
0 
4 
10 ■
2-hydroxylation 
Kn Vmax
6.4 - 1.2 2.2 i 1.3
5;1 - 1.1 2.0 i 1.0
6.1 - 1.4 3.1 - 1.2
4-hydroxylation 
Km Vmax
3.9 - 0.9 3.1 - 0.6
0.6 i 0.1 1.5 i 0.2
2.3 ± 1.1 2.2 i 0.6
Km values for the 4-hydroxylation of biphenyl at a magnesium 
concentration of 4 mmol/l were significantly different from 
values obtained with either 0 or 10 mmol/l magnesium (P<0.5). 
No significant variation in bipheny 1-2-tydroxylation kinetics 
was detectable.
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return to initial values was seen. In no case could significant 
differences in Km or Vmax values for bipheny1-2-hydroxylase be 
detected.
That magnesium can affect drug metabolism is not a novel 
finding. Mueller and Miller (1948) found that the déméthylation 
of 4-dime thy laminoazobenzene was increased by the addition of 
magnesium ions to rat liver homogenates. La Du et al. (1955) 
reported that aadnopyrine déméthylation was greater in the presence 
of magnesium. However, they found that magnesium did not affect 
the rate of déméthylation when NAEEH was added. Mazel et al. (1966) 
showed that the rate of puronycin déméthylation was identical in 
the presence or absence of magnesium, whereas Trivas (1964) 
observed that magnesium was essential for hexobarbital oxidase 
activity. A requirement for magnesium was observed by Nebert and 
Gelboin (I968) for benzpyrene hydroxylase activity using NADPH 
directly. Becking and Morrison ( 1970) have reported that magnesium 
deficient rats have much reduced drug metabolism capability. Thus 
in respect of Mg++ requirement, bipheny 1-4-hydroxylase behaves like 
other drug metabolism enjymes, e.g. hexobarbital oxidase. The age 
dependency of this phenomenon may reflect changes in the in vivo 
and hence basal jja vitro concentration of Mg++. Interestingly,
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biphenyl-2-hydroxylase did not shov/ this age-linked effect, indicating 
an apparent dissimilarity in the behaviour of these two systems. All 
further studies were carried out with Mg++ added to the incubation 
mixture to give a final concentration of 5 mm/l.
3.3.3 Variation of Biphenyl Metabolism with Age
The work of Basu et (l97l) was repeated in Wistar rats 
and also in hamsters and mice. Studies with rat foetus (l6 days) 
disclosed no detectable biphenyl metabolism.
From Pigs. 3.18 and 3*19 it can be seen that clear species 
differences occurred. Using rat bipheny1-2-hydroxy lase activities, 
it can be seen that enzyme activity fell as the animal matured.
In contrast, in both hamster and mouse only a slight decrease in the 
ability to 2-hydroxylate biphenyl with age was recorded. According 
to Basu (1971), after 70 days no bipheny 1-2-hydroxy lase
activity was detectable in the rat; this is in conflict with our 
findings of 0.8 nmoles/mg microsomal protein/min after 26 weeks. 
Indeed, from investigations presented later in this thesis biphenyl- 
2-hydro3ylase activity wan readily measurable even in two-year-old 
rats*
A probable explanation of this discrepancy is that these 
authors did not use assay conditions of sufficient sensitivity.
In the case of bipheryl-4”hydro>ylase, no marked species variations 
or rapid decline in activity with maturity was detectable.
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The variations in biphenyl metabolism with age obviously 
require a kinetic approach, and results of such an investigation 
are shown in Table 3.20. The initial increases in biphenyl metabolism 
in rats and hamsters were mirrored by changes in Km but not Vmax.
Thus Kra values of 12.3 -1.8 x 10~^ (niol/l) and 9.3 ±2.1 x 10~^
(mol/l) were recorded in 7 day old rats and hamsters for the 2-hydro­
xylation of biphenyl which decreased to 5.2 ±1.6 x lo”^ (mol/l) and 
7*8 -1,1 X 10 as the animals reached 25 days of age, and maximal 
bipheny 1-2-hydroxylase activity. As the rats aged a decline in 
bipheny1-2-hydroxylase activity was noted; again this behaviour was 
mirrored in Km values which increased to 14.1 ±1.4 x lo"^ at 60 days 
and 15.3 “1.5 X 10 ^ at 120 days, A slightly different picture 
occurred with the hamsters, with Km of 6.1 ±2.0 x 10~^ at 70 days 
and 7.1 -1.8 x 10 ^ at 120 days, in keeping with the fact that 
hamster biphenyl-2-hydro3qylase activity did not show the same decline 
in activity with age as the rat.
Increases in bipheny 1-4-hydroxylation as the animal matured 
were also paralleled by decreases in Km values. Thus in 7 day rats 
and hamsters. Km values of 8.7 -2.5 x lo"^ and 8.2 ±3.1 x lo"^ were 
recorded and after 25 days Km values fell to 3.1 ±0.76 x lo"^ and 
3.6 X 10 , these values reflecting the increase in bipheny 1-4-
hydroxy lase activity at this time.
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TABLE 3.20
Effect of Age upon Kinetic Parameters of Biphenyl-2- 
and -4-hydroxylase in Wistar Rats and Syrian Hamsters
Results are Km 10 ^ (mol/l) and Vmax 10 ^ (mol/min/mg microsomal 
protein) - S.D. (Eight animals).
Wistar rats
7
25
60
120
Biphenvl-2-hydroxylase Bipheny1-4-hydroxylase
Km Vmax ' Km Vmax
12.3 ± 1.8 3.1 ± 1.1 8.7 ± 2.5 3.9- 1.3
5.2 ± 1.6 3.6 ± 1.3 3.1 - 0.6 4.2 ± 1.0
14.1 ± 1.4 3.4 ± 1.2 3.7 - 1.4 4.4 ±1.3
15.3 - 1.5 3.6 ± 1.4 3.6 ± 1.1 4.1 ± 0.9
Syrian Hamsters
Ase (days) BiphenylT2-hydroxylase Biphenyl-4-hvdroxylase
L. -y 4 Vmax Km Vmax
7 9.3 - 2.1 3.9 i 1.2 8.2 ± 3.1 3.6 - 1.2
25 7.8 i 1.1 3.1 i 0.9 3.6 i 0.7 4.1 - 1.5
60 6.1 i 2.0 3.3 ± 1.4 4.1 i 1.2 4.1 i 1.3
120 7.1 ” 1.8 3.4 — 1.1 4.4 “ 0*9 3.8 ~ 1.0
• 8 8
3.4 CONCLUSIONS
Preliminaiy studies on the influence- of animal species and age 
upon optimal homogenisation procedures and assay conditions were 
carried out to remove the possibility of them contributing to the 
en2yme activiiy variations seen on changing the species or age of animals used.
The work of Basu et (l97l) was partially confirmed in 
Wistar rats, but in contrast to the rat, a rapid decline in 
bipheny 1-2-hydroxylase activity in either the mouse or the hamster 
was not observed. These species variations were reflected in Km 
but not Vmax: values.
As a result of this investigation, the following cofactor 
system was adopted in all future studies, viz. NADP, G-6-P, 
glucose-6-phosphate dehydrogenase and Mg++ (25 mm, 500 nM, 2 units/ 
ml and 0.5 mNT respectively).
Since the age dependent changes in bipheny 1-2-hydro^lase 
could be attributed to kinetic changes and biphery 1-2-hydroxy lase 
was undetectable in the foetus, this would appear to invalidate 
the conclusion that biphery 1-2-hydroxy lase is a "foetal enzyme" 
or a general indicator of immaturity in animals. Therefore the 
induction of biphenyl-2-hydroxylase following pretreatment of 
rats with ar-omatic hydrocarbon carcinogens is almost certainly not 
related to the tendency of these compounds to provoke a change of 
hepatic cells to a more primitive type.
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CHAPTER 4
INFLUENCE OF XENOBIOTICS ON
DRUG METABOLISM IN-VITRO
9 0
4.1 THE INFLUENCE OF CARCINOGENIC AND NON-CARCINOGENIC GOIvIPOUNDS 
UPON HEPATIC DRUG M5TAB0LISM SYSTEMS IN VITRO
4.1.1 Introduction
The endoplasmic reticulum appears to be implicated in the 
early toxic changes engendered by a variety of chemical agents.
It has been shown that a number of acutely and chronically toxic 
materials including many carcinogens can degranulate the rough 
endoplasmic reticulum (Orrenius, I965),
Accumulating evidence, indicates that free and bound poly­
somes are probably involved in the biosynthesis of different 
classes of protein, (Siekevitz and Palade, I96O; Campbell, I970). 
For example, it is probable that proteins exported from the cell 
are biosynthesised by membrane-bound polysomes (Siekevitz and 
Palade, i960), and this may also be true of other important 
classes of proteins, such as those whose biosynthesis is induced 
by steroid hormones (Cox and Mathias, I969). Clearly, the control 
of the interaction of polysomes with membranes could be of profound 
, inportance in dictating the tissue-specific pattern of protein 
biosynthesis which characterises the process of differentiation 
and development.
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Rabin and his colleagues, in a series of papers (Williams 
and Rabin, 1971; Rabin et al.. 1971» Sunshine et al.. 197l) 
have suggested that the ability of compounds when preincubated 
with a NADPH2 regenerating system to displace the polysomes from 
the hepatic rough micros ernes through the production of active 
metabolites might be an indication of their carcinogenic potential 
and could provide the basis for an ^  vitro screening test for 
possible carcinogens.
Brodie and co-workers (Mitchell al., 1971) have inplied 
from their studies on the effects of various conpounds, notably 
phenacetin and bromobenzene, on the liver, that chemicals which 
become covalently bound to the endoplasmic reticulum, either 
before or after metabolism ly the microsomal drug metabolising 
enzymes, may constitute a particular toxic threat. The investi­
gations of Rabin's and Brodie's groups both stress the inportance 
of the drug metabolising en^mes centred on cytochrome P450 in 
provoking a toxic response through the release of an active 
metabolites. The role of microsomal oxidation reactions in enabling 
potential chemical carcinogens to be transformed into reactive 
species, especially nuoleophilic and free radical species, which
9 2
initiate a sequence of events leading to tumour formation, has 
also been emphasised by mary other workers (Clayson et al.\ 1971; 
Huberman et , 1972; Magee, 1974).
Because of the importance of drug metabolism in both 
preventing and initiating deleterious structural changes in 
cellular conponents, it is important to establish whether the 
interaction of various chemicals with the drug metabolising 
en^mes of the endoplasmic reticulum reveals any unique features 
of toxic chemicals which may distinguish them and which might be 
used, together with other tests, as the basis for a simple 
routine screening procedure in toxicity testing., It has been 
known for some time that the pretreatment of rats with aromatic 
hydrocarbons, particularly the carcinogens benzpyrene and 
methylchoianthrene, modify the drug metabolising system in a 
different manner from that induced by drugs such as phenobarbitone 
(Gillette et al.. 1969).
Creaven ^  (1965 ) have shown that pretreatment of rats
with a number of aromatic hydrocarbon carcinogens markedly enhances
the hepatic vitro metabolism of biphenyl to 2-hydroxybiphenyl,
while only weakly stimulating formation of the normal major 
metabolite 4-hydroxybiphenyl. Non-carcinogenic aromatic hydro­
carbons and drugs such as phenobarbitone and nikethamide,on the
s 3
other hand, induce hiphenyl-4-hydroxylation hut not its 2- 
hydroxylation.
We have investigated the in vitro effects of various known 
toxic chemicals and other compounds on the hydroxylation of 
biphenyl and other drug metabolism systems*
4.1.2 Experimental
Preincubatioh studies were carried out as described in 
"Materials and Methods". Stringent controls were included in 
each study* These included addition of test conpound after 
incubation, incubation of denatured microsomes and omission of 
the NAHPH regenerating i^stem,
A preincubation time of 10 minutes was selected, alleging 
anple time for test conpound metabolism and yet restricting the 
in vitro degradation of the microsomal material*
A five minute incubation with thé substrate bipheryl was 
used since longer substrate incubations produced a non-linear 
relationship between product formation and time.
4.2 RESULTS
^•2.1 Effect of Carcinogenic and Non-carcinogenic Organic Compounds 
upon Rodent Hepatic Microsomal Biphenyl-2- and -4-hydroxvlase 
Activity in Vitro
Tables 4.1 to 4.3 illustrate the effect of adding a number 
of xenobiotic compounds upon biphenyl metabolism in vitro. The
9 4
effect of 49 conpounds upon biphenyl metabolism in rat, 34 
conpounds upon biphenyl metabolism in hamster and 19 conpounds 
utilising mouse preparations were examined. These conpounds were 
subdivided into two broad categories: carcinogenic and non-
carcinogenic conpounds. This subdivision was broad and based 
on rat lifetime studies with these conpounds. A variety of 
tissue specific carcinogens were studied including 3,4-benzpyrene 
(and many other aromatic hydrocarbons), skin and lung carcinogens,
^  -naphtlylamine (a bladder carcinogen), safrole, aflatoxin B-j, , 
and
Of the 49 conpounds studied, 19 have been reported to be 
carcinogenic, 25 as non-carcinogens and 5 conpounds potentially 
hazardous although not fully investigated.
Of the 19 carcinogenic compounds, 16 produced an enhancement 
of biphenyl-2-l:ydro:cylase activity in vitro. For example, 3»4- 
benzpyrene increases bipheryl-2-hydiPxylase activity by 17C^, 
saf role by 72^, p-naphthylamine by 102^ and dime thy Initrosamine 
by hBfo»
25 non-carcinogens were studied of which one, 4-acetamido- 
fluorene, produced an in vitro enhancement of bipheny1-2-hydroxylase 
activity. No increase of bipheryl-4-"hydroxylase activity in vitro 
was observ'ed in any study.
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Thus a general trend was apparent with carcinogenic 
compounds, producing an in vitro enhancement of biohenvl-2- 
hydroxylase activity, whereas non-carcinogens did not stimulate 
biphenyl-2-hydro3ylase activity.
The above comments are to some extent generalisations, 
and in view of their significance, the exceptions rather than 
the rule will be examined in some detail. For example, the 
"non-carcinogenic" 4-acetamidofluorene shows great similarities 
in behaviour to its carcinogenic isomer 2-acetamidofluorene.
On the other hand, the carcinogen dipherylnitrosamine produced 
no stimulation of biphenyl-2~hydroxylase activity; indeed, an 
inhibition of 36% was apparent. While atypical behaviour was 
noted in the case of methyl carbamate and methyl carbazate, 
where again no enhancement of biphenyl-2-hydroxylase activity 
was observed.
It is possible to postulate a number of reasons for this 
atypical behaviour; the most likely cause is the array of diug 
metabolism enzymes (and hence of carcinogen activating enzymes) 
present in the microsomal fraction; incomplete or atypical 
metabolism could occur in vitro.
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It is also worthy of note that when the effect of 2,4-xylidine 
(a suspected carcinogen; Grasso, 1976) was compared with its 
non-carcinogenic isomers, 2,5-xylidihe and 2,6-xylidine, only 
2,4“3ylidine enhanced bipheiyl-2-hydroxylase activity. Similarly, 
the carcinogen ^-naphthylamine enhanced bipheny1-2-hydroxylase, 
whereas the non-carcinogenic isomer K.-naphthylamine did not.
Although no enhancement of biphenyl-4~hydro3cylase was observed 
in this study, a number of cases of inhibition were noted, parti­
cularly with the methyl enedioxyphenyl compounds such as saf role 
on cytochrome P450 dependent en^mes. These effects are well 
documented (Elcombe et al. , 1975), and this probably explains the 
above phenomenon, ,
4*2,2 The Effects of Metallic Salts upon Biphenyl-2- and -4-hydroxvlase 
Activities in Vitro
Carcinogenic potential is not the sole prerogative of organic 
compounds. It has been reported that a variety of metal salts 
will produce tumours in various tissues. For example, trivaient 
arsenous salts have been reported to produce skin tumours in man 
(ïeh, 1963).
Cadmium salts are perhaps the best documented of inorganic 
carcinogens, with cadmium chloride producing pleomoiphic sarcomas
- 1 (3
after a single administration to rats (Gunn at al., I967).
Other inorganic compounds reported to be carcinogenic include 
zinc chloride in fowl (Carleton ^  , 1952) and lead acetate
in rat (Van Esch et al., I962).
The mechanism by which these various salts initiate 
malignant growths is far from clear.
To investigate the possibility that inorganic carcinogens 
might produce an enhancement of biphenyl-2-hydro3ylase activity, 
a number of metallic salts were preincubated with rat hepatic 
microsomes under conditions identical to those which produce 
enhancement of biphenyl-2-hydro3cylase with organic carcinogens.
The only difference was that lower concentrations of compounds 
were employed, since the toxicity of most compounds in vitro 
would preclude high levels of the test compound occurring in 
hepatic tissue (enhancement with organic carcinogens was easily 
detectable at equivalent concentrations).
Table 4.4 illustrates the effects of inorganic salts upon 
biphenyl-2- and -4-hydroxylase activity. It can be seen that no 
metallic ion produced significant enhancement. Some inhibitory 
effects of copper, lead and arsenous ions (l x 10  ^M) upon 
bipheny 1-4-hydroxylase v/ere observed (88^, 7A^ and 4 ^  of control 
values respectively), whilst inhibition of bipheny 1-2-hydroxylase
■ ■ 1 0 5
TABLE 4.4
The Effects of In Vitro Preincubation with "Carcinogenic” or 
"Non-carcinogenic” Metal Salts upon Hepatic Microsomal Biphenyl- 
2- and -4-hvdroxylase Activity in Male Wistar Rats (C" 150 gms).
Results are expressed as nmoles product per mg microsomal protein 
per minute - standard deviation six animals. Percentage changes 
in activity are expressed in parenthesis, 3,4-benzpyrene 1 mg/ml 
was administered in ground nut oil. Metallic salts were administered 
in distilled water to give a final concentration of 1 x 10  ^M.
Compound Sipheir^l-2-hydroxylase Bipheiy3^^4Thydroxylase
~ -K— .—  nmoles/mg microsomal nmoles/mg ndcrosomal
protein/mlh. protein/i^n.
Control X 0.30 0.03 ( - ) 1.4 0.2 ( - )
3,4-benzpy rene 
(positive control)
X
0.91
+ 0.07 (+302)^ 1.2 + 0.3 (-15)
Manganous chloride X 0.31
+
0.04 (+3) 1.5 0.3 (+7)
Cobalt nitrate X 0.32
+
0.02 (+6) 1.4
+
0.2 (O)
Cadmium sulphate X 0.30 0.04 (O) 1.5
4
0.1 (+7)
Lead acetate X 0.29 ± 0,02 (-3) 0,9 i 0.3 (-36)'^
Nickel acetate X 0.32 +- 0.04 (+6) 1.4
+ 0.4 (o)
Zinc chloride X 0.28 + 0.03 1-6) 1.4
+ 0.3 (0)
Arsenous nitrate X 0.20 0.06 (-33)^ 0.6 0.2 (-57)'^
Ferrous sulphate 0.31
+
0.02 (+3) 1.5
+
0.3 (+7)
Calcium chloride 0.30 + 0.03 (o) 1.5 0.2 (+7)
Copper sulphate 0.28 + 0.03 (-6) 1.1 + 0.2 (-22)'^
* reported to have carcinogenic properties.
Values significantly different from control values:
/ (P 1:0.5)
Î (P 40.005)
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was less apparent 97^ and 67^ of control values). These
results again highlight differences between biphery 1-2- and 
-4-hydroxylase, bipheny 1-4-hydroxylase showing the greater 
susceptibility to inhibition.
Thus in vitro the behaviour of these inorganic carcinogens 
appears to be fundamentally different to that of organic car­
cinogens, in that no enhancement was detectable of bipheny 1-2- 
hydroxylase activity in vitro. The inhibitory properties of 
some of these metals may promote toxicity by depressing the 
microsomal hydroxylases necessary for the deactivation of other 
toxic environmental chemicals. The relationship between the 
inhibitory effects of certain metals and their carcinogenic 
potential, if any, remains to be determined.
4.2.3 Effects of Carcinogenic and Non-carcinogenic Compounds upon 
Kinetic Parameters of Biphenvl Metabolism in Vitro
Table 4.5 illustrates the effect of preincubation with
3,4-benzpyrene and phenobàrbîtone upon Km and Vmax values for
bipheny 1-2- and -4-hydroxylasej without preincubation, Km values
of 4.3 - 1.4 (16 M) and Vmax values of 1,2 - 0,3 (10^ mol/min./
mg protein) were observed for bipheny1-2-hydroxylase. After
preincubation with 3,4-benzpyrene (l mg/ml) significant changes
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TABLE 4.5
The Effect of Preincubation with 3,4-beri2pyrene upon Hamster 
Hepatic Microsomal Blphenvl-2- and -4-hydroxylase Characteristics
Values are 10^ Km (mol/l) and 10^ Vmax: (mol/min./mg protein)
- S.D. Eight animals, î indicates values significantly different 
from control (P 4 0.05).
Km ( W M  Vmax (lO^)
Bipheny1-2-hydroxylase control 4.3 -1.4 1,2 i 0.3
.3,4-benzpyrene preincubated 0*14 - 0,2^ 6.7 - 0.6^
Phenobarbitone preincubated 4.7 - 1.3 1.7 - 0.7
Biphenyl-4-hydroxylase control 2.6 - 1,1 2.0 - 0.3
3,4-benzpyrene preincubated 2.3 i 1.4 1,9 - 0.2
Phenobarbitone preincubated 2.4 i 0.9 2.2 - 0.6
1 0.8
were observed, viz. Km 0.14 - 0.2, Vmax 6.7 - 0.6. After pre­
incubation with phenobarbitone, however, no signifioant changes 
in either Km or Vmax values were observed. Thus it would appear, 
that a consequence of the iu vitro enhancement of bipheryl-2- 
hydroxylase is a change in the mebrane-protein moiety that results 
in changes in both Km and Vmax values.
4.2.4 Effects of Preincubation upon the Metabolism of 2-hvdroxv 
and ^-hydroxy Biphenyl
In vivo studies have indicated that likely metabolites of 
biphenyl include 2-hydroxy, 3-hydroxy, 4-hydro3qy, 4,4'dihydroxy,
3,4’dihydroxy, 3-bydroxy-4-methoxy and 3-methoxy-4-hydroxy 
biphenyls, the hamster being enplcyed for most studies (Burke,
1973). 2- and 4-hydro3cybipheryl are the most important metabolites;
while 2,2'hydroxybiphenyl and 4,4'hydroxybiphenyl are formed to a ; 
lesser extent.
To investigate the possibility that carcinogenic compounds 
could, by interfering with the further metabolism of 2-hydroxy- 
biphenyl, produce an apparent increase in the measured levels of 
2-hydroxybipheryl, a number of preincubation and kinetic studies 
were carried out involving 2-hydroxy or 4-hydroxybiphenyl as 
substrate.
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Microsomes were preincubated with 3,4-benzpyrene, the 
most potent vitro enhancer of bipheryl-2-hydroxylation; 
however, 2-hydroxy or 4-hydroxybipheryl was substituted for 
biphenyl, A substrate concentration of 0.5 nM was employed, 
simulating the concentrations of 2-hydroxy and 4-hydroxybiphenyl 
found in vitro during the metabolism of biphenyl.
Figures 4.6 and 4*7 illustrate that on preincubating 
microsomes with 3,4-benzpyrene, no significant effect on the 
further metabolism of 2-hydroxy and 4-hydroxybiphenyl was 
discernible. Further support for this view comes from kinetic 
studies, for although it can be shown (Table 4.8) that in vitro 
preincubation with 3,4-benzpyrene caused changes in both the 
Km and Vmax values for bipheny 1-2-hydroxylase, when 2-hydroxy 
and 4-liydroxybiphenyl were substituted for biphenyl, no signi­
ficant changes in either Km or Vmax values were detectable.
4.2.5 Effects of Preincubation upon the Mcrosomal Metabolism 
of Biphenvl
To confirm that the detectable increase in fluorescence 
measured at an excitation wavelength of 290 nm and 415 nm 
emission was solely attributable to 2-hydroxybiphenyl, an 
investigation into the effects of preincubating rat hepatic 
microsomes with the carcinogens saf role or 3,4—benzpyrene or
1 1 r
FIGURE 4.6
Disa-ppearance of 2-hydroxy Biphenvl
from Microsomes Preincubated with 3 ^ 4~benzpvrene
Initial 2~hydroxybiphenyl concentration was 0,2 Æ ;  results are
for six animals, ( ■--- ■) control, ( #-— —#) test, 3,4-benzpy rene
p re incubated.
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Disappearance of i^-hydroxy Biphenvl
from Microsomes Preincubated with 3 A-benzpvrene
Initial 4-hydroxybiphenyl concentration was 0.5 mM; results are 
for six animals, (■ ■) control, (#— — #) test, 3,4-benzpyrene
p re incubated.
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TABLE 4.8
Effect of Preincubation upon the Kinetics of Microsomal 
Degradation of 2 and 4 Hydroxybiphenvl
6 9
Values shown are 10 Km (mol/l) and 10 Vmax (mol/min./mg protein)
- S.D. Six animals.
lÆLcrosome
Pretreatment
Control 
3,4-benzpy rene 
Safrole
Phenobarbitone
2-»hvdroxylation 4-hydroxylation
Km Vmax Km Vmax
' - 5.6 7.3 ± 3.1 7.9 -3.7 4.4 ± 3.2
; - 9.7 8* ^  — 2*/. 8.6 - 4.1 5.6 - 2,8
- 6.4 6.3 - 2.7 7.1 - 3.3 4.9 ± 3.3
- 7.1 7.9 ± 4.2 8.9 - 3.9 4.1 ± 2.8
Values obtained were not found to vary significantly from control 
values.
.113
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the non-carcinogen phenobarbitone upon ( c) biphenyl metabolism 
was made. Biphenyl and metabolites were detected by fluorescent 
quenching of the T.L.C. plates# Rf values for biphenyl and its 
metabolites are displayed in Table 4.9, whilst counting and 
recoveiy standardisation data is shown in Table 4.10.
Prom Table 4.11 it can be seen that in control (unpreincubated) 
samples, 5.6^ of the biphenyl was metabolised to 2-hydro%ybiphenyl, 
30.9^ to 4-hydroxybiphenyl, 2.6^ to 2,2'dibydroxybipheixyl and 1 . ^  
to 4,4 ' dihydrozybipheny 1, while 58.5^ of the biphenyl remained 
unchanged after 10 minutes.
After preincubation with 3,4-benzpy rene, 2-hydroxybiphenyl levels 
are two and a half-fold when compared to control values, this being 
comparable to increases in 2-hydroxybiphenyl detected by fluorescent 
procedures. A slight decrease in the amount of 4-hydroxybiphenyl 
was noted, while 2,2* and 4,4*dihydrbxybiphenyl levels were slightly 
increased.
These results suggested that the observed increase in 
2-hydroxybiphenyl provoked by carcinogens does reflect an increase 
in enzyme activity and not a conversion of biphenyl-4-hydroxylase 
activity to 2-hydroxylase (c.f. Jaffe et al., I969). These results 
also demonstrate that the observed increase in biphenyl-2-hydroxy- 
lation is not due to inhibition of its further metabolism to
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TABLE 4.10 
Counting and Recovery Standardisation 
for (C^) Biphenyl Metabolism Studies
Background (counter) 28 d.p.ra.
Background (T.L.C. plate) 8 d.p.m.
Counting efficiency (^C) toluene
standard 80^
Amount biphenyl incubated 2,988 d.p.m.
Maximal recovery (lOO^ S) 1,380 d.p.m.
Recovery obtained 72^
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2,2 ’dihydroxybipherçrl, for an increase rather than a decrease 
in the levels of 2,2 *dihydro3ymetabolite was found. The results 
also validate the fluorescent procedures described previously.
Using microsornes preincubated with safrole, a smaller 
enhancement of biphenÿl-2-hydroxylase activity was apparent, 
again paralleling fluorimetric studies, coupled with a marked 
decrease in the amount of 4-hydro3qybiphenyl produced. The 
inhibitory properties of methylenedioxy compounds such as 
safrole upon mixed function oxidase is well documented (Philpot 
and Hodgson, 1973; Elcombe et al.. 1975).
4.2.6 In Vitro Preincubation and its Effect upon Various Parameters 
of Drug Metabolism
In vitro addition of 3,4-benzpyrene or phenobarbitone to 
either rat or hamster hepatic microsornes, with the exception of 
biphenyl-2~hydro3qylase activity, caused no significant effect 
oh a number of drug metabolising enzymes studied. These were 
bipheryl~4"*lydroxyl8se, aniline hydro:3cylase, 4-chloromethylaniline 
demethylase, nitroreductase, benzpyrene hydroxylase, ethoay- 
coumarin deethylase, ethoryresorufin deethylase, ethylmoiphine- 
N-demethylase, cytochrome P450 reductase, NADH and NADPH cytochrome 
G reductase, cytochrome P450 and b5.
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These results may be taken as . an indication that the 
observed in vitro enhancement of biphenyl-2-lydroxylase is a 
relatively specific phenomenon. It is particularly worthy of 
note that neither the activity of cytochrome P450 nor NADPH 
qytochrome P450 reductase was significantly affected by in vitro 
preincubation, nor was ary enhancement of a type II substrate, 
i.e., aniline hydroxylase, detectable (Table 4.12). Bbrther, 
no qualitative changes in cytochrome Pif50-carbon monoxide or 
ethyl isocyanide liganding was detectsble. From these results, 
therefore, it is likely that the in vitro enhancement detectable 
for bipherg&g-hydroxylase activity after preincubation with 
chemical carcinogens is not caused by a modification of the normal 
cytochrome P450 dependent drug metabolism systems which are well 
documented in hepatic systems (Masters ^  al., 1973; Waterman 
et£l., 1973).
As has been described previously (Anders, 1968), acetone 
and 2,2 ’bipyridine markedly enhance aniline hydroxylase activities 
when added directly to incubation mixtures. Similar effects have 
been reported upon the addition of metyrapone (Leibman and Ortiz,
1973), and volatile anaesthetics (Van Dyke and Rikans, I970).
Thus the in vitro enhancement of a mixed function oxidase is not
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unique. To ascertain if the in vitro enhancement of biphenyl-2- 
hydroxylase is similar to the above mechanism, two approaches 
were employed, namely the effect of addition in vitro of acetone 
(0,25 M) and metyrapone (O.l M) on rat hepatic microsomal drug 
metabolism activity, and the effects of the in vitro addition 
of 3,4-benzpyrene and phenobarbitone upon drug metabolism systems 
other than bipheiyl-2- and -4-hydroxylase.
The addition in vitro of either metyrapone or acetone 
(Table 4.13) to rat hepatic microsornes, in contrast with 3,4- 
benzpyrene addition, produced an inhibition of biphenyl-2- and -4- 
tydroxylase. When 0.5 M acetone was emplcyed, biphenyl-2-hydro3ylase 
activity decreased by 35^, whilst biphenyl-2-hydroxylase activity 
decreased by 6^, Similarly, when 2o0 mM metyrapone was employed, 
biphenyl-2-hydroxylase activity decreased by 27%, whilst biphenyl- 
4-bydroxylase activity decreased by 5^. Thus in both cases, 
biphenyl-4-hydroxylase activity was inhibited to a greater extent 
than bipheny 1-2-hydroxylase. In agreement with the workers cited 
above, in vitro enhancement of aniline hydroxylase was apparent 
only at higher acetone concentrations (0.2-0.5 m) and metyrapone 
concentrations (5.0 mM) investigated, 0.5 M acetone produced 
a 58% elevation of aniline hydroxylase, and 5.0 mM metyrapone
1 2 2
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produced a 44% elevation in activity. These findings clearly 
indicate that the carcinogen mediated enhancement of bipheny1-2- 
hydroxylase is a distinctly different phenomenon from that 
observed for acetone and metyrapone on aniline-4-tydroxylation.
4.2,7 Carcinogen Activation as a Prerequisite for Enhancement of 
Biphenvl-2-Hvdroxylase Activity in Vitro
While it is probable that most carcinogens elicit in vivo 
damage through their conversion to an active electrophilic or 
free radical intermediate ( M a g e e ,  1974) ty the NADPH 
cytochrome P450 hydroxylating system, it is not possible to 
determine directly whether or not carcinogen metabolism is a 
prerequisite for the enhancement of biphenyl-2-hydroxylase 
activity. The use of inhibitors of cytochrome P450 is not prac­
tical, since this would also produce significant inhibition of 
biphenyl-2- and -4-bydroxylase activity which is thought to be 
at least partially cytochrome P450 dependent (Burke, 1973).
As an alternative approach, the period of preincubation of test 
compounds with microsornes was varied, with the consequent increase 
in the metabolism of the compound.
Such a regime was applied to à number of carcinogenic 
conpounds: 3,4-benzpyrene, 2-acetamidofluorene, safrole and
1 'hydroxy safrole; a questionable carcinogen, piperonyl butoxide; 
and the non-carcinogen (in the rat), phenobarbitone (results are 
shown in Figures 4-.34 to 4,19).
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FIGURE 4. IL 
Effect of Variation in Preincubation Time 
upon 2"»acetamidofluorene Mediated Enhancement 
of Biphenyl-'2-hydrolase Activity
Results shown are for unpreincuhated (• e) and preincubaled
(■----■) microsornes prepared from six rats.
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FIGURE 4.15 
Effect of Variation in Preincubation Time 
upon I’hvdroxysafrole Mediated Enhancement 
of Biphenyl~2~hvdroxvla3e Activity.
Results shown are for ur^ reincubated (# ■ ■ #) and pre incubated 
(■— — a) microsornes prepared frcm six rats.
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Effect of Variation in Preincüb ation Time 
upon Safrole Mediated Enhancement 
of Biphenvl~2~hydroxvlase Activity
(h a) microsornes prepared from six rats
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FIGURE 4.17 
Effect of Variation of Preincubation Time 
upon Piperonyl Butoxide Mediated Enhancement 
Of Biphenyl«»2~hydro3cyla3e Activity in Vitro
Results shorn are for unpreincuhated (e e) and preincuhated
(e— — ■) microsornes prepared from six ratSé
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FIGURE 4.18 
Effect of Variation of Preincubation Time 
upon 3 ^ 4-benzpyrene Mediated Enhancement 
of Biphenyl-2-hydrcDcyla3e Activity in Vitro
Results shoTOi are for unpreincubated (#— __#) and preincubated 
(b ■) microsornes prepared from six rats.
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FIGURE 4.19 
Effect of Variation of Preincubation Time 
upon Phenobarbitone Mediated Variation in 
Biphewl-2-hydroxvlase Activity in Vitro
Results shown are for unpreincubated (e and preincubated
(■--- ■) microsornes from six rats.
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In the case of. 2-acetamidofluorene, safrole, I'hydroxy- 
safrole and piperonyl butoxide, a direct relationship between 
preincubation time and enhancement of bipheny 1-2-hydroxylase 
activity was observed. In general, the longer the preincubation 
time, the greater the level of enhancement of bipheny1-2-fcydroxylase 
activity.
The behaviour of 3,4-benzpyrene was somewhat different; 
after the minimal practicable time period of preincubation 
(5 minutes), maximal enhancement occurred; increasing the pre­
incubation time did not increase the level of enhancementj There 
are two likely explanations for this phenomenon: either 3,4-
benzpyrene was rapidly metabolised in vitro. or no metabolism 
prior to enhancement was required. The former is probably more 
likely, since relatively high levels of benzpyrene l:\ydroxylase 
activity in rat liver microsomes have been reported (Lake et al..
1974; see Table 4.12).
Phenobarbitone, as expected, produced no enhancement of 
bipheny1-2-hydroxylase activity when preincubated for 5-30 minutes 
with, microsomes and a regenerating system.
Interestingly, piperonyl butoxide was almost indistinguishable 
from 2-acetamidofluorene, safrole and I'hydroxysafrole, although it 
has not been reported as a carcinogenic hazard.
1 3
Bipheny 1-2-hydroxy la se is an atypical drug metabolism 
enzyme in that it is less specific in its requirements for 
reduced co-factors than biphèryl-4-tydroxylase (Burke, 1973),
i.e., either NADHg or NADPHg will permit bipheny 1-2-hydroxylation 
to occur; substitution of NADPH^ by NADH^, however, markedly 
reduces bipheny 1-4-bydroxylase activity.
Since carcinogen metabolism is frequently dependent upon 
NADPHg, preincubations carried out with NADHg instead of NADPHg 
should allov/ biphenyl-2-hydroxy'lation to occur, but not carcinogen 
activation.
Table 4.20 shows the effect of such a regime with either 
rat or hamster hepatic microsomes preincubated with safrole* In 
the presence of NADPHg, enhancement of biphenyl-2-hydro3ylase 
of 6^  and in hamster and rat microsomes respectively was 
found. If, hov/ever, NADPH^ was replaced by NADH^, enhancements 
of only for hamster and 27^ for rat were observed with safrole, 
whilst control bipheny1-2-hydraxylase was not significantly 
affected, ,
These results indicate that metabolism of carcinogens such as 
safrole is required before the enhancement of bipheny 1-2-hydroxylase 
activity can occur. It should not be forgotten, however, that this 
conclusion is based on the assunption that the enhanceable form of 
biphenyl-2-hydroxylase is similar to the basal form with regard to its 
cofactor requirements.
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Finally, in this study the effect of glutathione upon the 
carcinogen mediated, enhancement of hi,pheryl*"2—hydroxylase activity 
was examined, because other workers (Bcyland and Williams, I965) 
have shown that it exerts à protective effect against the influence
of various compounds Upon microsomal membranes, probably ty
reducing the availability of active metabolites.
Glutathione in high concentrations reduced the in vitro 
enhancement of bipheny 1-2-hydrojylase after preincubation with 
either safrole or 3,4-benzpyrene (Figure ^ 2j), whereas bipheiyl- 
4-hydroxylase activity was unaffected. ;
Thus it would appear that a variety of organic carcinogens, 
but not inoiganic or non-carcinogens, possess the ability to 
enhance bipheny1-2-hydroxylase activity in vitro. This enhance- 
ment cannot be explained in terms of conversion of biphenyl-4- 
hydroxylase to bipheny 1-2-hydroxy lase; indeed^ the two enzymes 
appear to be independent. Decreases in both Km and Vmax occur 
upon preincubation of 3,4-benzpyrene, whilst time pre incubât ion 
studies, cofactor studies and the use of glutathione indicate the 
need for carcinogen metabolism prior to enhancement.
1 3 4
FIGURE 4.21
The Effects of iKLutathione upon PreincuUated Microsomes
Results shown are for preincuhation with safrole ( e- « biphenyl-2-
hydro3çrlase, G---O biphenyl--4-hydroxylase) and 3,4~benzpyrene
biphenyl-2~hydroxylase,/y_— -abiphenyl-i^-hydroxylase). Test conpounds 
and glutathione were added simultaneously prior to a 10 minute
values mean 
240 -
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200
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CHAPTER 3
STORAGE AND DRUG
3 INTRODUCTION 1 3 6
5.1 STABILITY- OF MICROSOMAL ENZYMES DURING STORAGE OF 
HEPATIC MICROSOmL PREPARATIONS
One of the more obvious problems to be faced in the examination 
of drug metabolism by the study of in vitro enzyme activity is the 
effect upon enzyme activity of the time-lag between the sacrifice 
of the experimental animal and commencement of assay. Further, 
knowledge as to the storage behaviour of microsomal preparations 
may allow the material to be stored and used at a later date, with 
obvious advantages to both research and routine drug metabolism 
assays.
A number of workers have investigated the storage charac-i- 
teristics of microsomal mixed function oxidase i^ sterns. For 
exanple, human post-mortem liver microsomal pellets retain their 
original (ureyl-C ) tolbutamide hydroxylation kinetics over two 
weeks storage at -20® ( D a r b y ^ .  , 1972), while Clark (1967) 
reported that freezing of 10,000 g supernatant prepared from rat 
liver homogenates did not inactivate pethidine-N-deraethylation over 
"several days". Pedersen and Aust (l970) have stated that storage 
at -15° under nitrogen and in the presence of 50^ glycerol has no 
effect upon aminopyrine-N-demethylation in rat liver microsomal 
suspensions. The authors, however, did not specify ary time limit 
for this phenomenon. Storage of rat or pig hepatic microsomes
1 3 7
at - 18® for 1-4 days had no significant effect upon the in vitro
metabolism of imipramine (Gigon and Bickel, 1971).
Investigations into the effects of storage upon spectral 
interaction activity have been carried out. Seven days' storage 
at -5 largely destroys the type I (hexobarbital) but not type II 
(aniline) spectral interaction activity of rat liver 10,000 g 
supernatant (Shoeman et al.. 1969)î the type I spectral interaction 
of benzphetamine and diphenylhydantoin diminishes by some 30^  ^after 
six hours and 80^ after 24 hours storage (Kutt ^  al^, 1970)•
o
storage of microsomal suspension at -15 for 18 days brought about
no loss of activity with respect to binding affinity, aniline
bydroxylation or aminopyrine déméthylation.
Early investigations by Leadbeater and Davies (1964) reported
that the loss of déméthylation activity from liver microsomes was
o'best prevented by storage as buffered suspensions at -40 ; this 
study was carried out for 30 days. Attempts to use "freeze-dried"
10,000 g supernatant or microsomal suspensions were less successful.
Storage of micros anal enzyme preparations at 0 have been 
singularly unsuccessful: Levin et al. (1969) reported that if
microsomes were to be stored for a time period greater than 24 hours 
it v/as essential that the material be stored at -15 as a pellet
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rather than a suspension or freeze-dried preparation. Similar 
results have been found for cytochrome P450 (v/ade et al., 1972: 
Burke, 1973).
In an attempt to rationalise microsomal storage changes, 
Hewick and Fouts (1970 ) measured a variety of drug metabolism 
parameters every 12 hours during a 96-hour storage period. The 
rat microsomal preparations were stored at -15® under nitrogen.
The formation of carbon monoxide and ethyl isocyanide - cytochrome 
P45O ligands and pyridine haemochromogen were almost totally 
stable during this period. In contrast, type I interactions 
showed a two-fold greater rate of decey, paralleling decreases in 
microsomal hydroxylation of type I and II substrates. Similar 
decay responses were reported by Wade et al. (1972).
Jefcoate and Gay lor (I969) reported that although microsomal 
P45O is stable for 24 hours at -15® with regard to its ability to 
ligand with CO, the high spin component of its E.S.R. signal is 
lost. The authors suggested that this phenomenon could be erqplained 
in terms of subtle changes in the oxidised cytochrome P450 haem 
environment. This is not the only explanation, however, since it 
has been proposed iy Ichikawa and Yamano (1970) that the high spin 
E.S.R. signal arises from the oxidised cytochrome P420 and that 
p420 is unstable to storage in the presence of oxygen (Hewick and 
Pouts, I970).
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During recent years, attempts have been made to explain
the cause of storage damage, Jacobson and Archakov (I971) and 
Karuzina (1971) have postulated that the inactivation of mixed 
function oxidase systems in an NADPH environment is due to the 
destruction of microsomal lipids which are vital for full mixed 
function oxidase activity. Burke (1973) indicated that degradative 
changes that occurred upon storage of hamster hepatic microsomes 
were acconç>anied by increases in lipid peroxidation measured by 
malonaldehyde production.
Lipid peroxidation is a reaction of oxidative deterioration 
of polyunsaturated lipids. It appears that the system responsible 
for lipid peroxidation is similar to the mixed function oxidase 
system. Peroxidation of the unsaturated fatty acids, particularly 
of liver microsomal phospholipids, readily occurs in the presence 
of NADPH and oxygen (Hochstein and Urns ter, 1963; May and McCay,
1968). Lipid peroxidation leads to loss of structure of certain 
phospholipids of the membrane, primarily as a result of attack on 
the unsaturated fatty acids of the -position (May and McCay ,
1968).
The. NADPH dependent flavoprotein NADPH cytochrome c reductase 
is involved in both lipid peroxidation and drug oxidation (l^ 
and McCay I968 b ; Pedersen at , 1972), suggesting a close
1 <1 o
relationship between lipid peroxidation and the mixed function 
oxidase activity in the liver. Further, Gran and Fouts (I966) 
have demonstrated a correlation between lipid peroxidation and 
the breakdown of cytochrome P/f50. The same authors suggested 
from malonaldehyde measurements that induction of lipid peroxi­
dation occurred after treatment of hepatic microsomes in vitro 
with ferrous ions and was related to a shaip decline in ethyl 
raorphine-N-demethylase.
Because of the apparent relationship between lipid peroxi­
dation and drug metabolism, it was possible that the enhancement 
of bipheny1-2-hydroxylase activity after treatment of microsoraes 
in vitro with carcinogens could be related to changes in lipid 
peroxidation. A study of the effects of carcinogens on lipid 
peroxidation would provide a useful complement to storage studies.
5.2 EXPERIMENTAL
The extent of lipid peroxidation was determined by the 
formation of malonaldehyde and like products (Slater and Sawyer, 
1971). It should be noted that the thiobarbituric acid method used 
to detect malonaldehyde is not a specific measure for the breakdown 
of microsomal membranes (Franz and Cole, 1962). Saslaw ^  (I966)
have shovm that peroxidation of linoleic and archidonic acid gives 
rise to a number of carbanol compounds but not to malonaldehyde.
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The use of either ettyl oleate or ground nut oil as solvent 
for the addition of test conpounds resulted in falsely high 
malonaldehyde values (Cox (1972)). A range of other solvents 
were tested and as a result of these studies 1.15^ KOI was emplcyed 
for the addition of phenobarbitone and dimethyInitrosamine, while 
ethanol was used for safrole,3A"henzpyrene and carbon tetrachloride. 
These solvents were employed because they gave rise to no spurious 
coloured products in the thiobarbituric acid reaction, nor to any 
increases in lipid peroxidation (Cox (1972)).
5.3 RESULTS
5*3.1 Effects of Storage upon the Ability of Carcinogens to Enhance 
BiT3henvl-2-hydroxylase in Vitro.
Tables 5.1 to 5.9 illustrate the effects of storage upon 
the ability of carcinogens to increase bipheny 1-2-hydroxylase 
activity vitro. From the above results, it is clear that 
storage has a profound effect upon tiiis phenomenon. In every 
case of microsomal storage, irrespective of either the preparative 
technique or storage procedures employed, no enhancement of 
biphenyl-2-hydroxylase activity was observed after the carcinogen 
treatment in vitro.
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TABLES 5.1 TO 5.9
Effects of Microsomal Storage upon Safrole 
or 3.4-benzpyreme Mediated Changes in Biphenyl-2- and -4- 
hydroxylase Activity in Vitro
Studies were carried out on rat hepatic raicrosomes, 
prepared by either differential centrifugation or isoelectric 
precipitation, or upon solid liver samples.
Material was stored at -20 or -40 either as a suspension 
of protein concentration 10 mg/m\ in media containing 0.01 M 
p-mercaptoethanol, 0.25 M sucrose and 0.1 M magnesium sulphate; 
other material was stored in pellet form overlayed with 0.1 M 
phosphate/20^ v/v glycerol buffer. Solid samples were stored as 
centimeter cubes at either -20° or -40°.
Results are expressed as nmol, product/rag microsomal 
protein/minute - S.D. (eight animals). Percentage variations 
from control are shown in parenthesis, control = lOC^. In each 
case, controls were regarded as the basal biphenyl-2- and -4- 
hydroxylase activity, prior to preincubation with the carcinogen.
For example, if microsomes stored for 72 hours were studied, the 
basal activities for biphenyl-2— and -4-hydroxylase recorded in 
those preparations prior to preincubation were regarded as the 
control activities.
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TABLE 5.1
Effects of Safrole epd 3.4~benzpvrene on Biphenyl Hydroxylation
by Microsomes Prepared by Differential Centrifugation and Stored
■ . oas a Pellet at -40
Time
0
24
72
120
Safrole preincubated
Biphenyl-2-hydroxylase
Control : Test
0.48 i 0.05 0.86 i 0.05 (l79)^
0.46 i 0.02 0.42 i 0.04 (9l)
0.46-0.01 0.44 ± 0.03 (96)
0.45 - 0.03 0.41 - 0.03 (91)
Biphenyl-4-hydroxylase
Control Test
4.2 ± 0.4 3.7 * 0.3 (88)'^  
3.4 * 0,2 (79)'^
3.0 - 0.4 (77)'^
3.0 * 0.3 (83)''
4.3 = 0.2 
3.9 * 0.5
3.6 - 0.5
3.4-benzpyrene preincubated
Storage
Time
Ihours)
0
24
72
120
Bipheny 1-2-hydroxylase 
Control Test
0.46 - 0.01 1.87 - 0.09 (407)^
0.44 - 0.03 0.42 i 0.03 (95)
0.43 - 0.03 0.41 - 0.05 (95)
0.41 - 0.02 0.41 - 0.04 (100)
B ipheny1-4-hydroxvlase 
Control Test
4.5 * 0.3 4.2 - 0^7 (93)
4.1 * 0.2 4.0 * 0.3 (98)
3.8 ± 0.4 3.4 * 0.1 (89)
3.6 * 0.2 3.5 * 0.4 (97)
Î P.^ 0.05
/ 0.5
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TABLE 5.2
Effects of Safrole and 5«4-benzpyrene on Biphenyl Hydroxylation 
by Microsomes Prepared bv Differential Centrifugation and Stored
as a Suspension at -40
Storage
Time
(hours)
0
24
72
120
Safrole preincubated.
Biphenyl-2-hydroxylase
Control Test
0.43 -0.04 0.76 ± 0.02 (177)*
0.40 i 0.06 0.37 i 0.03 (93)
0.38 - 0.05 0.34 i 0.04 (89)
0.36 - 0.04 0.35 - 0.03 (97)
Biphenyl-4-hydroxylase 
Control Test
4.2 * 0.4 3.0 ± 0.3 (71)''
4.2 ± 0.6 2.8 * 0.4 (66)''
3.7 * 0.3 2.6 i 0.2 (70)'^
3.4 * 0.2 2.3 * 0.5 (68)'^
Storage
Time
(hours)
0
24
72
120
3.4-benzpyrene preincubated 
Biphenyl-2-hydroxylasé
Control Test
0.42 - 0.03 1.67—  0.15 (398)*
0.41 - 0.04 0.39 - 0.02 (95)
0.39 - 0.04 0.39 - 0.03 (100)
0.34 - 0.03 0.36 i 0.05 (105)
Bipheny1-4-hydroxylase 
Control Test
4.2 * 0.6 3.9 * 0.4 (93)
4.0 * 0.2 3.8 * 0.3 (95)
3.7 * 0.3 3.4 * 0.4 (92)
3.2 * 0.2 3.3 ± 0,4 (103)
I 0.05
/ 0.5
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TABLE 5.3
Effects of Safrole and 3 «4-benzpyrene on Biphenyl Hydroxylation 
by Microsomes Prepared by Isoelectric Precipitation. 
Material Stored in Pellet Form at - 20?
Storage
Time
(hours)
0
24
72
120
Safrole preincubated 
Biphenyl-2-hvdroxyla se 
Control Test
0.58 ± 0.07 0.96 - 0.07 (167)*
0.31 - 0,05 0.29 - 0.03 (94)
0.27 - 0.05 0.26 - 0.06 (96)
0.18 ± 0.06 0.20 ± 0.03 (ill)
Bipheny1-4-hydroxy la se
Control Test
5.5 -0.5 4.2 i 0.5 (76)^
2.8 - 0.4 1.7 - 0.7 (60)^
2.4 - 0.6 1.4 - 0.4 (58)^
2.1 t 0.4 1.2 - 0.5 (57)^
3.4-benzpyrene pre incubated
Storage
Time
(hours)
0
24
72
120
Biphenyl-2-hydroxylase
Control Test
0.54 - 0.07, 2.03—  0.11 (377)*
0.33 - 0.02 0.34 - 0.06 (103)
0.31 - 0.02 0.28-0.04 (90)
0.17 - 0.03 0.16 - 0.05 (94)
Bipheny 1-4-hydroxylase 
Control Test
5.6 * 0.6 4.9 * 0.3 (87)
2.9 i 0.3 2.7 * 0,7 (93)
2.3 * 0.5. 2.1 * 0.3 (91)
2.0 * 0.4 2.0 * 0.6 (100)
Î p $  0.05
/ P ^  0.5
1 4 G
TABLE 5.4
Effects of Safrole and 3.4-benzpyrene on Biphenyl Hydroxylation 
by Microsomes Prepared by Isoelectric Precipitation. 
Mateidal Stored as Suspension at -20°
Storage
Time
(hours)
0
24
72
120
Safrole preincubated 
Bipheny1-2-hydroxylase 
Control Test
0.52 - 0.06 0,86 - 0.05 (167)*
0.37 - 0.04 0.35 - 0.03,(94)
0.26 - 0.02 0.27 - 0.02 (103)
0.18-0.03 0.1 9 - 0.06
Biphenyl-4-hydroxylase
Control Test
5.4 ± 0.6 4.7 - 0.4 (87)^
3.9 - 0.4 3.1 - 0.3 (79^
3.1 -0.5 2.4 i 0.5 (77)^
3.0 i 0.3 2.8 - 0.2 (93)
Storage
Time
(hours)
0
24
72
120
3,4-benzpyrene preincubated
Bipheny 1-2-hydroxylase 
Control Test
0.53 - 0.05 2.20 i 0.05 (117)
0.36 - 0.03 0.34 - 0.02 (94)
0.26 i 0.07 0.24 - 0.03 (92)
0.17 - 0.02 0.17 i 0.04 (100)
Biphenyl-4-hydroxyla se
Cont rol Test
5.6 - 0.6 5.4 - 0.2 (96)
3.7 - 0.3 3.3 - 0.3 (89)
3.0 i 0.2 2.9 - 0.2 (97)
2.6 - 0.4 2.7 - 0.7 (103)
Î P ^  0.05
/ p 0.5
TABLE 5.5
Effects of Safrole and 3.4-benzpyrene on Biphenyl Hydroxylation 
by Microsomes. Prepared from Intact Stored Liver
Material was stored as intact pieces of liver at -20°. Prior to 
assay, microsomes were prepared by differential centrifugation.
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Storage
Time
(hours)
0
24
72
120
Safrole preincubated
Bipheny1-2-hydroxylase
Control Test
0.49 - 0.06 0.82 i 0.03 (l69)*
0.42 - 0.04 0.54 - 0.07 (132)''
0.39 - 0.04 0.37 - 0.03 (95)
0.41 - 0.05 0.40 i 0,04 (97)
B ipheny1-4-hydroxylase 
Control
4.6 -  0.6
4.2 ± 0.7
4.3 ± 0.5
4.1 - 0.3
Test
3.6 ± 0.3 (82/
3.2 ± 0.5 (76)'^
3.4 ± 0.6 (so/
3.9 ±0.4 (76/
Storage
Time
3.4-benzpyrene preihcubated 
Biphenyl-2-hydroxyla se BiphenyI-4-hvdroxylase
(hours) Control Test Control Test
0 0.47 - 0.03 1.86 ± 0.09 (397)* 5.5 - 0.3 5.3 ± 0.5 (96)
24 0.43 - 0.05 0.91 ± 0.11 (212)* 4.3 - 0.7 4.1 ± 0.4 (95)
72 0.39 - 0.02 0.37 ± 0.02 (95) 4.1 — 0.2 3.8 ± 0.7 (92)
120 0.36— 0.04 0.34 ± 0.04 (97) 4.0 i 0.4 3.6 ± 0.3 (90)
Î p<: 0.05
/ 0.5
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TABLE 5.6
Effects of Safrole and 5.4-benzpyrene on Biphenyl Hydroxylation 
by Microsomes Prepared from Intact Stored Liver
Material was stored as intact pieces of liver at -40 . Prior to 
assay, microsomes were prepared by differential centrifugation.
Storage
-Time
0
24
72
120
Safrole preincubated
Biphenyl-2-hydroxylase
Control Test
0.52 i 0.07 0.87 i 0.03 (169)*
0.39 - 0.06 0.52 i 0.07 (134)
0.36 i 0.03 0.33 - 0.05 (91)
0.36 - 0.04 0.34 - 0.04 (94)
Bipheny1-4-hvdroxylase 
Control Test
4.7 - 0.8 3.8 ± 0.3 (80)*
4.5 * 0.6 3.1 - 0.5 (69/
4.1 ± 0.5 3.0 ± 0.6 (73)''
4.4 ± 0.8 2.9 ± 0.4 (67/
3.4-benzpyrene pre incubated
Storage
Time
(hours)
0
24
72
120
Biphenyl-2-hydraxylase 
Control Test
0.47 ± 0.04 1.87 ± 0.07 (383)*
0.48 ± 0.07 1.29 ± 0.90 (269)*
0.39 ± 0.02 0.37 ± 0.04 (95)
0.36 ± 0.04 0.35 ± 0.05 (97)
Biphenyl-4-hydroxylase 
Control Test
5.0 ± 0.3 4.8 ± 0.5 (94)
4.6 i 0.9 4.4 ± 0.4 (96)
4.1 - 0.4 3.8 ± 0.6 (93)
4.0 ± 0.5 3.7 ± 0.5 (92)
Î 0.05 
/ p 4  0.5
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TABLE 5.7
Effects of Safrole and 3.4-benzpyrene on Biphenvl Hydroxylation 
by Microsomes Prepared by Isoelectric Precipitation. 
and Stored in Pellet Form at
Storage
Time
Safrole preincubated 
B ipheny1-2-hydro xylase
(hours) Control Test
0 0.61 i 0.09 0.97 - 0.05 (159)
24 0.41 - 0.08 0.39 - 0.06 (95)
72 0.32 i 0.09 0.36 ± 0.03 (112)
120 0.39 i 0.07 0.35 - 0.04 (90)
Bipheny1-4-hyd roxylase 
Control Test
5.3 * 0.6 4.1 ± 0.9 (77)
3.9 ± 0.4 3.0 * 0.6 (77)''
3.6 - 0.7 2.9 * 0.6 (80)''
3.1 * 0.5 1.8 * 0.4 (60)*
(hours)
0
24
72
120
3.4-benzpyrene preincubated 
Bipheny1-2-hydro xylase 
Control Test
0.59 - 0.06 2.22 i 0.11 (377)
0.39 - 0.05 0.37 - 0.03 (95)
0.37 - 0.02 0.35 - 0.06 (95)
0.29 i 0.05 0.30 - 0.05 (103)
Ï P <  0.05
/ P ^  0.5
Bipheny 1-4-hydroxy lase 
Control Test
5*1 — 1.1 4*9 - 0.7 (96)
3.6 i 0.6 3.4 - 0.4 (94)
3.4 - 0.8 3.2 - 0.2 (94)
3.0 - 0.4 3.0 i 0.5
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TABIE 5.8
Effects of Safrole and 3.4-benzpyrene on Biphenyl Hydroxylation, 
by Microsomes Prepared by Isoelectric Precipitation. 
and Stored as a Suspension at -40°.
Storage
Time
IbpursJ!
0
24
72
120
Safrole preincubated
Bipheny1-2-hvdroxvlase
Control Test
0.55 - 0.07 0.86 i 0.07 (157)*
0.39 - 0.04 0.37 - 0.05 (95)
0.32 i 0.05 0.32 i 0.07 (100)
0.24 - 0.06 0.25 - 0.05 (104)
Biphe ny1-4-hydroxylase 
Control Test
4.9 * 0.6 3.9 * 0.4 ( 80)''
3.7 * 0.5 3.1 * 0.5 (84)''
3.1 * 0.7 2.0 * 0.6 (65)''
2.9 * 0.5 1.6 1 0.4 (55)''
Storage
Time
3.4-benzpyrene preincubated 
Biphenyl-2-hydroxylase Bipheny1-4-hydroxylase
LOurs ) Control Test Control Test
0 0.62 i 0.10 2.33 * 0.09 (377)* 5.3 * 0.5 5.4 * 0.2 (101)
24 0.44 i 0.05 0.43 * 0.03 (97) 3.6 - 0.3 3.3 * 0.2 (92)
72 0.38 ± 0.03 0.40 * 0.07 (105) 3.0 ± 0.5 2.9 * 0.4 (97)
120 0.27 - 0.06 0.29 * 0.04 (107) 2.7 * 0.7 2.2 ± 0.3 (82)
Î P -$0.05
/ p 4  0.5
TABLE 5.9
Effects of Safrole and 3,4-benzpyrene on Biphenyl Hydroxylation 
^Mlçrgspmes Prepared by Differential Centrifugation. 
and Stored as a Pellet at -20°.
1 s 1
Storage
Time
Ihours)
0
24
72
120
Safrole preincubated
Biphenyl-2-hydroxylase
Control Test
0.46 i 0.07 0.75 - 0.04 (164)''
0.44 ± 0.04 0.43 - 0.03 (97)
0.41 - 0.05 0.43 i 0.04 (104)
0.41 - 0.03 0.40 i 0.03 (98)
Bipheny1-4-hydroxylase
Control Test
4.4 - 0.3 3.1 - 0.2 (70)''
4.1 i 0.2 3.0 i 0.2 (71)''
4.2 i 0.5 2.8 i 0.4 (66)''
3.6 i 0.4 2,6 ± 0.2
Storage
Time
(hours)
0
24
72
120
3.4-benzpyrene pre incubated
Bipheny1-2-hydroxylase 
Control Test
0.48 i 0.04 1.84 - 0.09 (385)*
0.43 - 0.03 0.43 - 0.06 (100)
0.40 - 0.04 0.38 ± 0.05 (95)
0.3 8 - 0.06 0.3 6 - 0,0 2 (95)
Bipheny 1-4-hydroxvlase
Control Test
4.3 * 0.5 4.1 * 0.4 (95)
4.1 * 0.4 3.8 ± 0.5 (93)
4.0 - 0.5 3.6 - 0,3 (90)
4.0 * 0.2 3.4 * 0.2 (85)
Î P ^  0.05 
/ P < 0.5
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This was in marked contrast to fresh material, where 
bipheny 1-2-hydroxylase was consistently enhanced after treatment 
of microsomes ^  vitro with either safrole or 3,4-benzpyrene.
A marginal decrease in basal biphenyl-2- and bipheny1-4- 
hydroxylase activity was detectable after the 24-hour storage 
period (approximately iq& decrease)» The slight loss of 
biphenyl-2-hydroxylase activity could not explain the total loss 
of ”enhanceable" bipheny1-2-hydroxylase activity. Storage did 
not appear to significantly affect the inhibition of bipheny1-4- 
hy droxy la se by safrole; consistent inhibition values (^40^) 
occurring throughout the stuty.
With stored whole liver (Tables 5*5 to 5*6) it was possible 
to enhance bipheny 1-2-hydroxylase activity for storage periods of 
24 hours duration, although the levels of enhancement were con­
siderably reduced compared to fresh material (a decrease in 
enhancement ofll4^ after ]^-benzpyrene preincubation),
5.3.2 Effects of Microsomal Storage upon Basal Drug Metabolism Activities
Figures 5.10 to 5.16 illustrate the effects of various 
storage conditions upon activities of various mixed function 
oxidases. Conditions employed paralleled those described previously 
(pageif^ l^ ) when the effects of storage upon carcinogen mediated 
enhancement of bipheny1-2-hydroxylase were investigated.
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FIGURE 5.10: Storage of Hepatic Microsomal Fractions: Time
Dependent Increase in Malonaldehyde Levels.
FIGURES 5.11 to 5.16: Showing the Storage Characteristics of
Hepatic Mixed Function Oxidase Systems.
KSï
Normal microsomes Isoelectric Precipitated
Microsomes
-40°c , pellet '
-20°C, pellet A A
-ifO°C, suspension * *
-20°C, suspension ^
Stored whole liver:
Ordinate: Percentage activity relative to
fresh sample.
Abscissa: Storage time (hours).
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For this experiment microsomal fractions were again prepared 
by either differential centrifugation or isoelectric precipitation. . 
Preparations were stored as either suspensions or washed pellets. 
Studies utilising stored whole liver were also carried out.
It should be realised that each graphical point represents 
only one measurement and is therefore subject to error; it is, 
however, still of practical benefit to compare the decay charac­
teristics of each fraction employed.
At various time intervals the activities of aminopyrine, 
N-demethylase, biphenyl-2- and -4~hydro3cylase, aniline hydroxylase 
and NADPH cytochrome c reductase were measured together with the 
corre^ondihg levels of cytochrome P450 and malonaldehyde in each 
fraction.
From Figures 5*10 to 5.16 a number of observations can be 
made. For the first twenty hours of the study, bipheny 1-2- 
hydroxylase is more stable than bipheny 1-4-hydroxylase. After 
48 hours, hcv/ever, more 4-hydro xylase activity remains as compared 
with 2-hydroxylase activity. These results confirm previous work 
in this area (Burke M.D., 1973).
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This apparent initial stability of ‘biphenyl-2-hydroxylase 
activity is, however, in marked contrast to the effects of 
storage upon carcinogen mediated enhancement of bipheny 1-2- 
hydroxylase activity (see previous section).
It is also interesting to note that the decgy in metabolism 
of biphenyl, a type I substrate, to 2- and 4-hydroxybiphenyl 
follows that of aniline (a type II compound) more closely than 
that of aminopyrine (another type I compound). Also, in the initial 
stage of decay, NADPH cytochrome c reductase follows aminopyrine- 
N-demethylase more closely than aniline-4-hydroxylase. In the ' 
latter stages of the study^ this behaviour is reversed with the 
decay in reductase activity closely following the activity of 
ani line-4-hy drojgr la se.
It would appear that basal drug metabolism activity is best 
maintained by storage at low temperature, i.e.-20° or below, 
irrespective of the method of preparation. In general, pellet *
stored material is more stable than when stored as a suspension.
This was most apparent in the case of aminopyrine-N-demethylase.
Simultaneously with the decay of drug metabolism activity 
on storage was an increase in the malonaldehyde levels (Fig. 5.10). 
This inverse relationship between malonaldehyde and enzyme activities
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was apparent throughout the study. After l62 hours storage, 
enzyme activities were between Ofo and 20fo of the fresh sample; 
the malonaldehyde levels were "JOOfo to 1600^ of the starting 
values,
A further point of interest is that microsomes prepared 
by isoelectric precipitation appeared to be more labile than 
microsomes prepared by differential centrifugation. After 20 
hours, the initial decay in enzyme activity and P450 content is 
more rapid in microsomes prepared by isoelectric precipitation, 
and again this decline in activity is associated with increases 
in the levels of malonaldehyde (Fig. 5.10).
After the initial 20-hour period, the rates of decay for 
both types of microsomes were similar for all parameters studied.
5.3.3 Storage of Whole Liver
In stored whole liver preparations it was possible after 
24 hours to produce some enhancement of biphenyl-2-hydroxylase 
after pretreatment of microsomal preparations with chemical 
carcinogens.
Investigations of basal drug metabolism in stored solid liver 
indicated that the activity of the mixed function oxidase system 
was maintained at higher percentages than other preparations
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(Table 5 ’5). Both type I and type II metabolism and cytochrome 
P450 content were only marginally affected (decrease by
storage, as was the malonaldehyde level.
5.3.4 Lipid Peroxidation and the Enhancement of Biphenvl-2-hydroxylase 
Activity
Wills (1969) has shown that the induction of lipid peroxi­
dation in microsoraes by preincubation with ascorbate or NADPH dr, 
by treatment with ionizing radiation leads to a sharp decline in 
the ability of microsomes to oxidize aminopyrine or to hydroxy late 
aniline. It was suggested that inactivation of drug metabolising 
enzymes occurred with disintegration of microsomal membranes but 
not with inhibition by toxic products formed by lipid peroxidation, 
because addition of a product of lipid peroxidation, malonaldehyde, 
did hot cause any alterations in the capacity of fresh microsomes 
to oxidize aminopyrine. It has been hypothesized by several 
investigators (Wills, 1969,* Gram and Fouts, I966; Anders, I969) 
that apparent activation of drug-metabolizing enzymes should occur 
if lipid peroxidation was inhibited.
For example, addition of EDTA, an inhibitor of lipid peroxi­
dation, to microsomal incubations has been shown to improve the 
linearity with time of N-demethylation of ethylmorphine (Kamataki 
and Kitagawa, 1972). It also produced marked changes in Michaelis
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kinetics, the Km values being significantly smaller after 
treatment. Further work by the same authors (Kamataki and 
Kitagawa, 1973) indicated that EDTA inhibited lipid peroxidation 
and apparently stimulated the rate of N-deraethylation of 
ethylmorphine and aminopyrinq.
It should be noted that Anders (I969) reported that aniline 
hydroxylation was not increased by the addition of EDTA to 
inhibit lipid peroxidation; however, Kamataki and Kitagawa (1973) 
have pointed out that Anders employed 1 mM aniline which inhibits 
lipid peroxidation completely and therefore a further effect of v 
EDTA in inhibiting lipid peroxidation was not anticipated.
To investigate a possible relationship between changes in 
lipid peroxidation and carcinogen mediated enhancement of 
biphenyl-2-hydroxylase activity, the effect of a number of carcino­
genic and non-carcinogenic compounds upon lipid peroxidation was 
investigated. The effects of promoters and inhibitors of lipid 
peroxidation upon biphenyl—2— and —4-hydroxylase activity were 
also investigated.
Table 3.18 shows the effects of microsoraes preincubated with 
a variety of compounds on lipid peroxidation. Of the compounds 
examined, both carbon tetrachloride and dimethylnitrosamine
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produced significant increases in lipid peroxidation. (After 
30 minutes, carbon tetrachloride produced a 40^ increase in 
lipid peroxidation; a 64^ increase in lipid peroxidation 
occurred after 10 minutes preincubation with dimethylnitrosamine).
The effects of carbon tetrachloride upon lipid peroxidation have 
been examined in detail previously (Slater and Sai^ yer, 1971 a, b,
C o x  , 1972). Slater and Sawyer ( 1971b) reported than an
increase in lipid peroxidation of 26^ occurred after preincubation 
of microsomes for 30 minutes at 37 with 2 jxl of carbon tetra­
chloride. It can be seen that the results reported above for 
the effects of carbon tetrachloride upon lipid peroxidation are 
in agreement with previous workers.
In contrast, safrole (lOCÇS of control values at 30 mins. ) 
and 34 benzpyrene (l05^ of control values at 30 mins.) produced 
no significant effects upon lipid peroxidation, and were similar 
in this respect to the non-carcinogenic compound phenobarbitone 
(lOQ?o of control values at 30 mins.). No inhibition of lipid 
peroxidation was detectable with any compounds known to enhance 
in vitro biphenyl-2-t\ydroxylase activity.
To substantiate the hypothesis that there is no causal 
relationship between inhibition of lipid peroxidation and 
enhanced biphenyl-2-hydroxylation, compounds known to be effective
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inhibitors and stimulators of lipid peroxidation were examined 
■for their effect upon biphenyl-2- and -4-hydroxylation,
Cytochrome P450 concentration and ethylmoiphine N-demethylation 
since these have been widely reported to be sensitive to lipid 
peroxidation (e.g. Kamataki and Kitagawa, 1973;
Figures 3.17 and 3.18 illustrate the effect of EDTA and 
ferrous amnonium sulphate. In accordance with previously 
published work, EDTA (5 pM to 20 pM) was found to inhibit lipid 
peroxidation almost totally (9?^ inhibition at 10 pM EDTA), and 
ferrous ammonium sulphate enhanced it (34^ of control values at 
Pe++ 15 pM), EDTA increased apparent cytochrome p450 (ll^ of 
control value at 10 pM EDTA) levels and ethyl mo rphine-N- 
demethylase activity (138^ of control value at 10 pM EDTA), 
while ferrous ammonium sulphate caused a significant decrease 
in both parameters (values at 10 pM Fe++ were: qytochrorae p450
inhibited 14^ and ethyl mo rphine-N-demethylation inhibited by 
25^ relative to control values,).
Addition of EDTA at a concentration of 5 pM also produced 
an inhibition (64^ of control activity) of biphenyl-4-hydroxylase, 
whereas higher concentrations produced an increase in activity.
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The initial inhihitoiy effect is probably due to chelation of 
magnesium ions which appear to be a prerequisite for maximal 
biphenyl-4-hydroxylase activity (see Section 3.3). At higher 
EDTA concentrations the inhibition of lipid peroxidation becomes 
apparent and probably causes the measured increase of bipheny 1-4- 
hydroxylase activity.
After treatment with Pe++ (5-20 pM) a decrease {id/i at 10 pM) 
in bipheny 1-4-hydroxylase activity similar in magnitude to the 
previously reported decrease in cytochrome P450 and ethyl morphine- 
N-demethylase was noted.
Interestingly, biphenyl-2-hydroxylase was not significantly 
affected by Fe++ and only marginally affected hy EDTA, and in this 
respect the behavious of biphenyl-2- and -4-hydroxylase were 
dissimilar.
From the foregoing results it is clear that the in vitro 
enhancement of bipheryl-2~hydroxylase activity by benzpyrene or 
safrole is not attributable to either inhibition or promotion of 
lipid peroxidation. Furthermore, the p re treatment of microsomes 
with carcinogens (Table 5.18) produced no consistent changes in 
lipid peroxidation, i.e., carbon tetrachloride and dimethyl­
nitrosamine produced an increase in lipid peroxidation whilst 
safrole and 3j4--benzpyrene produced no detectable effect.
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From the work described in this chapter a number of 
interesting points arise. Firstly, upon storage of microsomal 
preparations, basal drug metabolism activities including 
biphenyl-2- and -4-iydroxylase activity were only marginally 
reduced after 24 hours. After preincubation of these stored 
microsomal preparations with carcinCgens, it was not possible 
to detect an enhancement of biphenyl-2-hydro3ylase activity; 
nor was it possible to correlate this effect of storage with 
changes in lipid peroxidation, since firstly, the carcinogens 
investigated (e.g. dimethylnitrosamine, carbon tetrachloride, 
safrole and 3^-benzpyrene) had no consistent effect upon lipid 
peroxidation, and secondly that either promoters or inhibitors of 
lipid peroxidation produced no significant enhancement of 
biphenyl-2-hydroxylase activity.
Thus the effects of microsomal storage in eliminating the 
carcinogen mediated enhancement of bipheryl-2-hydroxylase suggests 
that upon storage some facet of the mechanism for the enhancement 
of bipheny 1-2-hydroxylase is altered or damaged, whilst the lack 
of correlation with lipid peroxidation suggests that this phenomenon 
is a subtle change, rather than one related to the gross morphological 
^ d  chemical changes that occur upon storage of microsomal preparations.
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FIGURE 5.18: Effects of Ferrous Ions (as Fe(NH, 1 .6u
on Lipid PeroxidatlonT"
Results shown are for lipid peroxidation (#-#), ethyl morphine-
N-demethylation (v— v), cytochrome P450. (d  □), bipheny 1-2-
hydroxylase (o  o ) and biphenyl-4-hydro3Qrlase (a a) by
fresh liver microsomes prepared from male Wistar rats (250 gm). 
Incubations were carried out as described previously, but were 
continued for 30 minutes.
Results are expressed as nmoles product/mg microsomal protein/ 
minute except for cytochrome P450 (nmoles/mg microsomal protein) 
and lipid peroxidation (nmoles malonaldehyde/rnl suspension).
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FIGURE 5.18
Effects of Ferrous Ions upon Lipid Peroxidation
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FIGURE 3» 19' Effects of EDTA On Lipid Peroxidation.
Results shown are for lipid peroxidation ----#), ethyl
morphine-N-deme thy lase  y), cytochrome P450 {□--- □),
■bipher^l-2-hydroxylase (o-— o) and biphenyl-if-l^droxylase 
(A— — a) by fresh liver microsomes prepared from male Wistar 
rats (250 gm). Incubations were carried out as described 
previously but were continued for 30 minutes.
Results are expressed as nmoles product/mg microsomal protein/ 
minute, except for cytochrome P450 (nraoles/mg microsomal protein) 
and lipid peroxidation (nmoles raalonaldehyde/ml suspension).
FIGURE 5.19 
Effects of EDTA Upon Lipid Peroxidation
1 7 4
I
•SQ)4-»OU
a,
a
CO 
0) r—I
Q
10 20
EDTA concentration uM
1 7 5
CHAPTER 6
DRUG METABOLISM. IN VARIOUS SPECIES
1 7 6
6.1 INTRODUCTION
6.1.1 Effect of Tissue and Species Differences upon Carcinogen Mediated 
Changes in Biphenyl Metabolism in Vitro
Significant differences in the ability to hydrojcylate 
biphenyl in the ortho and para positions have been established 
in mature animals in a number of species, including rabbit, rat, 
cat, coypu, and frog (Creaven et , I965). The adult hamster 
and mouse were reported to show a greater ability to metabolise 
biphenyl in the ortho position than the rat. In contrast, in 
the young rat the activity of bipheny1-2-hydrozylase is relatively 
high (Basu et al.. 197l)« The age dependency of this enzyme is 
not, however, displayed by the hamster or mouse, which show the 
expected pattern of increased activity with age (see Chapter 3).
Biphenyl metabolism has also been examined ih rodent 
extra-hepatic tissue, studies being carried out in intestine, 
kidney, lung, testes and spleen (Lake et al.. 1973). In contrast 
to its influence on hepatic enzymes, phenobarbitone did not 
stimulate any of the enzymes in any of the tissues examined, 
similarly dietary 3-methylcholanthrene did not affect biphenyl 
metabolism by the intestinal mucosa.
An investigation of the effects of carcinogens upon biphenyl 
metabolism in vitro in various species is outlined below. The 
purpose of this study was twofold: firstly, to obtain information
1 .7 7
as to the evolutionary nature of this phenomenon; secondly, and 
perhaps of. greater importance, to determine how representative are 
the species employed in in vitro enhancement studies.
Investigations into the effects of carcinogens upon biphenyl
' '  ^ - 7
metabolism in extra-hepatic tissue were also carried out, in an 
attempt to determine if the elevation of bipheny1-2-hydroxylase 
activity elicited iy carcinogens was confined to hepatic tissues,
6,2 RESULTS
6,2,1 The Effect of In Vitro Preincubation of Hepatic Microsomes with
Safrole and 3.4-benzryrene upon Biphenyl Metabolism in 
Various Rodent Species
Age differences in bipheryl metabolism cannot be ascribed
to changes in cofactor requirements or enzyme stability with the
. age of the hamster, mouse or rat (Chapter 3). These observations
in the rat might be inteipreted as a conversion with age of tbs
active bipheny 1-2-hydroxy lase to a latent form in the endoplasmic
reticulum. On this basis, its enhancement in vitro would be
explained through its reactivation. However, since the
hamster and mouse (in which this unusual age dependence is not
seen) show similar jui vitro enhancement of 2-hydroxylase activity,
with 3 ,4-benzpyrene, 20-methylcholanthrene, isosafrole and safrole
(Table 6.1), it is unlikely that such an explanation is valid.
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6.2,2 Effects of Natural and Synthetic Glucocorticoids upon Hamster 
and Rat Biphenyl Metabolism in Vitro
The effect of the inclusion of several natural and synthetic 
glucocorticoids in the ija vitro assay system for biphenyl and 
aniline hydroxylation by rat and hamster liver microsomes is 
presented in Table 6.2. At a concentration of 10 ^ M, dexamethasone 
caused an inhibition of aniline hydroxylation (23^ inhibition). 
Cortisal, corticosterone betamethasone and prednisolone produced 
very little change in the bipheny 1-4-hydroxy lase and aniline-4- 
hydroxylase activities, while dexamethasone, betamethasone and 
prednisolone enhanced significantly rat liver microsomal 
biphenyl-2-hydroxylase activity. The increase observed at lo""^  M 
was 659^  for prednisolone, 140^ for corticosterone, 1 6 ^  for 
dexamethasone and 680^ for betamethasone.
In contrast, these steroids caused no similar increase in 
biphenyl-2-hydroxylation when hamster liver microsomes were 
employed. The only change observed was a snail inhibition of 
the bipheny 1-4-hydro^ylase activity. This is the most clear-cut 
species difference so far observed. The reason is not clear, 
but it may reflect differences in the metabolic fate of these 
steroids in hamster compared to rat.
1 8 Q
TABLE 6,2
Biphenyl and Aniline Metabolism by Rat and Hamster 
Liyer Microsomes in the Presence of Various Glucocorticoids
Added in Vitro
.
Each value represents the mean - S.D, of four separate determinations 
and Î indicates values significantly (P^ 0.05) different from the 
corresponding controls from which steroid (lO~^M)but not 10 ul of 
ethanol (steroid solvent) was omitted. Enzyme activities are 
expressed as nmol product/rag microsomal protein/hour. Percentage 
activities relative to control are shown in parenthesis.
Steroid Added 
Control
Corticosterone
Cortisol
6 -hydroijqy-
corticosterone
Prednisolone
Betamethasone
Dexamethasone
Compound Added
Control 
Corticosterone 
Prednisolone 
Hexamethas one 
Betamethasone 
3,4- benzpyrene
Rat 
Bipheny1-4- 
hydroxy lase
52.0 i 3.1 (100)
58.7 i 4.1 (ll3)
59.8 i 3.6 (ll5)
58.7 2 7.1 (113)
54.6 ± 3.2 (l05)
44.7 - 4.4 (86) 
47.3 - 4.3 (91)
Hamster
Bipheny1-4-
216
209
190
196
203
160
15.1
12.2 
7.7 
11.1
14.1
11.2
(100)
(91)
Biphenvl-2- 
hydroxylase
8.2 i 1.2 (100)3. 34.0 - 2.1 (100)
16.7 ± 3.1 (204) 28.9 - 1.8 (85)
7.1 - 1.1 (87)
Aniline-4- 
hydroxylase 
+
9.6 ± 1.4 (117)1
13.5 2 1.3 (165)1 31.3 - 1.4 (92)
63.9 % 7.1 (780)1 : 29.2 - 3.1 (86)
21.5 - 3.1 (263)* 26.2 ± 1.3 (77)
Biphenyl-2-
hydroxylase
18.6 + 2.3 
18.9 X 3.1
16.0 i 1.4
19.0 - 1.7
21.0 i 1.9i
61.2 - 7.4
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6.2,3 Effects of Preincubation in Vitro with 3.4-Benzpyrene. Safrole 
and Phenobarbitone on Biphenyl-2- and -4-hydroxylase Systems 
Present in the Soluble and Microsomal Fractions of the Avocado Pear
The effect of the addition in vitro of some compounds upon 
biphenyl metabolism in the avocado pear was examined, because it 
is a tissue biologically far removed from mammals but still has
considerable levels of cytochrcxne P43G. Use of this preparation
" - ' ■
had two main advantages: firstly, it enabled information to be
'
obtained with regard to the evolutionaiy occurrence of this 
phenomenon; secondly, and perhaps of greater inportance, use 
of the avocado pear mesocarp allowed the preparation of both a 
microsomal and a soluble fraction containing drug metabolism 
activity in similar amounts. From centrifugation and electron 
microscopy studies^ the soluble fraction appeared to be free of 
fragments of the endoplasmic reticulum. Thus from one species 
a preparation with bipheixyl-2-hydroxylase activity could be 
obtained both with and without the influence of sedimentable 
microsomal membranes. During these studies, hamster hepatic 
microsomal preparations were employed as positive controls.
After preincubation, safrole produced an enhancement of 
in vitro bipheny 1-2-hydroxy lase activity in the microsomal 
fraction of the avocado pear (l6^ and 131^ of control levels
1 8 2
respectively), but had no effect on the 2-tydroxylase activity 
of the soluble fraction (Table 6.3). The enhancement produced 
by safrole preincubation was similar to that in hamster hepatic 
preparations, 3,4-benzpyrene, however, produced a significantly 
lower degree of enhancement in the plant system. Since it is 
probable that an active metabolite is required for carcinogens 
to enhance biphenyl-2-hydro3ylase, the difference could be due 
to low benzpyrene hydroxylase activity found in these preparations 
(Markham, A., 1976). In both hamster hepatic tissue and plant 
tissue the non-carcinogenic conpounds, phenobarbitone and 
T >2,3,4-dibenzpyrene, produced no significant enhancement of 
biphenyl-2-hydroxylase in either the microsomal or the soluble 
fraction. These findings could be interpreted as implying that 
the enhancement of bipheny 1-2-lydro:jqylase by carcinogens in vitro 
is mediated through an effect upon the microsomal membrane rather 
than via direct conformational modification of the enzyme itself.
In an attempt to further discriminate between the microsomal 
and soluble biphenyl-2- and -^-hydroxylase activities, the effects 
of "classical" cytochrome P450 inhibitors such as CX) and SKP 525A, 
and the influence of storage, metal salt inhibition and NADH upon 
the activities of these enzymes were examined and conpared with
1 8 3
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those of biphenyl-2- and -4-hydroxylase in hamster preparations 
(Table 6.4)* In no case was it possible to discriminate between 
the properties of soluble and microsomal biphery 1-2- and -4- 
hydroxylase activity in the avocado pear. Avocado pear and 
hamster preparations were also similar in that biphery 1-2- 
hydroxy lation was less prone to cytochrome P450 inhibitors than 
bipheryl-4-hydroxylation. For example, saturation with carbon 
monoxide produced the following inhibition of control biphery 1-2- 
jydroxylase activities : avocado -microsomal, 14^ inhibition;
avocado - soluble, 8^ inhibition; hamster - microsomal, 23^ 
inhibition; while for biphenyl-4-hydro3ylase 2;^, 19^ and 73^ 
inhibition was recorded. Further, NADHg could be satisfactorily 
substituted for NADPH2 for the 2-hydroxy lation but not the -
4-hydroxylation of biphenyl. However, it is also apparent from 
the above data that the biphery 1-2- and -4-hydroxylase activities 
Of the avocado pear were less prone to the effects of cytochrome 
P45O inhibitors than hepatic microscxnal biphery 1-2- and -4- 
hydroxylase. This may be attributable either to differences 
in the microenvironment of the endoplasmic reticulum, or differences 
in the nature of cytochrome P450 in avocado pear and hamster 
systems.
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6.2.5 Effects of Preincubation in Vitro with Carcinogenic and
Non-carcinogenic Compounds upon Drug Metabolism Systems other 
than Bipheny1-2- and"-4-hydrolase
VTe have previously reported that after preincubation of 
mammalian hepatic microsomes with carcinogens only biphery 1-2- 
tydroxylase activity was enhanced; other drug metabolism 
systems were either unaffected or inhibited.
This study has how been extended to include other drug- 
raetabolism systems in the microsomal and soluble fractions of 
the avocado pear. Preincubation with 3,4-benzpyrene but not 
phenobarbitone with the microsomal fraction caused a selective 
enhancement of only biphery 1-2-hydroxylase activity. Other 
enzymes studied which were not significantly affected included 
bipheny 1-4-hydroxylase, aniline hydroxylase, p-chlorometlylaniline 
demethylase, p-nitroanisole-N-demethylase, cytochromes 1450 and b5, 
and, NADPH cytochrome P450 reductase (Table 6.5).
Again, this highly selective effect caused by 3,4-benzpyrene 
preincubation on the microsomal drug metabolising enzymes implies 
that a specific change of the hydroxylation system is involved.
This is supported by the observation that no significant changes 
% in either the content of cytochrome P450 or activity of cytochrome
P450 reductase are observed.
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It appears either that microsomal biphery 1-2-hydroxy lase, 
unlike other drug metabolism lystems studied in either plant or 
animal tissues, is not entirely cytochrome P450 mediated, or 
that in the case of the avocado the addition of 3,4-benzpyrene 
promotes a change in the binding of biphenyl with the endoplasmic 
reticulum in a particular orientation, thus facilitating 
bipheny 1-2-hydro 3y lation,
6, 2,6 Biphenyl Metabolism in Unicellular Organisms
The species studies were further extended to include yeast 
8hd Escherichia coli. which in respect of drug metabolism mgy be 
regarded as more primitive than the above species. Table 6,6 
illustrates a number of interesting observations with these two 
species; firstly, prior to preincubation no biphenyl-2-hydro3ylase 
activity was detectable, whilst biphenyl-4-hydro3ylase was just 
detectable. After preincubation with a variety of compounds 
including 3,4-benzpyrene, Safrole and 3-methylcholanthrene 
(efficient enhancers of bipheny 1-2-hydroxylase in rodent prepa­
rations) biphenyl-2-hydro3ylase was still undetectable in either 
yeast or E, coli.
Before interpretation of these results can be made, yeast 
end E. coli preparations should be examined with regard to their 
metabolic capacity for activating the chemical carcinogens, using 
aged microsomes.
1 8  9
TABLE 6.6
Effect of Carcinogenic and Non-carcinogenic Compounds upon Bjpheiyl 
Metabolism in Unicellular Organisms
Results are expressed as nmoles product/mg protein/hour. Results 
expressed relative to control value are shown in parenthesis.
Yeast
Treatment Biphe nvl-2-hvdroxy lase Biphenyl -4-hy droxylas e
Control < 0.006 1.3 - 0.06 (lOO)
Safrole < 0.006 1.2 i 0.09 (94)
5,4-benzpy rene < 0.006 1.3-0.15(98)
20 methylcholanthrene < 0.006 1.4 - 0.11 (103)
Phenobarbitone < 0.006 1.4 i 0.17 (102)
E. Coli
Treatment Biphenyl-2-hydroxylase Bipheny1-4-hvdroxylase
Control / 0.006 1.2 - 0.03 (lOO)
Safrole < 0.006 1.1 - 0.02 (97)
3,4-benzpy rene < 0.006 1.0 i 0.04 (93)
20 methylcholanthrene < 0.006 1.3 i 0.01 (101)
Phenobarbitone 40.006 1.0 - 0.02 (91)
No bipheryl-2-hydroxylase activily was detectable before or after 
preincubation with test conpounds.
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6.2.7 Effect of Preincubation with 3.4-benzpvrene^ Safrôle and 
Phenobarbitone upon Extrahepatic Metabolism
Microsome3 were prepared from rat intestine, rat lung and 
ethione induced rat hepatoma tissue, as described in "Materials 
and Methods”, Rat hqpatic microsoraes were also prepared, to 
provide a positive control. Table 6.7 illustrates the effects 
of preincubation in vitro of 3,4-benzpyrene, safrole and pheno­
barbitone upon these preparations. It can be seen that in all 
three preparations, viz, intestine, lung and tumour, enhancement 
of bipher\yl-2-hQ^droxylase occurred after preincubation with carcino­
gens, but not the non-carcinogen examined. Safrole produced 
enhancements of 57^, 3^% and 52^ in intestine, lung and tumour 
microsomes respectively. 3,4-benzpyrene produced enhancements of 
152^, 121^ and 65^ respectively in these tissues. Biphenyl-4- 
hydrox/lase activity , as might be expected, was significantly 
inhibited by safrole in intestine, lung and tumour {28^, 49^ 
and 43^ inhibition respectively).
Thus it would appear that although biphenyl-2-hydro3ylase 
activity was considehably lower in extrahepatic preparations 
than in hepatic preparations, the ability of carcinogens to 
enhance bipheny 1-2-hydroxylase activity dri vitro was still 
apparent. Further, it has previously been noted (Chapter 4 )
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that non-hepato carcinogens will enhance biphenyl-2-hydroxylase 
in hepatic preparations. It non appears that hepato carcinogens 
will enhance the levels of bipherçr 1-2-hydroxylase in extrahepatic 
tissue, e.g. safrole. A lung and skin carcinogen such as 3,4“ '
benzpyrene will enhance biphenyl-2-hydroxylase not only in the 
lung, but in hepatic, intestinal and tumour preparations also.
Thus this atypical behaviour of bipheny 1-2-hydroxylase in response 
to carcinogens is not confined to hepatic tissue but probably has 
a more general distribution in mammalian organs which have a drug 
metabolising capability.
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EFFECTS OF XENOBIOTICS ON DHUG
METABOLISM IN-VIVO
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7 THE EFFECT'S OF CARGINO&ENIC AND NON-CARGINOG-ENIC COMPOUNDS 
UPON THE ACTIVITY OF BIPHENYL-2- AM) -4-HYDROXYLASE IN VIVO
7.1 INTRODUCTION
In Chapters 4-o we have described how the addition of a variety 
of carcinogenic substances, but not non-carcinogens, to hepatic 
microsomes causes an enhancement of bipheny 1-2-hydroxylase, but not 
bipheryl-4-hydroxylase, activity. The question of the in vivo 
relevance of this phenomenon is D O W  examined.
Such an extrapolation is potentially fraught with difficulties; 
for example, optimal metabolism conditions ^  vitro may poorly 
resemble the natural environment of the endoplasmic reticulum. 
Further, many more metabolic interactions, both for carcinogens and 
biphenyl, may occur in vivo than ^  vitro.
Two different experimental approaches were employed for this 
investigation. Firstly, the work of Creaven and Parke (1966) was 
repeated and expanded to include a broader range of carcinogens. 
Secondly, the effects of carcinogenic and non-carcinogenic compounds 
upon drug metabolism activities were monitored for varying time 
periods; animals were sacrificed from 15 minutes post-administration
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7.2 RESULTS
7.2.1 Effects of Pretreatment on the Hydroxylation of Biphertyl by Rat Liver 
Utilising similar techniques to Creaven and Parke (I966), the 
work of the above authors was repeated. Both qualitatively and 
quantitatively the results presented here are in agreement with 
these workers. Carcinogens provoking a preferential increase in 
bipheny 1-2-ly droxy la se activity relative to biphery 1-4-hydroxylase 
activity. Quantitatively, the levels of induction were also similar.
This study was then extended to include a wider variety of 
compounds, particularly compounds that had behaved atypically in 
the in vitro situation; results are shown in Table 7.2. The non- 
carcinogen 4-acetamidof luorene, which was found to enhance bipheryl- 
2-bydroxylase activi ty vitro also induced bipheny 1-2-hydroxylase 
activity 24 hours after i.p. administration in vivo. Similarly, 
diphenylnitrosamine, which produced a pronounced inhibition of 
biphenyl-2-hydro:^lase jui vitro, also inhibited bipheny 1-2-hydro:>ylase 
in vivo (24 hours after administration). Piperoryl butoxide also 
induced in vivo. Thus the anomalies apparent after preincubation 
in vitro were also apparent after ^  vivo administration. Of the 
other Gonpounds examined, the pattern was consistent (carcinogens 
preferentially induced bipheny 1-2-hydroxylase while non-carcinogens 
had little effect upon 2-hydro:ylation).
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7*2.2 Correlation of the Enhancement of BiT)henvl-2-hydroxylase Activity 
in Vitro and in Vivo
We have shown the enhancement of bipheny 1-2-hydroxylase to 
occur in vitro after 10 minutes p re incubât ion with a variety of 
carcinogens, while following intraperitoneal administration of 
similar compounds induction of bipheny1-2-hydroxylase occurs after 
24 hours. In an attempt to correlate these two observations,
3,4-benzpyrene, safrole and 3-methylcholanthrene were administered 
intraperit oneally to rats. The animals were sacrificed at inter­
vals after adndnis t rati on of between 15 minutes and 48 hours, and 
the activities of bipheryl-2- and -4-hydroxylase were determined. 
Figure 7,3 shows a typical result, in this case for safrole. It is 
apparent that after intraperitoneal administration, increases in the 
levels of biphenyl-2-hydrotylasé were clearly detectable sifter two 
houi^, with no corresponding increase in either cytochrome P450 or 
b5, while bipheny 1-4-hydroxylase was inhibited. The levels of 
bipheryl-2-hydroxylase increased to reach a maximum about four hours 
after administration, falling to almost basal levels after eight to 
ten hours. A second phase of increase bipheiyl-2-hydro3ylation 
occurred after 24 hours, at which time increases in cytochrome P450 
and other parameters of drug metabolism were observed.
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FIGURE 7.3
Showing the Effects of a Single Dose of Safrole (73 mg/Kg),
Administered i.p. to Male Adult Wistar Albino Rats
Results are shown for biphenyl-2-hydro3(ylase {a— — bipheny 1-4-
hydroxylase -a); aniline hydroxylase ( o— — o)î cytochrome
P450 (■--- *); and cytochrome b5 (*— — #).
Mean values from six animals are shown in each case and expressed 
relative to controls. Significant increases in enzyme activity
were detectable after 4 hours only in the case of bipheny1-
2-hydroxy lase.
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Administration of 3-methylcholanthrene and 3,4-benzpyrene 
produced similar effects; the effects of 3,4-benzpyrene are shown 
in Table 7*4: animals killed two hours after administration showed
even greater increases in biphenyl-2-hydro3ylation than occurred 
after treatment with safrole, and these differences correlated 
with the different levels of enhancement produced by these 
carcinogens in vitro (Table 7.4).
Upon examination of a non-carcinogenic compound, i.e., 
phenobarbitone, a different pattern was observed; between 0 and 8 
hours after administration no sign5,ficant increases in bipheny1-2- 
hydroxylase or other drug metabolism activities were detectable.
24 hours after administration small increases in drug metabolism 
activities were detected, for example, cytochrome P430 levels 
increased 20^ relative to control and bipheny 1-4-hydroxylase, 
activity increased by 15^, bipheny 1-2-hydroxylase activity ty 10^ 
(Figure 7.5).
7.2.3 Effect of Actinomvcin D upon in Vivo and in Vitro Carcinogen 
Mediated Increases in Binheny1-2-hydroxvlase Activity
The veiy rapid initial increase of biphènyl-2-lydroxylation 
following pretreatment with safrole, 3,4-benzpyiène or 3-methyl- 
cholanthrene dn vivo would tend to preclude ^  novo protein
2 0 1
TABLE 7.4
Changes in Rat Hepatic Microsomal Biphenyl-2- and -4-hydroxylase 
Activity after Preincubation and after Intraperitoneal 
Administration of 3.4-benzpyrene. 3~methy1cholanthrene. Safrole
or Phenobarbitone
Results are expressed as percentage increase of enzyme activity 
- S.D,. for six animals, observed after 10 min. preincubation or 
2 hours.after intraperitoneal administration.
A. Biphenvl-2-hydroxylase
Treatment
3,4-benzpyrene
3-methylcholanthrene
Safrole
Phenobarbitone
B, Biphenvl-4-hydroxylase
Treatment
10 minute 2 hours after
in vitro preincubation i.p. adminis tration
+ 253 - 23* + ; 240 i 19*
+ 125 i 11* + 137 - 21*
+ 82 i 7* + 80 - 14*
- 7 - 9 6 - 7
10 minute 2 hours after
in vitro preincubation i.p. adminis t ration
3,4-benzpyrene - 9 - 6 - 17 - 12
3-methylcholanthrene - k -  7 - 11 - 7
Safrole - 34. i 6* - 37 ± 11'
Phenobarbitone - 8-4- + 3 - 6
Î indicates values significant]y different from control (P 4- 0,05)
2 0 2
FIGURE 7.5
Demonstrating the Effects of a Single Dose of Phenobarbitone
(lOO mg/kg) administered i.p. to Male Wistar Albino Rats,
Results shown are for 'bipher5rl~2~hydroxylase (a--- a), hiphenyl-
4-hydroxylase (à- aniline hydro:^lase (o— o), cytochrome
P450 (■— !— ■) and cytochrome h5 (•■----40.
\
Mean values for six animals are shov/n in each case and expressed 
relative to control values. No significant increases in enzyme 
activity were detectable after 4 hours.
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synthesis as the cause of enhancement of this enzyme. However, 
the secondary phase of increase in enzyme activity is probably 
due to de novo protein synthesis since both biphenyl-2- and 
-4-hydroxylation are increased.
Support for this interpretation was found upon simultaneous 
dosing with  ^,4-be nzpy re ne (75 mg/Kg) and actinomycin D (l mg/kg) 
and comparing the results to 5,4-benzpyrene given alone (Table 7.6).
Four hours after administration of 3,4-benzpyrene, biphenyl- 
2-hydroxylase activity was increased by 350^; with the same time 
interval after administration of 3,4-benzpyrene and actinonycin D 
a similar increase of 34-0^  was observed, an insignificant difference. 
When, however, bipheny 1-2-lydroxylase activities were measured at 
40 hours, amarked difference was observed. A single dose of
3,4-benzpyrene induced bipheny 1-2-hydro%rlase activity by 280^; 
after the simultaneous dose of 3,4-benzpyrene and actinomycin D, 
induction of 18C^ was recorded. The use of actinonycin D implicates 
de novo protein synthesis in the second phase of biphenyl-2-hydroxy- 
lase increase but not the first.
Returning to the in vitro situation, it can be seen (Table 7.7) 
that no significant differences in the levels of enhancement were 
obtained when either 3,4-benzpyrene or 3,4-benzpyrene plus actino­
nycin D were preincubated with hepatic microsomes.
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TABI£ 7.6
The Effects of a Single Dose of 3 .4-benzpyrene 
(75 mg/Kg). a Simultaneous Dose of 3.4-benzpyrene (20 mg/Rg) 
and Actinomvcin D ( 1 mg/kg) . or Two Doses of 3.4-benzpyrene,
(75 mg/kg).the second Dose Administered 6 hours after the 
first, upon Bipheny 1-2-hydroxy la se Activity in Male Wistar
Albino Rats
The test conpounds were administered intraperitonealy in ground 
nut oil.
Results shoY/n are expressed as nmol/mg microsomal protein/min.
- S.D. six animals; percentage changes relative to control values 
are expressed in parenthesis.
Time after
Admini­
stration
3,4-benzpyrene 
Pretreatment
Dual 3.4-benzpyrene 
Pretreatment
3,4-benzpyrene 
+ Actinomycin D
(hours)
0 0.23 - 0.02 (100) -, 0.24 - 0.03 (100)
0.25 0.37 - 0.01 (I6l)* — 0.36 - 0.02 (150)
2 0.51 - 0.03 (331)* - 0.52 - 0.04 (216)
4 0.80 - 0.04 (347)* — 0.82 - 0.05 (341)
6 0.44 - 0.03 (191)* 0.42 - 0.02 (182) 0.43 - 0.04 (179)
8 0.28 -0.04 (121) 0.29 i 0.01 (126) 0.28 - 0.02 (116)
24 0.45 - 0.03 (196)* 0.49 - 0.02 (213) 0.32 - 0.04 (133)
40 0.51 - 0.04 (221)* 0.57 - 0.04 (247) 0.37 - 0.03 (154)
48 0.65 - 0.02 (282)* 0.39 - 0.04 (162)
Significance
Biphenyl-2-hydroxylase activity was significantly stimulated after 
pretreatment with 3,4-benzpyrene (P^^ 0.05). A second dose of 3,4- 
benzpyrene did produce a fuither significant increase in bipheny1-2- 
hydro3ylase activity, nor did actinomycin D significantly affect the 
stimulation observed.
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TABLE 7.7
Effects of Preincubation of 3.4-Benzpyrene. or 3.4-Benzpyrene 
plus Actinomycin D . Upon Biphenyl Metabolism in V i t r o .
Hepatic microsomes were prepared from mature male wistar rats ;
3.4-benzpy rene was added in ground nut oil (l mg/ml). Actino­
mycin D (l mg/ml in 1,15^ w/v KGl) was added simultaneously with
3.4-benzpyrene (img/lKg in ground nut oil). Enzyme activities are 
expressed as nmoles product/mg microsomal protein/min. - S.D, 
eight animals. Percentage activity relative to control is shown 
in parenthesis.
Biphenyl-2-hvdroxylase Bipheny 1-4-hy droxylas e
Control 0.24 - 0.02 (lOO) 2.3 - 0.03 (100)
3.4-benzpyrene 0.74 - 0*06 (308)* 2.0 - 0.04 (87)
3.4-benzpyrene
plus actinonycin D 0.72 - 0.04 ( 300) 2.0 - 0.06 ( 87)
Î indicates values significantly different from control (P ^  0.05). 
Addition of actinonycin D did not significantly affect 3,4-benzpyrene 
mediated enhancement of bipheryl-2-hydroxylase.
S O S
7.2.4 Kinetic Changes During the Initial Transient Increase in Biphenyl-2- 
hydipxylase Activity
An investigation into Km and Vmax changes that take place 
during the initial transient increase of bipheny 1-2-hydroxylase 
following i.p. administration of 3,4-benzpyrene (Table 7.8) indicates 
that this initial increase of bipheny 1-2-hy droxyl as e is due both to 
a lowering of the Km and an increase in Vmax values: control Km
5.1 X 10 mol/l, Vmax 2.2 x 10^ mbl/min/mg. microsomal protein.. 
(expressed in similar units), 4 hours after carcinogen administration 
Km was 0.21, Vmax 7.6. After 8 hours the Km and Vmax tended to 
return to basal levels once more (Km 3.9, Vmax 3.2), Conparison 
with the values obtained after in vitro enhancement (Chapter 4) 
indicates that these two situations are comparable.
7.2.5 In Vivo Effects of Steroids upon Biphenyl Metabolism
The effects of addition of steroid hormones to rat and hamster 
hepatic microsomes in vitro have been discussed previously, beta­
methasone enhancing rat but not hamster bipheny 1-2-hydroxylase 
activity.
When betamethasone was administered i.p. to rats and hamsters, 
cytochrome P450 and hip heny 1-4-hydroxy las e activi ty Were initially 
depressed, whereas aniline-4-hydroxylation was marginally higher than 
the control values (0-8 hours after administration) (Figures 7.9 and
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7;10). A slow rise in all three parameters then followed in both 
species. After 48 hours in the hamster, but not the rat, the 
increase of enzyme activities and cytochrome P450 content 
continued until the experiment was terminated 64 hours after the 
administration of betamethasone.
The response of b ipheiy 1-2-hy droxylas e to betamethasone was 
markedly different in the two species. In the hamster, after the 
i.p. administration of betamethasone a veiy gradual rise in bipheryl- 
2-hydro3qylase activity was observed, which became prominent after 
24 hours and rose to 26c^ and 380^ of the control values at 48 
and 64 hours respectively. On the other hand, in the rat a shaip 
rise in biphery 1-2-hydro^ylation occurred soon after betamethasone 
administration, peaking at four hours to 340^ of the control value. ■ 
An equally rapid fall in the enzyme activity then followed, reaching 
106^ of the control value, in eight hours. After this time, biphezyl- 
2-hydroxylase activity rose again to 310^ and 350^ of the control 
value at 48 and 64 hours respectively, paralleling the observations 
made in the hamster at these times.
7.2.6 Enhancement of Biphenvl-2-hvdroxvlase by Chemical Carcinogens - 
Reversible or Irreversible 9
Utilising the transient in vivo increase in bipheny 1-2-hydroxy- 
lase activity, a stu<^ was made of its reversibility or irreversibility 
in two ways.
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FIGIJBE 7.9
The Rat Liver Microsomal Biphenyl and Aniline Hydro3(ylation 
in Vitro after a Single Intraperitoneal Dose of Betamethasone
One dose (i6 pmol/kg body weight) of betamethasone was given intra- 
peritoneally. The results, mean from four animals, are
expressed as a percentage of control values. The symbols are:
A— - - "'A biphery 1-2-hy droxyl as e:
▼— — V bipheryl-if~hydroxylase:
■ ■ aniline-if~hydroxylase:
#--- # cytochrome P450:
280_
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The Hamster Liver Microsomal Biphenyl and Aniline Hydroxylation 
in Vitro after a Single Intraperitoneal Dose of Betamethasone
Betamethasone was given int rape ri t oneally CVt a dose level of 36pmol/ 
Kg bodl,y weight. The results, mean from four animals, are
expressed as a percentage of control values. The symbols are:
▲----▲ bipherorl-2-hydroxylase:
yf--- V bipheny 1-4-hydroxylase :
m— — ■ aniline-if-hydrojqylase:
 # qytochrome P450:
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In one experiment, two groups of animals were given a single 
intraperitoneal dose of 3,Wenzpyrene (75 mg/kg). After 2,4,5,6 
or 8 hours, one group of animals was sacrificed and bipheny1-2- 
hydroxylase activity was measured (see Figure 7.11 ); with the 
second group of animals again sacrifices were made at 2 and 4 hours, 
a second dose of 3,4-benzpyrene (75 mg/kg) was administered to the 
remaining animals which were then sacrlfied 1,2 and 4 hours after 
this second administration.
Following 3,4-benzpyrene pretreatment, after the first four 
hours, maximal activity of bipheny 1-2-lrQrdroxylase is found which 
subsequently diminishes. If this phenomenon is reversible, the 
second dose of 3,4-benzpyrene should once again stimulate biphenyl- 
2-hydroxylase activity. From Figure 7.11 it can be seen that this 
is not the case. The second dose of 3,4-benzpyrene produced no 
significant effects upon the decline of biphenyl-2-hydro3qylase 
activity from 4-8 hours after the initial dose was administered.
The second approach utilises a combination of in vivo and 
in vitro techniques. 3,4-benzpyrene (75 mg/kg) was administered 
intraperitoneally; animals were sacrificed 1,2,3,6 and 8 hours 
after administration. Microsomes were prepared and bipheny 1-2- 
hydroxylase activity was determined. Using sanples of the microsomes
2 1 2
FIGURE 7.11
Showing: the Effects of Two Intraperitoneal Administrations
of 3 A-benzTTyrene upon Biphenyl-2-»hydroxylase Activity
3,4-benzpyrene was administered i.p, in each case at a concentration 
of 75 mg/Kg; the second dose was administered six hours after the
first. Results shown are for single dose (#--- #) and second dose
(h ■). Results are expressed relative to control values.
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prepared in this way, attempts were made to enhance bipheny1-2- 
hydroxylase activity by 3,4-benzpyrene. Thus enhancement studies 
were carried out upon material already showing the in vivo transient 
increase in biphenyl-2-hydroxylase activity.
Figure 7»12 illustrates the results of such studies. For 
the first four hours of the stuty, it can be seen that while 
material was showing transient increases in bipheny 1-2-hydroxylase, 
enhancement to a level of 400^ occurred after preincubation vitro.
Once the transient peak had been passed, however, and bipheny 1- 
2-hydro3ylase activity had begun to decline, it was not possible to 
enhance biphenyl-2-hydroyylase activity in vitro. !Nomal enhancement 
occurred throughout the study when 3,4-benzpyrene was pre incubated 
with control microsomes.
These results reinforce the view that the in vivo transient 
increase after carcinogen pretreatment results from irreversible 
changes in the system, the nature of which remain to be defined.
7*2.7 Rat Hepatic Ultrastructure Changes Four Hours after 3.4-benzpyrene 
Administration
We have previously discussed (Chapter 4) the work of Rabin 
et al. (l97l). who have demonstrated the ability of a variety of 
carcinogens to remove ribosomes from the rough endoplasmic 
reticulum (degranulation).
■ 21 ^
FIGURE 7.12
Effects of Addition of 3.4-benzpyrene in Vitro upon Biphenyl-
2-hydroxylase Actiyity following Intraneritoneal Administration
of 3.4-benzpyrene.
Results shown are for the effects of 3,4-benzpyrene upon freshly
prepared microsomes in vitro ( ▲-- _a ) , hepatic microsomes prepared
from animals having received 3,4-benzpyrene intraperitonealy (#-- —•) ,
and enhancement studies carried out ih vitro upon hepatic microsomes
that had previously received 3,4-benzpyrene (75 mg/Kg) (■--- ■)«
Results are expressed relative to control values.
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To investigate the possibility of a correlation between 2 1 5
this phenomenon and the transient increase in biphenyl-2-hydro3cylase 
activity, electron micrographs were prepared from hepatic tissue 
obtained from control rats, and rats that had received 3,4-benz- 
pyrene (75 mg/Kg) four hours previously. It can be seen from 
Figure 7.13 that in both cases, ribosomes were still attached to 
the endoplasmic reticulum, suggesting that the transient increase 
of biphenyl-2-hydro3ylation and the degranulation of the rough 
ehdoplasmic reticulum are not directly related.
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FIGURE 7.15
Effect o f 5A-benzpyrene upon Rat Hepatic Ultrastructure
3,4-benzpyrene (75 mg/Kg) was administered intraperitoneally to 
male wistar rats; four hours after administration, animals were 
sacrificed and electron micrographs prepared.
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CHAT'TtP 8
DIETARY ADMINISTRATION OF SaFEOLE
ITS Eî'FECTS ON DRUG METABOLISM
2 18
8. . EFFECTS OF LONG-TERM SAFROLE ADMINISTRATION
UPON BIPHENYL METABOLISM IN PARTICULAR 
AND DRUG METABOLISM IN GENERAL
8.1 INTRODUCTION
Cancer is considered to be primarily a disease of old age.
The highest mortality from cancer occurs in humans after the age 
of 50 (Schoental, 1974)* However, this is not necessarily because 
younger animals are less susceptible; for example, newborn 
animals receiving certain carcinogens, e.g. polycyclic hydro­
carbons, aromatic amines, azo compounds and urethane, have proved 
to be more vulnerable than adults (Toth, I968; Dellaporta and 
Terracini, I969; Roe and Walters, I968). At the onset of 
senescence, the susceptibility to tumour development again increases; 
for example, a single application of dime thy Ibenz(cA) anthracene 
causes a higher incidence of benign papillomas on skin grafted from 
14 month donor mice as compared with young (2 months) donors 
(Ebbesen, 1973, 1974).
The importance of immunodeficiency for the effects of many 
carcinogens has been amply demonstrated. Co-occurrence of decreased 
immune reactivity and high incidence of tumours in old animals, 
(Teller and Marion, 19&7; Hanna, 197l) suggests that deterioration
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of the general immune status is important for the increased risk 
of developing spontaneous neoplasm with increasing age. Age 
dependent changes in hormonal status have also been suggested as 
being of general importance for neoplasia development in. older
animals (Dilman, 1971)*
Thus with changes in the age of the animal, susceptibility 
to carcinogens can vary. Previous chapters have described the 
effects of carcinogens upon biphenyl-2-hydro3çylation ija vitro and 
in vivo in adult animals. To extend this investigation, a long­
term dietary experiment was embarked on, animals being fed a 
powdered diet containing 0.25^ (w/v) safrole ad libitum for 410 
days. Controls consisted of animals fed the same diet, without 
the safrole, for 410 days* éO-day-old rats were also included in 
the study to permit comparisons with the adult animals normally 
used in studies described in this thesis.
Electron microscopy was initiated to permit a correlation 
of changes in enzyme behaviour (if any) with changes in cellular 
ultrastructure. Our main concern in this study centred upon the 
endoplasmic reticulum, this being the site of drug metabolism 
activities under investigation. Svobode and Higginson (I968) 
have reported that after both acute and chronic administration of
2 2 0
aflatoxin diethylnitrosàmine, dimethylnitrosamine and 
thioacetamide thére was ribosomal detachment from the rough 
endoplasmic reticulum and increased smooth endoplasmic reticulum* 
However, it should be noted that detachment of ribosomes 
can occur after treatment with non-carcinogens (Barker et al.. 
1963).,\
8.2 EXPERIMENTAL AND RESULTS
8.2.1 Effects of Long-term Safrole Intake upon Basal Drug Metabolism 
Activities
After removal of animals from safrole intake ten days prior 
to study, the activities of biphenyl-2- and -4"hydrolase, aniline 
hydro3ylase, 4-chloromethylaniline demethylase, ethyl morphine-N- 
demethylase, nitro reductase, benzpyrene hydroxylase, cytochrome 
P450 and b5, NADPH cytochrome P450 reductase and NADH cytochrome C 
reductase were measured, treated 420 day animals being compared 
with 420 and 60 day old controls. As might be expected, drug 
metabolism activities were lower for 420 day old than 60 day old 
control animals (Table 8.1). Basu ^  al. (l97l) reported no 
measurable biphenyl-2-hydroxylase activities in rats of 60 days 
of age or over. Our study has again shown (Chapter 3) that 
biphenyl-2-hydroxylase is present over a far greater age range.
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TABLE 8.1
Microsomal Drug Metabolism Activities in Male Wistar Albino Rats
Animals were either untreated 60 or 420 day old, or 420 day old 
rats that had received a diet of 0.25^ safrole daily ad libitum 
for 410 days.
Untreated 
éo day old
Untreated 
420 day old
Safrole diet 
420 day old
Bipheny1-2-hydroxylase 0.26 + 0.07 0.038
+ 0.01 0.027
■ + 0.01
Bipheny1-4-hydroxylase 2.3
+ 0.08 0.91
+
0.03 0.83
+ 0.02
Aniline hydroxylase 1.8 + 0.04 0.52 0.01 0.46 + 0.01
4-chloromethylaniline
demethylase 4.1
+
0.15 1.1 0.03 0.81
+
0.04
Ethylmoxphine-N-
deraethylase 3.1 0.17 1.4 0.06 0.64
+
0.07
Nitro reductase 3.4
+ 0.06 0.8 + 0.04 0.52
+
0.03
Benzpyrene hydroxylase 0.09
4"
0.003 0.003
+ 0.0002 0.002 + 0.0004
Qytochrome P450 1.32 i 0.02 0.41
+ 0.01 0.38 + 0.02
Cytochrome b5 0.79
+
0.04 0.23
+ 0.02 0.17
+ 0.01
NADPH cytochrome P450 
reductase 5.7
+ 0.26 1.8 + 0.07 0.77
+ 0.08
NADH cytochrome C 
reductase 391 + 27 93 ± 15 74
+
7
Results of enzyme activities are expressed as nmoles/mg microsomal 
protein/min; cytochromes as nmoles/mg protein; ethylmorphine-N- 
demethylase activities were expressed as nmoles HCHO formed/mg 
protein/min.
In all cases, drug metabolism activities were signi-ficantly lower 
( P 0.05) in 420 day old untreated and treated animals when compared 
to 60 day controls.
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The effect of prolonged safrole intake, produced decreases 
of activities for all the drug metaholism systems examined. The 
inhibitory effects of methylene dioxyphenol compounds such as 
safrole are well documented and have been discussed previously 
(Chapter 4), It is possible therefore that the observed lower 
drug metabolism activities observed in animals that had received 
a prolonged intake of safrole could be attributed to the inhibitory 
properties of this compound.
To ascertain the inhibitory effects of safrole, animals 
were removed from the diet for time periods of between 2-20 deys, 
Biphenyl-2- and -4~lydro3ylase activities were then determined and 
compared to activities in untreated»410 day old animals (Figures 8,2- 
8,3), Slight increases in bipheny1-2- and -4-hydroxylase activity 
were noted 2-8 days after removal fron the diet; drug metabolism 
activities were hov/ever still lower than control values.
These results suggest that although the relatively low drug 
metabolism activities in animals that had received a prolonged 
safrole diet can only partly be explained in terms of safrole 
inhibition, other changes in the endoplasmic reticulum, perhaps 
of a subtle morphological character, may also occur.
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TABLE 8.2
Removal of Animal from Safrole Diet, and its Effect upon Bipherryl-
4-hydroxylase Activity
Animals received a diet containing 0,25^ (w/w) safrole diet ad 
libitum for 410 days.
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TABLE 8.3
Removal of Animals From Safrole Diet and its Effect upon 
Bipheny 1-2-hvdroxyl ase Activi tv
Animals received a diet containing 0.2^(w/w) safrole diet ad 
libitum for 410 days.
0.0&-1
+>
S
A
1
:
*1
m(D
rHO
•rl+Î
8
<D
3
r4
I
Ï
cij
A
I
pq
0.05-
0.04—
0.03-
0.02-
0.01-
2 ' ~l 1  ~ ~ T  ~
Time after removal from safrole diet (days).
Results shown are for 410 day control groups (#--- #) and animals
receiving the safrole diet for 410 days (a ■).
%
2 2 5
8.2,3 Kinetics of Biphenyl Metabolism in Safrole Pretreated Animals 
Investigation of the kinetic properties of bipheiyl-2- 
and -4-hydroxylase in 60 and 420 day old controls, and 420 day 
test animals (410 days safrole intake, removed from diet 10 days 
prior to study) are shown in Table 8.4. In the control groups 
little variation in either Km or Vmax values occurred. Km and 
Vmax values for bipheny 1-2-lydroxylase activity in 60 day old 
control animals were 8.1 -0.9 and 6.9 - 1.8 respectively, whilst 
for 4-hydroxylase activity Km was 5.2 - 1.2, Vmax 3.9 - 0.7. In 
420 day old control animals Km was 14.2 - 0.6, Vmax 7.7 - 2,1 for 
biphenyl-2-hydroxylase (Significantly different from 60 day control 
groups 0.05).
Significant differences (P'^ 0.05) were observed in animals
that had received the safrole diet; here Km values of 22.4 - 2.1 
and Vmax values of 19.7 - 1.8 were obtained. No variations in 
either Km or Vmax for biphenyl-4-hydroxyl ase relative to control 
values were recorded.
8.2.4 Properties of Biphenvl Metabolism in Long-term Safrole Pretreated 
Animals
Having considered kinetic parameters, the study was extended 
to include pH optima, storage characteristics and heat stabilities 
at 55°.
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TABLE 8.4
Kinetics of Biphenvl Metabolism in Rat Hepatic Microsomes
Investigations were carried out utilising untreated 60 day end 
420 day old animals, and 420 day old animals that had received 
0.25^ safrole diet for 410 days. Results are expressed as 
10 A  Km (mol/l) and 10 ^  Vmax (mol/min/mg protein).
Biphenvl-2-hydroxylase
60 day old, untreated 
420 day old, .untreated 
420 day old, safrole diet
8.1 -  0.9 
14.2 i 0.6*
22.4 - 2.1*
Vmax 
6.9 ± 1.8 
7.7 - 2.1 
19.7 - 1.8*
Bipheny1-4-hydroxylase
Vmax
60 day old, untreated 5.2 - 1.2 3.9-0.7
420 day old, untreated 3.7 - 0.7 5.1- ± 0.9
420 day old, safrole diet 6.1 i 1.3 4.9 ±1.1
Î indicates values significantly different from 60 day old control 
values (P<<r 0.05).
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Figure 8.5 shows a similar pH profile for hiphenyl-Z- 
hydroxylase activity in control groups; the optima was pH 7.6, 
and in safrole-treated animals 7.8.
Biphenyl-4-hydroxylase showed no pH variation due to 
safrole intake or age, an optima of pH 7.4 being recorded.
When liver microsomes were stored as a pellet at -40^ no 
differerK5es in biphenyl-4-hydroxylase from either control or 
treated groups were observed (Figure 8.7). Biphenyl-2-hydroxylase 
in pretreated animals appeared to be more labile than controls 
(Figure 8.8). In the preparation from safrole pretreated animals,
50^ of biphenyl-2-hydroxylase was lost after 8 hours; no activity 
was detectable after 24 hours storage. In control animals 50^ 
of activity was lost after 40 hours storage. It is interesting 
to note that a similar lability of "enhanceable” bipheryl-2- 
hydroxylase has also been shown (Chapter 5).
This lability of bipheny 1-2-hydroxylase was also mirrored 
in heat stability studies carried out at 55°. In microsomes 
from safrole pretreated animals, no bipheny1-2-hydroxy lase activity 
was detectable after 15 minutes, whereas in controls 50^ of acti­
vity was lost after approximately 30 minutes at 55° (Figure 8.9).
In contrast, no differences in bipheny1-4-hydro:y 1ase activity 
between test and control animals were observed (Figure 8.10).
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FIGURE 8.3 
pH Profiles of Biphenyl-2"hvdroxyla3e
Results shown are for (*— — ■) 6o day controls, (e *) 420 day
control and 420 day old animals having received safrole for 410 
days (at— — a ).
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FIGURE 8.6 
pH Profiles of Biphenyl-^-hydiroxylase
Results shown are for (■----,) 60 day control, (#_-- #) 420 day
control and 420 day old animals that had received safrole for 
410 days — _a)
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FIGURE 8.7
Storage Characteristics of Biphenyl-^-hydroiicylase
Results shown are for 420 day old control (e— — #) and 420 day 
old animals that received safrole diet for 410 days (■— — a). 
Material was stored as a microsomal pellet at -40 .
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FIGURE 8.8
Storage Characteristics of Biphewl-2-hyôlroxvlase
Results shorn! are for 420 dgy old control (# •) and 420 day old
animals that received a safrole diet for 410 days (h -a).
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FIGURE 8.9
Heat Sbabilities of Bipherwl~2-hydro3cylase in Wistar Rats
Heat studies were carried out at 55°« Results sho^ vn are for 
( B— t) 60 day control animals, (e— — #) 420 day old control 
animals and 420 day animals receiving 0,25% safrole diet (a a ),
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FIGURE 8.10
Heat Stabilities of Biphenyl-^-hvdroxylase in Wistar Rats
Heat stability studies were carried out at 55°. Results shown 
are for (■— :— ■) 60 day control animals, (#— — o) 420 day old 
control animals, and 420 day old animals receiving 0,25^ safrole
diet ad libitum (>—  a )
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8.2*5 Effects of Cytochrcme P450 Inhibitors
Carbon monoxide, SKF 525A, styrene oxide, meiyrapone and 
NADH were utilised to determine if ary changes in the nature of 
the cytochrome P450 dependency of bipheiyl-2- and -'4-hydroxylase 
had occurred after long-term administration of safrole. Prom 
Table 8*11 it can be seen that the behaviour of bipheny1-2- 
hydroxylase in the 60 and 420 day old control groups and animals 
receiving dietary safrole did not vary significantly with ary 
of the inhibitors employed. Also, as reported previously, NADH 
was utilised as a cofactor substitute for NADPH in each case 
studied.
A similar pattern emerged with bipheny 1-4-hydroxylation 
(Figure 8.I3J , although it was more prone to inhibition by 
compounds such as metyrapone and carbon monoxide.
8.2.0 The Effect of Addition of Carcinogenic Ccanpounds upon Biphenyl-2- 
Hydroxvlase Activity in Vitro
Having established the effects of long-term safrole dosage 
upon the properties of bipheny 1-2-hydroxylase, the final phase of 
this study was designed to determine the enhancement of biphenyl-2- 
hydroxylase activity after preincubation of microsomes with either 
3|4-benzpyrene or safrole.
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Table 8,13 illustrates the effect of in vitro addition of
safrole to microsomes prepared from both the 60 and 420 day old
control groups, and 420 day old animals previously on the safrole
diet. It can be seen that in the 60 dsy and 420 day control
groups , 69^  and 75^ increases in bipheny 1-2-hydroxylase activities
were detected. In animals that had received the safrole diet,
however, no enhancement of biphenyl-2-hydro:>y'lase activity was
detectable. As the animals had been removed from the diet 10 days
prior to experimentation, the lack of enhancement is probably not
solely attributable to the presence of residual safrole. Since
marked inhibition of bipheny 1-4-hydroxylase was observed on its
in vitro addition, it may be argued that relatively high levels
of residual safrole were not present, otherwise further addition
of safrole in vitro would riot have increased the level of inhibition,
A similar pattern was observed upon the addition im vitro of
3,4-benzpyrene (Table 8.I4). Enhancement of biphery 1-2-hydroxylase
activity was observed in both the 60 and 420 day control groups,
but not in animals that had previously received the safrole diet.
8.2.7 Effects of Long-term Safrole Administration upon Cellular Ultrastructure 
Figures 8,15 to 8,17 illustrate the effect of a diet containing 
safrole upon rat hepatic ultrastructure. Control studies are shown 
in Figures 8,18-8,20, The endoplasmic reticulum in animals receiving
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FIGURES 8.13 and 8.I6 
Illustrating the Effects of Long-term Safrole Administration 
upon Rat Hepatic Ultrastructure
Animals were provided with powdered lahoratoiy diet containing 
0*23% (w/w) safrole and water ^  libitum for 410 days.
X 7500
X  24000
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FIGURE 8.17
Illustrating the Effects of Long-term Safrole Administration
upon Rat Hepatic Ultrastructure
Animals were provided with powdered laboratory diet containing 
0,25^ (w/w) self role, and water ^  libitum for 410 days.
X 90^000
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FIGURES 8.18
The Effect of Normal
Rats were permitted normal laboratory diet and water ^  libitum 
for 410 days.
X 18.000
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FIGURE 8.20
The Effect of Normal Laboratory Diet
upon Rat Hepatic Ultrastructure
Rats were permitted normal laboratory diet and water ^  libitum 
for 410 days.
X 30.000
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a safrole diet was aberrant. This organelle was found in tightly 
stacked formations surrounding mitochondria, or closely associated 
with the nucleus. Upon closer investigation, numerous ribosomes 
were seen to be tightly associated with the membrane. This is 
particularly worthy of coiranent because frcsn the work of Rabin et 
al. (1971) one might expect degranulation of the rough endoplasmic 
reticulum.
Safrole itself has been reported to be a weak hepatocarcinogen; 
its potential for degranulation has as yet not been investigated.
It is, however, not outside the realms of possibdlifcy that some 
post-degranulation repair mechanism was operational.
No proliferation of the smooth endoplasmic reticulum was 
observed in any of the preparations studied. No consistent mito­
chondrial lesions were found after safrole pretreatment. Suoboda 
and Higginson (1968) reported in acute experiments with carcinogens 
that the main mitochondrial change observed consisted of swelling 
and accumulation of dense matrix deposits. No such swelling .was 
observed after examination of the safrole-pretreated material.
Glycogen bodies were found, often in close associated with 
membranes of the endoplasmic reticulum; a similar response has 
been reported after ethionine intoxication (Henshaw et al., I963),
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while depletion of glycogen and encroachment upon glycogen spaces 
by smooth endoplasmic reticulum was a conspicuous early finding 
after administration of butter yellow (Porter and Brui, 1959).
8.3 DISCUSSION
From the studies described above, a number of comments can 
be made. Firstly, drug metabolism activity in both the 420 day 
old control and test group was lower than the 60 day old control 
group, animals that received the safrole diet having the lowest 
activities of all. The difference between the two control groups 
is explicable in terms of decreased drug metabolism activity with 
age* described by previous authors and discussed earlier (see 
Chapter 3).
The lower drug metabolism activity in animals that had 
received the safrole diet could partly be explained in similar 
fashion when conparing activities to 60 day control groups, but 
not when compared to 420 day old control groups. It is possible, 
although unlikely, that trace amounts of residual safrole were 
partly inhibiting these enzymes.
When the properties of biphenyl-2-hydroxy 1 ase from animals 
administered the safrole diet were examined and compared to 420 
day old control groups, it was found that parameters such as pH
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Optima, storage characteristics, thermal stability and Km and 
Vmax values were altered by long-term administration of safrole, 
while its dependency upon cytochrome P450 (or cytochrome P448) 
was unchanged. As the characteristics of bipheryl-4-hydroxylation 
were not significantly altered by the treatment, it would appear 
that the above changes in behaviour of bipheny 1-2-hydroxylase 
are relatively specific in nature.
Electron microscopy indicated some modification of cellular 
Ultrastructure, the endoplasmic reticulum being tightly stacked 
after long-term safrole administration.
Although susceptibility to chemical carcinogen attack appears 
to be increased as the age of the animal increased, this was not 
reflected in the ability of Carcinogens to enhance bipheny1-2- 
iydro%ylase activity in vitro.
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9. FINAL DISCUSSION AND CONCLUSIONS
We have examined the effects of a variety of carcinogenic 
and non-carcinogenic conpounds upon biphenyl metabolism jn vivo 
end in vitro. The activity of bipheiy 1-2-hydroxylase was 
enhanced by the addition of carcinogens to the incubation 
medium. A variety of carcinogens with vaiying structures have 
been examined in this way. Results obtained so far with approxi­
mately 60 organic co mpounds suggest that the enhancement of 
biphenyl-2-hydroxylase jji vitro elicited by chemical carcinogens 
may provide an accurate in vitro screen for putative carcinogens^
The assays described above are dependent upon the estimation of 
2-hydroxybiphepyl and 4-hydroxybiphepyl flüoriraetricàlly ; this 
work has also been confirmed utilising (^C) biphenyl, however.
Studies utilising glutathione, timed preincubation studies 
and utilisation of NADH indicated that metabolic activation of 
the carcinogen was required for the carcinogens to enhance 
bipheny1-2-hydroxylase activity, whilst kinetic studies indicated 
changes in both Km and Vmax after such treatment.
Preincubation with carcinogens did not significantly enhance 
other drug metabolism activities, including cytochrome P450 and 
cytochrome P450 reductase, whilst compounds such as metyrapone
2 4 9
which have previously been reported to enhance type II substrate 
metabolism did not enhance biphenyl-2-hydroxylation. This suggests 
that preincubatioh with carcinogens elicits some precise change 
affecting biphenyl-2-hydroxylase activity.
Hamster, mouse and rat hepatic microsomes produced similar
'
enhancement effects, whilst preincubation of carcinogens with 
"microsomal" and "soluble" avodado pear preparations produced 
enhancements solely in the microsomal fraction, suggesting that 
the endoplasmic reticulum was an essential part of the mechanism 
for the enhancement of biphenyl-2-hydro3qylase vitro.
Storage characteristics of "enhanceable" biphenyl-2-hydroxylase 
highlighted the lability of at least part of the mechanism and again 
could be considered indicative of some membrane change, whilst the 
lack of correlation with lipid peroxidation was an indication of 
the specific nature of the carcinogen induced change.
Certain steroids in the rat,but not hamster hepatic tissue 
also produced an enhancement of biphenyl-2-l)ydroxyla8e activity 
in vitro. The nature of the species differences remains to be 
determined, and may involve differences in the metabolic activation 
of these compounds.
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When the investigation was expanded to the Jui vivo situation, 
pretreatment of rat or hamster with carcinogens produced maximal 
increases in biphenyl-2-hydro3ylase after about 4 hours; a return 
to basal levels was observed 8-10 hours after administration, 
Actinonycin D did not affect this early vivo increase in 
activity, indicating that ^  novo synthesis of protein was not 
involved, A second administration of carcinogen after maximal 
bipheny 1-2-hydroxy 1 ase activity had passed produced no response, 
suggesting that the carcinogen mediated change is irreversible.
Some parallels exist between biphenyl-2-hydroDylase enhance­
ment and the degranulation of the endoplasmic reticulum after 
treatment with carcinogens vitro. However, the weight of 
evidence suggests that any relationship is of an indirect nature 
since EDTA, a potent degranulator, did not significantly enhance 
bipheny1-2-hydroxy 1ase activity, nor did electron microscopy 
indicate degranulation 4 hours after administration of carcinogen, 
whereas maximal biphenyl-2-hydroxylase activity was found at this 
time. Finally, the lability to storage which is characteristic of 
enhanceable biphenyl-2-hydroxylase activity was not shown in 
degranulation studies.
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To conclude, the results presented in this thesis cannot 
be used to precisely define the mechanism of carcinogen mediated 
enhancement of bipheny 1-2-hydroxyl ase activity vivo or in 
vitro. It appears that an active carcinogen metabolite induces 
a precise modification in the endoplasmic reticulum, but not in 
cytochrome P450 itself; as a result of this change* bipheryl-2- 
bydroxylase activity is enhanced. Although the mechanism of 
enhancement cannot yet be precisely defined, this does not detract 
•from the potential of the bipheryl-2-hydroxylase system as an 
in vitro "screen" for chemical carcinogens. Further investigations 
are obviously required with a greater range of compounds to establish 
the true potential of this system and to determine the precise 
mechanism for the enhancement of biphenyl-2-hydroxylase activity 
in vitro and its relationship to the initiation of chemical 
carcinogenesis.
It is hoped that further studies will be carried out in an 
attempt to correlate the enhancement of biphenyl-2-hydroxylase 
with phenomena such as alkylation of DNA or electrophilic attack 
upon subcellular organelles. Such a study may be of great value 
in elucidating the mechanism of bipheny1-2-hydroxylase enhancement.
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